{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>.container { width:100% !important; }</style>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from IPython.core.display import display, HTML\n",
    "display(HTML(\"<style>.container { width:100% !important; }</style>\"))\n",
    "import os\n",
    "from functools import reduce\n",
    "from itertools import chain\n",
    "import pandas as pd\n",
    "import json\n",
    "from tqdm import tqdm\n",
    "from pprint import pprint\n",
    "from collections import defaultdict\n",
    "from ema.utils import get_names_synonyms_doid, get_doid_names, clean_text, contains_word\n",
    "import pickle\n",
    "from wikidataintegrator import wdi_helpers, wdi_core\n",
    "import unicodedata\n",
    "pd.set_option('display.max_colwidth', -1)\n",
    "pd.set_option('display.max_rows', 100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "deletable": true,
    "editable": true
   },
   "source": [
    "site uses ridiculous coldfusion shit which Im not going to figure out, so go this url  \n",
    "http://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm\n",
    "\n",
    "change records per page to 9999, hit run search  \n",
    "save page as page.html"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4015"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_html(\"page.html\", header=0, index_col=None)[2]\n",
    "del df['#']\n",
    "df = df.loc[df['Generic Name'].notnull(), :]\n",
    "len(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid</td>\n",
       "      <td>Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy</td>\n",
       "      <td>03/31/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of Stage IIB through Stage IV malignant melanoma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                     Generic Name  \\\n",
       "0  (+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid   \n",
       "1  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "2  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "3  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "4  (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                      \n",
       "\n",
       "                                                                                            Orphan Designation  \\\n",
       "0  Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy   \n",
       "1  Treatment of Stage IIB through Stage IV malignant melanoma                                                    \n",
       "2  Treatment of cholangiocarcinoma                                                                               \n",
       "3  Treatment of pancreatic cancer                                                                                \n",
       "4  Treatment of Fragile X syndrome                                                                               \n",
       "\n",
       "  Designation Date    Designation Status  \n",
       "0  03/31/2003       Designated/Withdrawn  \n",
       "1  02/01/2008       Designated/Withdrawn  \n",
       "2  01/10/2008       Designated/Withdrawn  \n",
       "3  01/10/2008       Designated/Withdrawn  \n",
       "4  10/12/2011       Designated            "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3148"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "products = list(set(list(df['Generic Name'])))\n",
    "len(products)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "# use OPSIN to convert IUPAC names to InChI keys https://bitbucket.org/dan2097/opsin/\n",
    "with open('input.txt', 'w') as f:\n",
    "    for x in products:\n",
    "        f.write(x + '\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "!java -jar ../data/opsin-2.2.0-jar-with-dependencies.jar -ostdinchikey input.txt output.txt 2> output.err"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "prod_inchi = dict()\n",
    "with open('output.txt', 'r') as f:\n",
    "    for count, x in enumerate(f.readlines()):\n",
    "        ikey = x.strip()\n",
    "        if ikey:\n",
    "            prod_inchi[products[count]] = ikey"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "261"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(prod_inchi)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "inchi_wd = wdi_helpers.id_mapper(\"P235\")\n",
    "wd_inchi = {v:k for k,v in inchi_wd.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "158"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# map inchikey back to wdid\n",
    "prod_wdid = {prod: inchi_wd[inchi] for prod,inchi in prod_inchi.items() if inchi in inchi_wd}\n",
    "len(prod_wdid)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "drug_qid_map = pickle.load(open(\"../data/drug_qid_map.pkl\", 'rb'))\n",
    "#drug_qid_map = get_drug_qid_map()\n",
    "wdid_search_name = {x:drug_qid_map[x.lower()] for x in products if x.lower() in drug_qid_map}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1061"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(wdid_search_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "prod_wdid.update(wdid_search_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "df['drug_qid'] = df['Generic Name'].apply(prod_wdid.get)\n",
    "df['inchi'] = df['Generic Name'].apply(prod_inchi.get)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "      <th>drug_qid</th>\n",
       "      <th>inchi</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid</td>\n",
       "      <td>Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy</td>\n",
       "      <td>03/31/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27088744</td>\n",
       "      <td>ZVVCSBSDFGYRCB-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of Stage IIB through Stage IV malignant melanoma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q6589598</td>\n",
       "      <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>(1,3)-ß-D-glucan synthesis inhibitor</td>\n",
       "      <td>Treatment of invasive Aspergillus infections</td>\n",
       "      <td>08/22/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-broethyl) diamidophosphate</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>06/05/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate</td>\n",
       "      <td>Treatment of soft tissue sarcoma</td>\n",
       "      <td>03/09/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>(1OR)-7-amino-12-fluoro-2,10,16-trimethyl-15 oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile</td>\n",
       "      <td>Treatment of anaplastic lymphoma kinase (ALK)-positive or ROS1-positive non-small cell lung cancer</td>\n",
       "      <td>06/23/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>(1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate-</td>\n",
       "      <td>Treatment of vaso-occlusive crisis in patients with sickle cell disease.</td>\n",
       "      <td>02/17/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride</td>\n",
       "      <td>Treatment of T-cell non-Hodgkin's lymphoma</td>\n",
       "      <td>01/29/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride</td>\n",
       "      <td>Treatment of acute lymphoblastic leukemia</td>\n",
       "      <td>08/13/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia</td>\n",
       "      <td>08/10/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>(1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)-pyrimidin-4-ylamino)bicycle[2.2.1]hept-5-ene-2-carboxamide benzoate</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>01/19/2010</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>(1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride, (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride</td>\n",
       "      <td>Treatment of infantile spasms</td>\n",
       "      <td>09/15/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>(2'R,3'S)-2'-hydroxy-N-carboxy-3'-amino-5'-methyl-hexanoic,N-tert-butyl ester, 13 ester 5B-20-epoxy-1B,2a,4a,7B,9a,10a,13a-heptahydroxy-4,10-diacetate-2-benzoate-(1\"S)-7,9-acrolein acetal-11(15-1)-abeotaxane</td>\n",
       "      <td>Treatment of progressive supranuclear palsy</td>\n",
       "      <td>06/23/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>(2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride</td>\n",
       "      <td>Treatment of Rett Syndrome.</td>\n",
       "      <td>05/18/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27252594</td>\n",
       "      <td>FEQOLYDPQKHFTD-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>(2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>11/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258687</td>\n",
       "      <td>VLIUIBXPEDFJRF-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>(2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)</td>\n",
       "      <td>Treatment of systemic sclerosis.</td>\n",
       "      <td>10/14/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258840</td>\n",
       "      <td>RGYQPQARIQKJKH-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>(2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate</td>\n",
       "      <td>Treatment of retinitis pigmentosa</td>\n",
       "      <td>12/02/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenyl acetate 9-cis-retinyl acetate (API)</td>\n",
       "      <td>Treatment of Leber congential amaurosis (LCA) due to inherited mutations in RPE65 (encoding the protein retinal pigment epithelial protein 65) or LRAT (encoding the enzyme lecithin:retinol acyltransferase)genes.</td>\n",
       "      <td>12/02/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid</td>\n",
       "      <td>Treatment of primary biliary cirrhosis</td>\n",
       "      <td>10/31/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>XULSCZPZVQIMFM-IPZQJPLYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid</td>\n",
       "      <td>Treatment of progressive familial intrahepatic cholestatis</td>\n",
       "      <td>10/31/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>XULSCZPZVQIMFM-IPZQJPLYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>(2Z)-2-cyano-3-3hydroxy-N-[4-(trifluoromethly)phenyl]-2-hepten-6-ynamide</td>\n",
       "      <td>Prevention of acute rejection following kidney, heart, and liver transplantation</td>\n",
       "      <td>01/10/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>(3'R,4'S,5'R)-N-[(3R,6S)-6-Carbamoyltetrahydro-2H-pyran-3-yl]-6''-chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indole]-5'-carboxamide mono(4-methylbenzenesulfonate) monohydrate</td>\n",
       "      <td>Treatment of liposarcoma</td>\n",
       "      <td>02/13/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>WPJOGWGXMTUHPW-CIPNXXNHSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide</td>\n",
       "      <td>Treatment of chronic myelogenous leukemia.</td>\n",
       "      <td>03/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>03/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019</td>\n",
       "      <td>Treatment of Glioma</td>\n",
       "      <td>03/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>(3E,5E)-3,5-bis[(4-fluoro-3-nitrophenyl)methylidene]-1-(prop-2-enoyl)azepan-4-0ne</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>04/30/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>(3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one</td>\n",
       "      <td>Treatment of Fragile X Syndrome.</td>\n",
       "      <td>12/09/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>HWSLMIXAPNOWGU-AWEZNQCLSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>(3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate</td>\n",
       "      <td>Treatment of Gaucher disease</td>\n",
       "      <td>09/11/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27274745</td>\n",
       "      <td>YFHRCLAKZBDRHN-MRXNPFEDSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>(3S)-1-azabicylo[2.2.2]oct-3yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate</td>\n",
       "      <td>Treatment of Fabry's disease</td>\n",
       "      <td>08/26/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>(3S)-3-(4-trifluoromethoxybenzyloxy)-6-nitro-2H-3,4-dihydroimidazo[2,1-b]oxazine</td>\n",
       "      <td>Treatment of tuberculosis</td>\n",
       "      <td>07/05/2007</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>(3S)-3-[(2S)-2-({N-[2-tert-butyl)phenyl]carbamoyl}carbonylamino) propanoylamino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy) pentanoci acid</td>\n",
       "      <td>Treatment of patients undergoing solid organ transplantation.</td>\n",
       "      <td>08/19/2003</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>(3S)-3-[({1-(2-Chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3yl}amino)carbonyl]amino-3-(4-methylphenyl)propanoic acid monosodium salt</td>\n",
       "      <td>For mobilization of hematopoietic stem cells</td>\n",
       "      <td>04/25/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>QUXHOILDLMWREY-FYZYNONXSA-M</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (2R,3R)-2,3-dihydroxybutanedioate</td>\n",
       "      <td>Treatment of pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (JIA) ILAR categories excluding systemic JIA</td>\n",
       "      <td>09/18/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>WQDBPGWQDBPVQZ-NBCXFSEXSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride</td>\n",
       "      <td>Treatment of alagille syndrome</td>\n",
       "      <td>09/04/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride</td>\n",
       "      <td>Treatment of primary sclerosing cholangitis</td>\n",
       "      <td>09/04/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride</td>\n",
       "      <td>Treatment of primary biliary cirrhosis</td>\n",
       "      <td>09/04/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>(4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime</td>\n",
       "      <td>Treatment malignant glioma</td>\n",
       "      <td>11/29/2002</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride</td>\n",
       "      <td>Treatment of erythromelalgia</td>\n",
       "      <td>01/30/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27268497</td>\n",
       "      <td>HEPUBAGOKRIZEO-PPPUBMIESA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>(5R)-5-(4-{[2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride</td>\n",
       "      <td>Treatment of trigeminal neuralgia</td>\n",
       "      <td>07/24/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>(5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>04/14/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>XNLCCACCEOWFNQ-OSPRVTPDSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>(6-maleimidocaproyl)hydrazone of doxorubicin</td>\n",
       "      <td>Treatment of soft tissue sarcoma</td>\n",
       "      <td>06/29/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>(6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine)</td>\n",
       "      <td>Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics</td>\n",
       "      <td>02/21/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>(6aR, 10aR)-3-(1’,1’-dimethylheptyl)-delta8-tetrahydro-cannabinol-9-carboxylic acid</td>\n",
       "      <td>Treatment of cystic fibrosis.</td>\n",
       "      <td>10/13/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>(6aR, 10aR)-3-(1â¿¿,1â¿¿-dimethylheptyl)-Î¿8-tetrahydro-cannabinol-9-carboxylic acid</td>\n",
       "      <td>Treatment of systemic sclerosis</td>\n",
       "      <td>06/10/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>(6R,S)5,10-methylene-tetrahydrofolic acid</td>\n",
       "      <td>For use in combination with 5-fluorouracil for the treatment of patients with pancreatic cancer</td>\n",
       "      <td>08/13/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q26995704</td>\n",
       "      <td>QYNUQALWYRSVHF-OLZOCXBDSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>(9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid</td>\n",
       "      <td>Prevention of post-operative complications of aortic anuerysm surgical repair</td>\n",
       "      <td>12/08/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>(E)-N’-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate</td>\n",
       "      <td>Treatment of Ewing's sarcoma.</td>\n",
       "      <td>01/12/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>JIPBQMGGMHCGBW-CWUUNJJBSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3965</th>\n",
       "      <td>Venetoclax</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>08/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3966</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>09/20/2012</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3967</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>02/04/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3968</th>\n",
       "      <td>verteporfin</td>\n",
       "      <td>Treatment of chronic or recurrent central serous chorioretinopathy</td>\n",
       "      <td>03/09/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q782318</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3969</th>\n",
       "      <td>Vibrio alginolyticus collagenase</td>\n",
       "      <td>Treatment of advanced Dupuytren's disease (Dupuytren's contracture)</td>\n",
       "      <td>10/12/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3970</th>\n",
       "      <td>vibriolysin</td>\n",
       "      <td>Debridement of severe, deep dermal burns in hospitalized patients</td>\n",
       "      <td>06/16/2006</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3971</th>\n",
       "      <td>vigabatrin</td>\n",
       "      <td>Treatment of infantile spasms.</td>\n",
       "      <td>06/12/2000</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q421663</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3972</th>\n",
       "      <td>viloxazine HCL</td>\n",
       "      <td>Treatment of cataplexy and narcolepsy</td>\n",
       "      <td>06/11/1984</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3973</th>\n",
       "      <td>vinCRIStine sulfate LIPOSOME injection</td>\n",
       "      <td>Treatment of acute lymphoblastic leukemia</td>\n",
       "      <td>01/08/2007</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3974</th>\n",
       "      <td>vincristine sulfate liposomes</td>\n",
       "      <td>Treatment of metastatic uveal melanoma.</td>\n",
       "      <td>06/24/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3975</th>\n",
       "      <td>vintafolide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>12/16/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7932801</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3976</th>\n",
       "      <td>Virulizin</td>\n",
       "      <td>Treatment of pancreatic cancer.</td>\n",
       "      <td>02/01/2001</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3977</th>\n",
       "      <td>vitamin A palmitate</td>\n",
       "      <td>Prevention of bronchopulmonary dysplasia.</td>\n",
       "      <td>07/14/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3978</th>\n",
       "      <td>volanesorsen sodium, apolipotrotein C-III antisense oligonucleotide</td>\n",
       "      <td>treatment of familial chylomicronemia syndrome</td>\n",
       "      <td>06/23/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3979</th>\n",
       "      <td>volasertib</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>04/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7939986</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3980</th>\n",
       "      <td>von Willebrand Factor Human Concentrate</td>\n",
       "      <td>Treatment of Von Willebrand Disease</td>\n",
       "      <td>05/29/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3981</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>06/12/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3982</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of advanced melanoma (stages IIb, IIc, III, and IV)</td>\n",
       "      <td>10/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3983</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of mesothelioma</td>\n",
       "      <td>03/17/2004</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3984</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of T-cell non-Hodgkin's lymphoma</td>\n",
       "      <td>03/16/2004</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3985</th>\n",
       "      <td>vosaroxin</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>10/28/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q18395775</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3986</th>\n",
       "      <td>Water-miscible vitamin A palmitate</td>\n",
       "      <td>Prevention of bronchopulmonary dysplasia.</td>\n",
       "      <td>03/26/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3987</th>\n",
       "      <td>Wharton's jelly mesenchymal stem cells</td>\n",
       "      <td>Treatment of graft-versus-host disease</td>\n",
       "      <td>09/27/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3988</th>\n",
       "      <td>Xenogeneic hepatocytes</td>\n",
       "      <td>Treatment of severe liver failure.</td>\n",
       "      <td>11/27/1998</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3989</th>\n",
       "      <td>xenon gas</td>\n",
       "      <td>Treatment of hypoxic ischemic encephalopathy</td>\n",
       "      <td>12/03/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3990</th>\n",
       "      <td>xenon gas</td>\n",
       "      <td>To improve neurological outcome in hospitalized cardiac arrest patients.</td>\n",
       "      <td>05/18/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3991</th>\n",
       "      <td>Yersinia pestis plague recombinant antigen (rF1V; F1 capsular protein fused to V antigen; E. coli) vaccine with aluminum hydroxide</td>\n",
       "      <td>Prevention of plague (Yersinia pestis)</td>\n",
       "      <td>11/30/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3992</th>\n",
       "      <td>Yttrium (90Y) antiferritin polyclonal antibodies</td>\n",
       "      <td>Treatment of Hodgkin's disease.</td>\n",
       "      <td>09/18/2006</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3993</th>\n",
       "      <td>Yttrium(90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10</td>\n",
       "      <td>Treatment of soft tissue sarcoma</td>\n",
       "      <td>12/03/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3994</th>\n",
       "      <td>Yttrium-90 radiolabeled humanized monoclonal anti-carcinoembroyonic antigen IgG antibody</td>\n",
       "      <td>Treatment of ovarian carcinoma.</td>\n",
       "      <td>08/03/1999</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3995</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>06/28/1988</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3996</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>12/09/1986</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3997</th>\n",
       "      <td>zidovudine</td>\n",
       "      <td>Treatment of AIDS</td>\n",
       "      <td>07/17/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q198504</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3998</th>\n",
       "      <td>Zinc acetate</td>\n",
       "      <td>Treatment of Wilson's disease.</td>\n",
       "      <td>11/06/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q204639</td>\n",
       "      <td>DJWUNCQRNNEAKC-UHFFFAOYSA-L</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3999</th>\n",
       "      <td>Zoledronate</td>\n",
       "      <td>Treatment of tumor induced hypercalcemia.</td>\n",
       "      <td>08/18/2000</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q218507</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4000</th>\n",
       "      <td>zoledronate D,L-lysine monohydrate (ZLM)</td>\n",
       "      <td>Treatment of complex regional pain syndrome (CRPS)</td>\n",
       "      <td>04/15/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4001</th>\n",
       "      <td>zoledronic acid</td>\n",
       "      <td>Treatment of complex regional pain syndrome (CRPS).</td>\n",
       "      <td>05/06/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q218507</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4002</th>\n",
       "      <td>Zosuquidar trihydrochloride</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>12/15/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27269191</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4003</th>\n",
       "      <td>[131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide</td>\n",
       "      <td>Treatment of metastatic melanoma, stages IIB, IIC, III and IV</td>\n",
       "      <td>09/17/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4004</th>\n",
       "      <td>[5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride</td>\n",
       "      <td>Treatment of Amyotrophic Lateral Sclerosis</td>\n",
       "      <td>11/04/2003</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4005</th>\n",
       "      <td>[5-(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride salt</td>\n",
       "      <td>Treatment of pigmented villonodular synovitis/giant cell tumor of the tendon sheath</td>\n",
       "      <td>02/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>CJLUYLRKLUYCEK-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4006</th>\n",
       "      <td>[5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>10/20/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>IJDQETGUEUJVTB-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4007</th>\n",
       "      <td>[a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr</td>\n",
       "      <td>Treatment of glioblastoma multiforme</td>\n",
       "      <td>05/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4008</th>\n",
       "      <td>[AC3-yCD2(V)] and Flucytosine (5-FC XR)</td>\n",
       "      <td>Treatment of glioblastoma multiforme</td>\n",
       "      <td>01/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4009</th>\n",
       "      <td>[F18] florilglutamic acid</td>\n",
       "      <td>For the diagnosis of hepatocellular carcinoma</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4010</th>\n",
       "      <td>[F18] florilglutamic acid</td>\n",
       "      <td>Diagnostic for the management of hepatocellular carcinoma</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4011</th>\n",
       "      <td>[Lu-177]-DOTA-Tyr3-Octreotate</td>\n",
       "      <td>Treatment of gastro-entero-pancreatic neuroendocrine tumors</td>\n",
       "      <td>01/12/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4012</th>\n",
       "      <td>[met5]-enkephalin</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/24/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4013</th>\n",
       "      <td>[Î±â¿¿N-(2â¿¿succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr</td>\n",
       "      <td>Treatment of breast cancer patients with brain metastases</td>\n",
       "      <td>04/15/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4014</th>\n",
       "      <td>{2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl](3H-benzo[f]azepin-4-yl)}-N,N-dipropycarboxamide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>04/10/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4015 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                       Generic Name  \\\n",
       "0     (+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid                                                                                                                                                  \n",
       "1     (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                                                                                                                                                                    \n",
       "2     (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                                                                                                                                                                    \n",
       "3     (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                                                                                                                                                                    \n",
       "4     (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                                                                                                                                                                     \n",
       "5     (1,3)-ß-D-glucan synthesis inhibitor                                                                                                                                                                                                                            \n",
       "6     (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-broethyl) diamidophosphate                                                                                                                                                                                \n",
       "7     (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate                                                                                                                                                                              \n",
       "8     (1OR)-7-amino-12-fluoro-2,10,16-trimethyl-15 oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile                                                                                                      \n",
       "9     (1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate-                                                                                                                                                                                         \n",
       "10    (1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride                                                                                                                                                                                  \n",
       "11    (1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride                                                                                                                                                                                  \n",
       "12    (1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride                                                                                                                                                                                  \n",
       "13    (1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)-pyrimidin-4-ylamino)bicycle[2.2.1]hept-5-ene-2-carboxamide benzoate                                                                                                            \n",
       "14    (1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride, (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride                                                                                                        \n",
       "15    (2'R,3'S)-2'-hydroxy-N-carboxy-3'-amino-5'-methyl-hexanoic,N-tert-butyl ester, 13 ester 5B-20-epoxy-1B,2a,4a,7B,9a,10a,13a-heptahydroxy-4,10-diacetate-2-benzoate-(1\"S)-7,9-acrolein acetal-11(15-1)-abeotaxane                                                 \n",
       "16    (2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride                                                                                                                                                                                         \n",
       "17    (2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)                                                                                                                                                                    \n",
       "18    (2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)                                                                                                                                                         \n",
       "19    (2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate                                                                                                                                                           \n",
       "20    (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenyl acetate 9-cis-retinyl acetate (API)                                                                                                                                         \n",
       "21    (2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid                                                                            \n",
       "22    (2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid                                                                            \n",
       "23    (2Z)-2-cyano-3-3hydroxy-N-[4-(trifluoromethly)phenyl]-2-hepten-6-ynamide                                                                                                                                                                                        \n",
       "24    (3'R,4'S,5'R)-N-[(3R,6S)-6-Carbamoyltetrahydro-2H-pyran-3-yl]-6''-chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indole]-5'-carboxamide mono(4-methylbenzenesulfonate) monohydrate   \n",
       "25    (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide                                                                                                                                                                  \n",
       "26    (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide                                                                                                                                                                  \n",
       "27    (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019                                                                                                                                                        \n",
       "28    (3E,5E)-3,5-bis[(4-fluoro-3-nitrophenyl)methylidene]-1-(prop-2-enoyl)azepan-4-0ne                                                                                                                                                                               \n",
       "29    (3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one                                                                                                                                                                     \n",
       "30    (3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate                                                                                                                                                                  \n",
       "31    (3S)-1-azabicylo[2.2.2]oct-3yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate                                                                                                                                                                    \n",
       "32    (3S)-3-(4-trifluoromethoxybenzyloxy)-6-nitro-2H-3,4-dihydroimidazo[2,1-b]oxazine                                                                                                                                                                                \n",
       "33    (3S)-3-[(2S)-2-({N-[2-tert-butyl)phenyl]carbamoyl}carbonylamino) propanoylamino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy) pentanoci acid                                                                                                                            \n",
       "34    (3S)-3-[({1-(2-Chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3yl}amino)carbonyl]amino-3-(4-methylphenyl)propanoic acid monosodium salt                                                                                                              \n",
       "35    (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (2R,3R)-2,3-dihydroxybutanedioate                                                                                                             \n",
       "36    (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride                                                                         \n",
       "37    (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride                                                                         \n",
       "38    (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride                                                                         \n",
       "39    (4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime                                                                                                              \n",
       "40    (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride                                                                                                                                                                                     \n",
       "41    (5R)-5-(4-{[2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride                                                                                                                                                                                      \n",
       "42    (5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide                                                                                                                   \n",
       "43    (6-maleimidocaproyl)hydrazone of doxorubicin                                                                                                                                                                                                                    \n",
       "44    (6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine)                                                                                                                                                         \n",
       "45    (6aR, 10aR)-3-(1’,1’-dimethylheptyl)-delta8-tetrahydro-cannabinol-9-carboxylic acid                                                                                                                                                                             \n",
       "46    (6aR, 10aR)-3-(1â¿¿,1â¿¿-dimethylheptyl)-Î¿8-tetrahydro-cannabinol-9-carboxylic acid                                                                                                                                                                            \n",
       "47    (6R,S)5,10-methylene-tetrahydrofolic acid                                                                                                                                                                                                                       \n",
       "48    (9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid                                                                                                                                                    \n",
       "49    (E)-N’-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate                                                                                                                                                 \n",
       "...                                                                                                               ...                                                                                                                                                 \n",
       "3965  Venetoclax                                                                                                                                                                                                                                                      \n",
       "3966  venetoclax                                                                                                                                                                                                                                                      \n",
       "3967  venetoclax                                                                                                                                                                                                                                                      \n",
       "3968  verteporfin                                                                                                                                                                                                                                                     \n",
       "3969  Vibrio alginolyticus collagenase                                                                                                                                                                                                                                \n",
       "3970  vibriolysin                                                                                                                                                                                                                                                     \n",
       "3971  vigabatrin                                                                                                                                                                                                                                                      \n",
       "3972  viloxazine HCL                                                                                                                                                                                                                                                  \n",
       "3973  vinCRIStine sulfate LIPOSOME injection                                                                                                                                                                                                                          \n",
       "3974  vincristine sulfate liposomes                                                                                                                                                                                                                                   \n",
       "3975  vintafolide                                                                                                                                                                                                                                                     \n",
       "3976  Virulizin                                                                                                                                                                                                                                                       \n",
       "3977  vitamin A palmitate                                                                                                                                                                                                                                             \n",
       "3978  volanesorsen sodium, apolipotrotein C-III antisense oligonucleotide                                                                                                                                                                                             \n",
       "3979  volasertib                                                                                                                                                                                                                                                      \n",
       "3980  von Willebrand Factor Human Concentrate                                                                                                                                                                                                                         \n",
       "3981  vorinostat                                                                                                                                                                                                                                                      \n",
       "3982  vorinostat                                                                                                                                                                                                                                                      \n",
       "3983  vorinostat                                                                                                                                                                                                                                                      \n",
       "3984  vorinostat                                                                                                                                                                                                                                                      \n",
       "3985  vosaroxin                                                                                                                                                                                                                                                       \n",
       "3986  Water-miscible vitamin A palmitate                                                                                                                                                                                                                              \n",
       "3987  Wharton's jelly mesenchymal stem cells                                                                                                                                                                                                                          \n",
       "3988  Xenogeneic hepatocytes                                                                                                                                                                                                                                          \n",
       "3989  xenon gas                                                                                                                                                                                                                                                       \n",
       "3990  xenon gas                                                                                                                                                                                                                                                       \n",
       "3991  Yersinia pestis plague recombinant antigen (rF1V; F1 capsular protein fused to V antigen; E. coli) vaccine with aluminum hydroxide                                                                                                                              \n",
       "3992  Yttrium (90Y) antiferritin polyclonal antibodies                                                                                                                                                                                                                \n",
       "3993  Yttrium(90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10                                                                                                                                                                      \n",
       "3994  Yttrium-90 radiolabeled humanized monoclonal anti-carcinoembroyonic antigen IgG antibody                                                                                                                                                                        \n",
       "3995  Zalcitabine                                                                                                                                                                                                                                                     \n",
       "3996  Zalcitabine                                                                                                                                                                                                                                                     \n",
       "3997  zidovudine                                                                                                                                                                                                                                                      \n",
       "3998  Zinc acetate                                                                                                                                                                                                                                                    \n",
       "3999  Zoledronate                                                                                                                                                                                                                                                     \n",
       "4000  zoledronate D,L-lysine monohydrate (ZLM)                                                                                                                                                                                                                        \n",
       "4001  zoledronic acid                                                                                                                                                                                                                                                 \n",
       "4002  Zosuquidar trihydrochloride                                                                                                                                                                                                                                     \n",
       "4003  [131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide                                                                                                                                                                               \n",
       "4004  [5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride                                                                                                                                                                      \n",
       "4005  [5-(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride salt                                                                                                                                 \n",
       "4006  [5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone                                                                                                                                                                      \n",
       "4007  [a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr                                                                                  \n",
       "4008  [AC3-yCD2(V)] and Flucytosine (5-FC XR)                                                                                                                                                                                                                         \n",
       "4009  [F18] florilglutamic acid                                                                                                                                                                                                                                       \n",
       "4010  [F18] florilglutamic acid                                                                                                                                                                                                                                       \n",
       "4011  [Lu-177]-DOTA-Tyr3-Octreotate                                                                                                                                                                                                                                   \n",
       "4012  [met5]-enkephalin                                                                                                                                                                                                                                               \n",
       "4013  [Î±â¿¿N-(2â¿¿succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr                                                                               \n",
       "4014  {2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl](3H-benzo[f]azepin-4-yl)}-N,N-dipropycarboxamide                                                                                                                                                                     \n",
       "\n",
       "                                                                                                                                                                                                       Orphan Designation  \\\n",
       "0     Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy                                                                                                           \n",
       "1     Treatment of Stage IIB through Stage IV malignant melanoma                                                                                                                                                            \n",
       "2     Treatment of cholangiocarcinoma                                                                                                                                                                                       \n",
       "3     Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "4     Treatment of Fragile X syndrome                                                                                                                                                                                       \n",
       "5     Treatment of invasive Aspergillus infections                                                                                                                                                                          \n",
       "6     Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "7     Treatment of soft tissue sarcoma                                                                                                                                                                                      \n",
       "8     Treatment of anaplastic lymphoma kinase (ALK)-positive or ROS1-positive non-small cell lung cancer                                                                                                                    \n",
       "9     Treatment of vaso-occlusive crisis in patients with sickle cell disease.                                                                                                                                              \n",
       "10    Treatment of T-cell non-Hodgkin's lymphoma                                                                                                                                                                            \n",
       "11    Treatment of acute lymphoblastic leukemia                                                                                                                                                                             \n",
       "12    Treatment of chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia                                                                    \n",
       "13    Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "14    Treatment of infantile spasms                                                                                                                                                                                         \n",
       "15    Treatment of progressive supranuclear palsy                                                                                                                                                                           \n",
       "16    Treatment of Rett Syndrome.                                                                                                                                                                                           \n",
       "17    Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "18    Treatment of systemic sclerosis.                                                                                                                                                                                      \n",
       "19    Treatment of retinitis pigmentosa                                                                                                                                                                                     \n",
       "20    Treatment of Leber congential amaurosis (LCA) due to inherited mutations in RPE65 (encoding the protein retinal pigment epithelial protein 65) or LRAT (encoding the enzyme lecithin:retinol acyltransferase)genes.   \n",
       "21    Treatment of primary biliary cirrhosis                                                                                                                                                                                \n",
       "22    Treatment of progressive familial intrahepatic cholestatis                                                                                                                                                            \n",
       "23    Prevention of acute rejection following kidney, heart, and liver transplantation                                                                                                                                      \n",
       "24    Treatment of liposarcoma                                                                                                                                                                                              \n",
       "25    Treatment of chronic myelogenous leukemia.                                                                                                                                                                            \n",
       "26    Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "27    Treatment of Glioma                                                                                                                                                                                                   \n",
       "28    Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "29    Treatment of Fragile X Syndrome.                                                                                                                                                                                      \n",
       "30    Treatment of Gaucher disease                                                                                                                                                                                          \n",
       "31    Treatment of Fabry's disease                                                                                                                                                                                          \n",
       "32    Treatment of tuberculosis                                                                                                                                                                                             \n",
       "33    Treatment of patients undergoing solid organ transplantation.                                                                                                                                                         \n",
       "34    For mobilization of hematopoietic stem cells                                                                                                                                                                          \n",
       "35    Treatment of pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (JIA) ILAR categories excluding systemic JIA                                                                                           \n",
       "36    Treatment of alagille syndrome                                                                                                                                                                                        \n",
       "37    Treatment of primary sclerosing cholangitis                                                                                                                                                                           \n",
       "38    Treatment of primary biliary cirrhosis                                                                                                                                                                                \n",
       "39    Treatment malignant glioma                                                                                                                                                                                            \n",
       "40    Treatment of erythromelalgia                                                                                                                                                                                          \n",
       "41    Treatment of trigeminal neuralgia                                                                                                                                                                                     \n",
       "42    Treatment of ovarian cancer                                                                                                                                                                                           \n",
       "43    Treatment of soft tissue sarcoma                                                                                                                                                                                      \n",
       "44    Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics                                                                                    \n",
       "45    Treatment of cystic fibrosis.                                                                                                                                                                                         \n",
       "46    Treatment of systemic sclerosis                                                                                                                                                                                       \n",
       "47    For use in combination with 5-fluorouracil for the treatment of patients with pancreatic cancer                                                                                                                       \n",
       "48    Prevention of post-operative complications of aortic anuerysm surgical repair                                                                                                                                         \n",
       "49    Treatment of Ewing's sarcoma.                                                                                                                                                                                         \n",
       "...                             ...                                                                                                                                                                                         \n",
       "3965  Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "3966  Treatment of chronic lymphocytic leukemia                                                                                                                                                                             \n",
       "3967  Treatment of acute myeloid leukemia.                                                                                                                                                                                  \n",
       "3968  Treatment of chronic or recurrent central serous chorioretinopathy                                                                                                                                                    \n",
       "3969  Treatment of advanced Dupuytren's disease (Dupuytren's contracture)                                                                                                                                                   \n",
       "3970  Debridement of severe, deep dermal burns in hospitalized patients                                                                                                                                                     \n",
       "3971  Treatment of infantile spasms.                                                                                                                                                                                        \n",
       "3972  Treatment of cataplexy and narcolepsy                                                                                                                                                                                 \n",
       "3973  Treatment of acute lymphoblastic leukemia                                                                                                                                                                             \n",
       "3974  Treatment of metastatic uveal melanoma.                                                                                                                                                                               \n",
       "3975  Treatment of ovarian cancer                                                                                                                                                                                           \n",
       "3976  Treatment of pancreatic cancer.                                                                                                                                                                                       \n",
       "3977  Prevention of bronchopulmonary dysplasia.                                                                                                                                                                             \n",
       "3978  treatment of familial chylomicronemia syndrome                                                                                                                                                                        \n",
       "3979  Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "3980  Treatment of Von Willebrand Disease                                                                                                                                                                                   \n",
       "3981  Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "3982  Treatment of advanced melanoma (stages IIb, IIc, III, and IV)                                                                                                                                                         \n",
       "3983  Treatment of mesothelioma                                                                                                                                                                                             \n",
       "3984  Treatment of T-cell non-Hodgkin's lymphoma                                                                                                                                                                            \n",
       "3985  Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "3986  Prevention of bronchopulmonary dysplasia.                                                                                                                                                                             \n",
       "3987  Treatment of graft-versus-host disease                                                                                                                                                                                \n",
       "3988  Treatment of severe liver failure.                                                                                                                                                                                    \n",
       "3989  Treatment of hypoxic ischemic encephalopathy                                                                                                                                                                          \n",
       "3990  To improve neurological outcome in hospitalized cardiac arrest patients.                                                                                                                                              \n",
       "3991  Prevention of plague (Yersinia pestis)                                                                                                                                                                                \n",
       "3992  Treatment of Hodgkin's disease.                                                                                                                                                                                       \n",
       "3993  Treatment of soft tissue sarcoma                                                                                                                                                                                      \n",
       "3994  Treatment of ovarian carcinoma.                                                                                                                                                                                       \n",
       "3995  Treatment of AIDS.                                                                                                                                                                                                    \n",
       "3996  Treatment of AIDS.                                                                                                                                                                                                    \n",
       "3997  Treatment of AIDS                                                                                                                                                                                                     \n",
       "3998  Treatment of Wilson's disease.                                                                                                                                                                                        \n",
       "3999  Treatment of tumor induced hypercalcemia.                                                                                                                                                                             \n",
       "4000  Treatment of complex regional pain syndrome (CRPS)                                                                                                                                                                    \n",
       "4001  Treatment of complex regional pain syndrome (CRPS).                                                                                                                                                                   \n",
       "4002  Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "4003  Treatment of metastatic melanoma, stages IIB, IIC, III and IV                                                                                                                                                         \n",
       "4004  Treatment of Amyotrophic Lateral Sclerosis                                                                                                                                                                            \n",
       "4005  Treatment of pigmented villonodular synovitis/giant cell tumor of the tendon sheath                                                                                                                                   \n",
       "4006  Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "4007  Treatment of glioblastoma multiforme                                                                                                                                                                                  \n",
       "4008  Treatment of glioblastoma multiforme                                                                                                                                                                                  \n",
       "4009  For the diagnosis of hepatocellular carcinoma                                                                                                                                                                         \n",
       "4010  Diagnostic for the management of hepatocellular carcinoma                                                                                                                                                             \n",
       "4011  Treatment of gastro-entero-pancreatic neuroendocrine tumors                                                                                                                                                           \n",
       "4012  Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "4013  Treatment of breast cancer patients with brain metastases                                                                                                                                                             \n",
       "4014  Treatment of ovarian cancer                                                                                                                                                                                           \n",
       "\n",
       "     Designation Date    Designation Status   drug_qid  \\\n",
       "0     03/31/2003       Designated/Withdrawn  Q27088744   \n",
       "1     02/01/2008       Designated/Withdrawn  None        \n",
       "2     01/10/2008       Designated/Withdrawn  None        \n",
       "3     01/10/2008       Designated/Withdrawn  None        \n",
       "4     10/12/2011       Designated            Q6589598    \n",
       "5     08/22/2016       Designated            None        \n",
       "6     06/05/2013       Designated            None        \n",
       "7     03/09/2012       Designated            None        \n",
       "8     06/23/2015       Designated            None        \n",
       "9     02/17/2009       Designated            None        \n",
       "10    01/29/2004       Designated            None        \n",
       "11    08/13/2004       Designated            None        \n",
       "12    08/10/2004       Designated            None        \n",
       "13    01/19/2010       Designated/Withdrawn  None        \n",
       "14    09/15/2010       Designated            None        \n",
       "15    06/23/2014       Designated            None        \n",
       "16    05/18/2016       Designated            Q27252594   \n",
       "17    11/29/2016       Designated            Q27258687   \n",
       "18    10/14/2015       Designated            Q27258840   \n",
       "19    12/02/2010       Designated            None        \n",
       "20    12/02/2010       Designated            None        \n",
       "21    10/31/2012       Designated            None        \n",
       "22    10/31/2012       Designated            None        \n",
       "23    01/10/2005       Designated            None        \n",
       "24    02/13/2017       Designated            None        \n",
       "25    03/18/2011       Designated            None        \n",
       "26    03/18/2011       Designated            None        \n",
       "27    03/18/2011       Designated            None        \n",
       "28    04/30/2014       Designated            None        \n",
       "29    12/09/2015       Designated            None        \n",
       "30    09/11/2014       Designated            Q27274745   \n",
       "31    08/26/2014       Designated            None        \n",
       "32    07/05/2007       Designated            None        \n",
       "33    08/19/2003       Designated            None        \n",
       "34    04/25/2016       Designated            None        \n",
       "35    09/18/2015       Designated            None        \n",
       "36    09/04/2013       Designated            None        \n",
       "37    09/04/2013       Designated            None        \n",
       "38    09/04/2013       Designated            None        \n",
       "39    11/29/2002       Designated/Withdrawn  None        \n",
       "40    01/30/2017       Designated            Q27268497   \n",
       "41    07/24/2013       Designated            None        \n",
       "42    04/14/2016       Designated            None        \n",
       "43    06/29/2011       Designated            None        \n",
       "44    02/21/2014       Designated            None        \n",
       "45    10/13/2015       Designated            None        \n",
       "46    06/10/2015       Designated            None        \n",
       "47    08/13/2004       Designated            Q26995704   \n",
       "48    12/08/2004       Designated            None        \n",
       "49    01/12/2017       Designated            None        \n",
       "...          ...              ...             ...        \n",
       "3965  08/29/2016       Designated            Q23671272   \n",
       "3966  09/20/2012       Designated/Approved   Q23671272   \n",
       "3967  02/04/2016       Designated            Q23671272   \n",
       "3968  03/09/2012       Designated            Q782318     \n",
       "3969  10/12/2016       Designated            None        \n",
       "3970  06/16/2006       Designated            None        \n",
       "3971  06/12/2000       Designated/Approved   Q421663     \n",
       "3972  06/11/1984       Designated/Withdrawn  None        \n",
       "3973  01/08/2007       Designated/Approved   None        \n",
       "3974  06/24/2008       Designated            None        \n",
       "3975  12/16/2013       Designated            Q7932801    \n",
       "3976  02/01/2001       Designated            None        \n",
       "3977  07/14/2015       Designated            None        \n",
       "3978  06/23/2015       Designated            None        \n",
       "3979  04/14/2014       Designated            Q7939986    \n",
       "3980  05/29/2014       Designated            None        \n",
       "3981  06/12/2003       Designated/Withdrawn  Q905901     \n",
       "3982  10/13/2016       Designated            Q905901     \n",
       "3983  03/17/2004       Designated/Withdrawn  Q905901     \n",
       "3984  03/16/2004       Designated/Approved   Q905901     \n",
       "3985  10/28/2009       Designated            Q18395775   \n",
       "3986  03/26/2010       Designated            None        \n",
       "3987  09/27/2016       Designated            None        \n",
       "3988  11/27/1998       Designated            None        \n",
       "3989  12/03/2014       Designated            None        \n",
       "3990  05/18/2015       Designated            None        \n",
       "3991  11/30/2016       Designated            None        \n",
       "3992  09/18/2006       Designated            None        \n",
       "3993  12/03/2012       Designated            None        \n",
       "3994  08/03/1999       Designated            None        \n",
       "3995  06/28/1988       Designated/Approved   Q2344582    \n",
       "3996  12/09/1986       Designated            Q2344582    \n",
       "3997  07/17/1985       Designated/Approved   Q198504     \n",
       "3998  11/06/1985       Designated/Approved   Q204639     \n",
       "3999  08/18/2000       Designated/Approved   Q218507     \n",
       "4000  04/15/2015       Designated            None        \n",
       "4001  05/06/2013       Designated            Q218507     \n",
       "4002  12/15/2005       Designated            Q27269191   \n",
       "4003  09/17/2008       Designated            None        \n",
       "4004  11/04/2003       Designated            None        \n",
       "4005  02/14/2014       Designated            None        \n",
       "4006  10/20/2014       Designated            None        \n",
       "4007  05/14/2014       Designated            None        \n",
       "4008  01/12/2011       Designated            None        \n",
       "4009  07/13/2016       Designated            None        \n",
       "4010  07/13/2016       Designated            None        \n",
       "4011  01/12/2009       Designated            None        \n",
       "4012  01/24/2013       Designated            None        \n",
       "4013  04/15/2015       Designated            None        \n",
       "4014  04/10/2014       Designated            None        \n",
       "\n",
       "                            inchi  \n",
       "0     ZVVCSBSDFGYRCB-UHFFFAOYSA-N  \n",
       "1     None                         \n",
       "2     None                         \n",
       "3     None                         \n",
       "4     ZFPZEYHRWGMJCV-ZHALLVOQSA-N  \n",
       "5     None                         \n",
       "6     None                         \n",
       "7     None                         \n",
       "8     None                         \n",
       "9     None                         \n",
       "10    None                         \n",
       "11    None                         \n",
       "12    None                         \n",
       "13    None                         \n",
       "14    None                         \n",
       "15    None                         \n",
       "16    FEQOLYDPQKHFTD-UHFFFAOYSA-N  \n",
       "17    VLIUIBXPEDFJRF-UHFFFAOYSA-N  \n",
       "18    RGYQPQARIQKJKH-UHFFFAOYSA-N  \n",
       "19    None                         \n",
       "20    None                         \n",
       "21    XULSCZPZVQIMFM-IPZQJPLYSA-N  \n",
       "22    XULSCZPZVQIMFM-IPZQJPLYSA-N  \n",
       "23    None                         \n",
       "24    WPJOGWGXMTUHPW-CIPNXXNHSA-N  \n",
       "25    None                         \n",
       "26    None                         \n",
       "27    None                         \n",
       "28    None                         \n",
       "29    HWSLMIXAPNOWGU-AWEZNQCLSA-N  \n",
       "30    YFHRCLAKZBDRHN-MRXNPFEDSA-N  \n",
       "31    None                         \n",
       "32    None                         \n",
       "33    None                         \n",
       "34    QUXHOILDLMWREY-FYZYNONXSA-M  \n",
       "35    WQDBPGWQDBPVQZ-NBCXFSEXSA-N  \n",
       "36    None                         \n",
       "37    None                         \n",
       "38    None                         \n",
       "39    None                         \n",
       "40    HEPUBAGOKRIZEO-PPPUBMIESA-N  \n",
       "41    None                         \n",
       "42    XNLCCACCEOWFNQ-OSPRVTPDSA-N  \n",
       "43    None                         \n",
       "44    None                         \n",
       "45    None                         \n",
       "46    None                         \n",
       "47    QYNUQALWYRSVHF-OLZOCXBDSA-N  \n",
       "48    None                         \n",
       "49    JIPBQMGGMHCGBW-CWUUNJJBSA-N  \n",
       "...                           ...  \n",
       "3965  None                         \n",
       "3966  None                         \n",
       "3967  None                         \n",
       "3968  None                         \n",
       "3969  None                         \n",
       "3970  None                         \n",
       "3971  None                         \n",
       "3972  None                         \n",
       "3973  None                         \n",
       "3974  None                         \n",
       "3975  None                         \n",
       "3976  None                         \n",
       "3977  None                         \n",
       "3978  None                         \n",
       "3979  None                         \n",
       "3980  None                         \n",
       "3981  None                         \n",
       "3982  None                         \n",
       "3983  None                         \n",
       "3984  None                         \n",
       "3985  None                         \n",
       "3986  None                         \n",
       "3987  None                         \n",
       "3988  None                         \n",
       "3989  None                         \n",
       "3990  None                         \n",
       "3991  None                         \n",
       "3992  None                         \n",
       "3993  None                         \n",
       "3994  None                         \n",
       "3995  None                         \n",
       "3996  None                         \n",
       "3997  None                         \n",
       "3998  DJWUNCQRNNEAKC-UHFFFAOYSA-L  \n",
       "3999  None                         \n",
       "4000  None                         \n",
       "4001  None                         \n",
       "4002  None                         \n",
       "4003  None                         \n",
       "4004  None                         \n",
       "4005  CJLUYLRKLUYCEK-UHFFFAOYSA-N  \n",
       "4006  IJDQETGUEUJVTB-UHFFFAOYSA-N  \n",
       "4007  None                         \n",
       "4008  None                         \n",
       "4009  None                         \n",
       "4010  None                         \n",
       "4011  None                         \n",
       "4012  None                         \n",
       "4013  None                         \n",
       "4014  None                         \n",
       "\n",
       "[4015 rows x 6 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "# https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwixz4Knh6PSAhVjrFQKHWr0C-QQFggaMAA&url=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FForIndustry%2F...%2FHowtoapplyforOrphanProductDesignation%2FUCM162066.xls&usg=AFQjCNFnMUzkWwsJCPnmqzabQeAIUOicVQ&sig2=OD5moBW6BuDdi6K2PGag1A&bvm=bv.147448319,d.cGw"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Generic Name          4015\n",
       "Orphan Designation    4015\n",
       "Designation Date      4015\n",
       "Designation Status    4015\n",
       "drug_qid              1753\n",
       "inchi                 323 \n",
       "dtype: int64"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.count()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "deletable": true,
    "editable": true
   },
   "source": [
    "## Indications"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "treatment      3306\n",
       "for            254 \n",
       "prevention     164 \n",
       "prophylaxis    29  \n",
       "to             28  \n",
       "management     20  \n",
       "diagnostic     17  \n",
       "1.             15  \n",
       "as             12  \n",
       "use            11  \n",
       "Name: Orphan Designation, dtype: int64"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "first_word = df['Orphan Designation'].str.split(\" \").apply(lambda x:x[0].lower())\n",
    "first_word.value_counts().head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2315"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "first_word_idx = first_word.isin({'treatment', 'prevention', 'diagnosis', 'prophylaxis', 'management', 'diagnostic'})\n",
    "df.loc[first_word_idx, 'indication'] = df.loc[first_word_idx, 'Orphan Designation'].str.split(\" \").apply(lambda x: \" \".join(x[2:]).lower())\n",
    "df.loc[~first_word_idx, 'indication'] = df.loc[~first_word_idx, 'Orphan Designation']\n",
    "df.indication = df.indication.str.lower()\n",
    "df.indication = df.indication.dropna().apply(lambda x:x[:-1] if x.endswith('.') else x)\n",
    "diseases = set(list(df['indication'].dropna().str.strip())) - {\"\"}\n",
    "len(diseases)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "262"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## orphanet\n",
    "#http://data.bioontology.org/ontologies/ORDO/download?apikey=8b5b7825-538d-40e0-9e9e-5ab9274a9aeb&download_format=csv\n",
    "ordo = pd.read_csv(\"../data/ORDO.csv.gz\")\n",
    "ordo.dropna(subset=['Preferred Label'], inplace=True)\n",
    "name_ordo = dict(zip(ordo['Preferred Label'].str.lower(), ordo['Class ID']))\n",
    "name_ordo = {k: v for k,v in name_ordo.items()}\n",
    "for _, row in ordo[ordo.Synonyms.notnull()].iterrows():\n",
    "    for syn in row.Synonyms.split(\"|\"):\n",
    "        name_ordo[syn.lower()] = row['Class ID']\n",
    "del name_ordo['disease']\n",
    "ordo_matches = {x:name_ordo[x] for x in diseases if x in name_ordo}\n",
    "len(ordo_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "21114\n",
      "26710\n"
     ]
    }
   ],
   "source": [
    "# match to DO or HPO\n",
    "def onto_synonyms(json_path):\n",
    "    doid = json.loads(open(json_path).read())\n",
    "    graph = doid['graphs'][0]\n",
    "    nodes = graph['nodes']\n",
    "    name_doid = dict()\n",
    "    for node in nodes:\n",
    "        if 'meta' in node and 'deprecated' in node['meta'] and node['meta']['deprecated']:\n",
    "            continue\n",
    "        if 'lbl' not in node:\n",
    "            continue\n",
    "        name_doid[node['lbl'].lower()] = node['id']\n",
    "        if 'meta' in node and 'synonyms' in node['meta']:\n",
    "            for syn in node['meta']['synonyms']:\n",
    "                name_doid[syn['val'].lower()] = node['id']\n",
    "    return name_doid\n",
    "name_doid = onto_synonyms(\"../data/doid.json\")\n",
    "name_hpo = onto_synonyms(\"../data/hp.json\")\n",
    "print(len(name_doid))\n",
    "print(len(name_hpo))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "297"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "doid_matches = {x:name_doid[x] for x in diseases if x in name_doid}\n",
    "len(doid_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "124"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hpo_matches = {x:name_hpo[x] for x in diseases if x in name_hpo}\n",
    "len(hpo_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "# create mesh title synonyms dict\n",
    "# json is created from https://github.com/stuppie/mesh-parser\n",
    "mesh = json.load(open(\"/home/gstupp/projects/mesh/mesh.json\"))\n",
    "name_mesh = dict()\n",
    "for record in mesh.values():\n",
    "    if record['record_type'] == 'C':\n",
    "        continue\n",
    "    name_mesh[record['term'].lower()] = record['_id']\n",
    "    for syn in record.get('synonyms', []):\n",
    "        name_mesh[syn.lower()] = record['_id']\n",
    "mesh_name = {v:k for k,v in name_mesh.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "376"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mesh_matches = {x:name_mesh[x] for x in diseases if x in name_mesh}\n",
    "len(mesh_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1847"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "diseases_not_matched = {x for x in diseases if x not in doid_matches and x not in ordo_matches and x not in mesh_matches and x not in hpo_matches}\n",
    "len(diseases_not_matched)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'for the treatment of graft versus host disease',\n",
       " 'prophylaxis of bleeding episodes in patients with hemophilia a or b with inhibitors to factor viii or factor ix',\n",
       " 'hepatitis c infection in liver transplant recipients',\n",
       " 'patients at high risk of graft rejection following penetrating keratoplasty',\n",
       " 'invasive candida infections, including candidemia',\n",
       " 'stage ii (t4), iii or iv malignant melanoma',\n",
       " 'idiopathic thrombocytopenia purpura',\n",
       " 'partial onset or primary generalized tonic-clonic seizures for hospitalized epilepsy patients or epilepsy patients being treated in an emergency care setting who are unable to take oral topiramate',\n",
       " 'patients with lymphatic malformations',\n",
       " 'for post-exposure prophylaxis of anthrax disease resulting from suspected or confirmed bacillus anthracis exposure',\n",
       " 'for localization of sentinel lymph nodes in patients with melanoma',\n",
       " 'patients with known hepatocellular carcinoma (hcc)',\n",
       " 'hyperuricemia in patients with gout refractory to conventional therapy or in whom conventional therapy is contraindicated',\n",
       " 'stage iib, iic, iii and iv melanoma',\n",
       " 'fatty acid disorders',\n",
       " 'inborn errors of cholesterol and bile acid synthesis and metabolism',\n",
       " 'pediatric and adult eosinophilic esophagitis',\n",
       " 'restore the structure and function of the esophagus subsequent to esophageal damage due to cancer, injury, or congenital abnormality',\n",
       " 'patients with esophageal varices that have recently bled, to prevent rebleeding',\n",
       " 'for the prevention of hepatitis b virus (hbv) reinfection in patients who have received a liver transplantation',\n",
       " 'increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available',\n",
       " 'to facilitate the removal of lung secretions in the treatment of patients with primary ciliary dyskinesia',\n",
       " 'leber congential amaurosis (lca) due to inherited mutations in rpe65 (encoding the protein retinal pigment epithelial protein 65) or lrat (encoding the enzyme lecithin:retinol acyltransferase)genes',\n",
       " 'neuromyelitis optica and neuromyelitis optica spectrum disorder',\n",
       " 'delayed graft function following renal transplant',\n",
       " 'pseudomonas aeruginosa pulmonary infections in cystic fibrosis patients',\n",
       " 'delayed graft function in renal transplant recipients',\n",
       " 'pigmented villonodular synovitis/giant cell tumor of the tendon sheath',\n",
       " 'radiosensitizer to be used during radiation treatment of glioblastoma multiforme',\n",
       " 'vulvar dystrophies',\n",
       " 'human cytomegalovirus viremia and disease in at risk populations',\n",
       " 'patients with aids who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir',\n",
       " 'poliovirus infection',\n",
       " 'patients with follicular thyroid carcinoma, medullary thyroid carcinoma, anaplastic thyroid carcinoma, and locally advanced and metastatic papillary thyroid carcinoma',\n",
       " 'as supplementation therapy for alpha-1-antitrypsin deficiency in the zz phenotype population',\n",
       " 'basal cell carcinoma nevus syndrome',\n",
       " 'topical treatment of fungal otitis externa (otomycosis)',\n",
       " 'cystic fibrosis liver disease',\n",
       " 'ischemia reperfusion injury associated wth solid organ transplantation',\n",
       " 'advanced adenocarcinoma of the ovary',\n",
       " 'acute and chronic leukemia',\n",
       " \"ewing's sarcoma family of tumors\",\n",
       " 'cardiomyopathy for chilren and adolescents 0 through 16 years of age treated with anthracyclines',\n",
       " 'for use in mr imaging for the mangement of brain tumors',\n",
       " 'acute herpetic keratitis caused by herpes simplex virus type 1 and 2',\n",
       " 'a diagnostic for the management of moyamoya disease (mmd)',\n",
       " 'to lower the defibrillation energy requirement sufficiently to allow automatic implantable cardioverter defibrillator therapy in those patients who could otherwise not use the device',\n",
       " 'for use as enzyme replacement therapy for patients with types i, ii, or iii gaucher disease',\n",
       " 'deep vein thrombosis which may lead to pulmonary embolism in pediatric patients',\n",
       " 'recurrent respiratory papillomatosis (rrp)',\n",
       " \"tourette's syndrome in children 0-16 years old\",\n",
       " 'acromegly',\n",
       " 'topical treatment of mycosis fungoides',\n",
       " 'inhalation therapy for the treatment of congential deficiency of alpha1-proteinase inhibitor',\n",
       " 'onchocerhiasis (\"river blindness\") caused by the filarial nematode onchocerca volvulus',\n",
       " 'hepatitis b reinfection in patients undergoing liver transplantation secondary to end-stage chronic hepatitis b infection',\n",
       " 'pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (jia) ilar categories excluding systemic jia',\n",
       " 'bleeding episodes in hemophilia a or b patients with inhibitors to factor viii or factor ix',\n",
       " '1. prevention of calcium renal stones in patients with hypocitraturia 2. for avoidance of the complication of calcium stone formation in patients with uric lithiasis',\n",
       " 'for the suppression and control of colonic adenomatous polyps in the inherited disease adenomatous polyposis coli',\n",
       " \"for use as rescue treatment for early morning motor dysfunction in late-stage parkinson's disease\",\n",
       " 'patients with symptomatic orthostatic hypotension',\n",
       " 'renal cell carcinoma in hla-a*2 positive patients',\n",
       " 'pediatric multiple sclerosis in patients less than or equal to 16 years of age',\n",
       " 'intratumoral treatment of anatomically accessible oral and pharyngeal cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity)',\n",
       " 'selected, refractory patients with epilepsy on stable regimens of antiepileptic drugs, who require intermittent use of diazepam to control bouts of increased seizure activity',\n",
       " 'for acceleration of corneal epithelial regeneration and the healing of stromal tissue in the condition of non-healing corneal defects',\n",
       " 'symptomatic enteroviral infection in the neonate',\n",
       " 'pulmonary fungal infections in patients at risk for aspergillosis due to immunosuppressive therapy including those receiving organ or stem cell transplants, or treated with chemotherapy or radiation for hematologic malignancies',\n",
       " 'bronchopulmonary dysplasia in premature neonates weighing less than 1500 grams',\n",
       " 'pediatric patients 0 to <18 yrs of age with oligoarticular-course and polyarticular-course juvenile idiopathic arthritis',\n",
       " 'for use in combination with cisplatin and pemetrexed for the treatment of patients with mesothelioma',\n",
       " 'for treatment of patients with known or suspected internal contamination with plutonium, americium or curium to increase the rates of elimination',\n",
       " 'hormone refractory prostate cancer',\n",
       " 'radiation- or chemotherapy-induced oral mucositis in cancer patients',\n",
       " 'for use as replacement therapy in patients with hemophilia b for the prevention and control of bleeding episodes, and during surgery to correct defective hemostasis',\n",
       " '1. treatment of hepatocellular carcinoma and hepatoblastoma 2. treatment of alpha-fetoprotein producing germ cell tumors',\n",
       " 'organ rejection in renal allograft recipients',\n",
       " 'acute myelocytic leukemia subtypes m0, m1, m2, m4, m5, m6 and m7',\n",
       " 'xerostomia induced by radiation therapy for head and neck cancer',\n",
       " 'duchenne muscular dystrophy patients bearing mutations that can be corrected by skipping exon 52',\n",
       " 'radiation sensitizer in the treatment of primary brain tumors',\n",
       " 'cutaneous t-cell lymphomas, acute t-cell leukemia-lymphoma, and related mature t-cell malignancies',\n",
       " 'stage iib-stage iv melanoma',\n",
       " 'for the control and prevention of hemorrhagic episodes and for surgical prophylaxis in patients with hemophilia a (congenital factor viii deficiency or classic hemophilia)',\n",
       " 'as adjuvant therapy in the treatment of primary brain tumors',\n",
       " 'as replacement therapy for growth hormone deficiency in adults after epiphyseal closure',\n",
       " 'for immune reconstitution and prevention of graft versus host disease following allogeneic hematopoietic stem cell transplantation',\n",
       " 'anaplastic glioma',\n",
       " 'primary amebic encephalitis (pam)',\n",
       " 'symptomatic stage of acute porphyria',\n",
       " 'sickle cell disease (this includes the treatment and prevention of complications of sickle cell disease)',\n",
       " 'patients with anaplastic thyroid cancer and locally advanced or metastatic papillary thyroid cancer whose tumors harbor a braf v600 mutation',\n",
       " 'pediatric patients with schizophrenia',\n",
       " 'acute attacks of angioedema in individuals with hereditary angioedema',\n",
       " 'in imaging systemic and nodal melanoma metastasis',\n",
       " 'acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria',\n",
       " 'metachromatic leukodystrophy (mld)',\n",
       " 'hypoprolactinemia in breastfeeding mothers, and in some hypoprolactinemic conditions following the use of cabergoline or bromocriptine in mothers who wish to initiate or return to breastfeeding',\n",
       " 'ototoxicity caused by platinum-based chemotherapeutic agents used to treat pediatric cancers',\n",
       " 'behavioral abnormalities associated with fragile x syndrome',\n",
       " 'replacement of heparin in patients requiring hemodialysis and who are at increased risk of hemorrhage',\n",
       " 'intraperitoneal treatment of gastric cancer',\n",
       " 'for protection of donor organ tissue from damage or injury mediated by oxygen-derived free radicals that are generated during the necessary periods of ischemia (hypoxia, anoxia), and especially reperfusion, associated with the operative procedure',\n",
       " 'symptomatic patients with the aids including all patients with cd4 t-cell counts less than 200 cells per mm3',\n",
       " \"diffuse non-hodgkin's lymphoma, including aids-related diffuse non-hodgkin's lymphoma\",\n",
       " 'treatment of delayed graft function after solid organ transplantation',\n",
       " 'neoplastic meningitis',\n",
       " 'the management of glioma',\n",
       " 'primary immunodeficiencies associated with t-cell defects',\n",
       " 'epilepsy patients who cannot take anything by mouth (npo)',\n",
       " 'assessing the risk of administrating penicillin when it is the preferred drug of choice in adult patients who have previously received penicillin and have a history of clinical sensitivity',\n",
       " 'secondary and primary myelofibrosis',\n",
       " 'for post-exposure prophylaxis and treatment of inhalation anthrax',\n",
       " 'stage llb, llc, lll and iv melanoma',\n",
       " 'stage iib to iv melanoma',\n",
       " 'pulmonary arterial hypertension (who group 1)',\n",
       " 'recurrent clostridium difficile infection (clostridium difficile gastrointestinal disease)',\n",
       " 'schwannoma of the central nervous system',\n",
       " 'for use as a diluent in the intrathecal administration of methotrexate and cytarabine for the prevention or treatment meningeal leukemia and lymphocytic lymphoma',\n",
       " 'non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in patients with von willebrand disease',\n",
       " 'documented or suspected exposure to marburg virus',\n",
       " 'short stature in patients with prader-willi syndrome',\n",
       " \"advanced (involutional or residual stage) dupuytren's disease\",\n",
       " 'amyotropic lateral sclerosis',\n",
       " 'leber congenital amaurosis due to rpe65 mutations',\n",
       " 'adjunct to gonadotropin therapy in the induction of ovulation in women with anovulatory or oligo-ovulatory infertility who fail to ovulate in response to adequate treatment with clomiphene citrate alone and gonadotropin therapy alone',\n",
       " 'achromatopsia due to mutations in the cngb3 gene',\n",
       " 'pulmonary infections in patients with cystic fibrosis including infections due to pseudomonas aeruginosa,burkholderia cepacia and other bacteria',\n",
       " 'for use in conjunction with a thermal or epithermal neutron beam in boron nuclear capture therapy of glioblastoma multiforme',\n",
       " 'plague (yersinia pestis)',\n",
       " 'bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam',\n",
       " 'for the concomitant administration with teceleukin for the treatment of metastatic renal cell carcinoma',\n",
       " 'bronchiectasis patients infected with pseudomonas aeruginosa',\n",
       " 'patients with multiple myeloma for whom oral therapy is inappropriate',\n",
       " 'infant respiratory distress syndrome associated with prematurity',\n",
       " 'for reversing the anticoagulant effect of direct or indirect factor xa inhibitors in patients experiencing a serious uncontrolled bleeding event or who require urgent or emergent surgery',\n",
       " 'burn injury progression of acute, deep dermal burns in hospitalized patients',\n",
       " 'routine prophylaxis to prevent bleeding episodes in patients with hemophilia a and b patients with inhibitors',\n",
       " 'immune tolerance induction in hemophilia a patients with inhibitors',\n",
       " 'symptoms of grade 2 and grade 3 late xerostomia from parotid gland hypofunction caused by radiotherapy for cancer of the oral cavity',\n",
       " 'for the exogenous depletion of cd14 and cd15 positive acute myeloid leukemic bone marrow cells from patients undergoing bone marrow transplantation',\n",
       " 'preparative therapy for pediatric patients undergoing bone marrow transplantation',\n",
       " 'verocytotoxogenic e. coli infections',\n",
       " 'levodopa-induced dyskinesias',\n",
       " 'graft loss in pancreatic islet transplantation',\n",
       " 'for use as a diagnostic adjunct in patients with pheochromocytoma',\n",
       " 'type i diabetes with residual beta cell function',\n",
       " 'implantation failure and unexplained recurrent miscarriage',\n",
       " 'for the stimulation of appetite and prevention of weight loss in patients with a confirmed diagnosis of aids',\n",
       " 'chronic opioid-induced constipation unresponsive to conventional therapy',\n",
       " 'access graft disease in hemodialysis patients',\n",
       " 'protocadherin 19 (pcdh19) female epilepsy',\n",
       " 'tuberculosis infections',\n",
       " 'pediatric patients with hepatitis c virus infection (0 through 16 years of age)',\n",
       " 'patients with non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase(alk)-positive',\n",
       " \"for the intralesional and/or systemic treatment of aids-related kaposi's sarcoma\",\n",
       " 'metastatic renal cell carcinoma',\n",
       " 'hcg producing tumors such as germ cell and trophoblastic cell tumors',\n",
       " 'solitary (unicameral) bone cysts',\n",
       " 'to improve renal function and prevent delayed graft function following renal transplantation',\n",
       " 'mycobacterium avium complex in patients with aids',\n",
       " \"huntington's disease (prodromal stage huntington's disease and diagnosed huntington's disease)\",\n",
       " 'mucopolysaccharidosis type 1 (mps)',\n",
       " 'glioblastoma multiforme (gbm)',\n",
       " 'hypertension in pediatric patients 0 through 16 years of age',\n",
       " \"for use in corneal melting syndromes of known or presumed immunologic etiopathogenesis, including mooren's ulcer\",\n",
       " 'for the photodynamic therapy of patients with primary or recurrent obstructing (either partially or completely) esophageal carcinoma',\n",
       " 'burn patients hospitalized with burn-induced edema',\n",
       " 'paralysis due to spinal cord injury',\n",
       " 'anemia of prematurity in preterm infants',\n",
       " 'topical treatment for the prevention of soft tissue injury following extravastion of cytotoxic drugs',\n",
       " 'patients with autosomal recessive polycystic kidney disease (arpkd)',\n",
       " 'immunotherapy for acceleration of t-cell reconstitution in patients undergoing allogeneic hematopoietic stem cell transplantation',\n",
       " 'herpes zoster (shingles) in immunocompromised patients',\n",
       " 'amyotrophic lateral sclerosis and its variants',\n",
       " 'acute myeloid leukemia (aml)',\n",
       " 'adjuvant therapy for the treatment of ovarian cancer',\n",
       " 'esophageal ulcers',\n",
       " 'refractory childhood acute lymphocytic leukemia',\n",
       " 'cachexia associated with aids',\n",
       " 'ricin intoxication',\n",
       " 'symptomatic transthyretin (ttr) amyloid cardiomyopathy',\n",
       " 'alk-positive non-small cell lung cancer',\n",
       " 'to assist in establishing the diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism',\n",
       " 'body dysmorphic disorder in children and adolescents',\n",
       " 'tumor induced hypercalcemia',\n",
       " 'ischemia reperfusion injury in the lung during lung tranplantation',\n",
       " 'cytomegalovirus infections in allogenic bone marrow transplant patients',\n",
       " 'idiopathic pulmonary fibrosis (ipf)',\n",
       " 'for use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis',\n",
       " 'acute spinal cord injury',\n",
       " 'bleeding in patients experiencing intracranial hemorrhage',\n",
       " 'treament of acute radiation syndrome',\n",
       " 'primary and secondary carnitine deficiency of genetic origin',\n",
       " 'for adjunctive therapy in the prevention and treatment of hyperammonemia in patients with urea cycle enzymopathy due to carbamylphosphate synthetase, ornithine, transcarbamylase, or argininosuccinate synthetase deficiency',\n",
       " 'for use as hematopoietic support in patients with relapsed or refractory hematologic malignancies who are receiving high-dose therapy',\n",
       " 'tdt-positive acute lymphocytic leukemia',\n",
       " 'patients 16 years of age and younger with immune-mediated t1dm and preserved pancreatic beta cell function',\n",
       " 'pulmonary fungal infections in patients with cystic fibrosis',\n",
       " 'acute allograft rejection in adult recipients in solid organ transplantation',\n",
       " 'bleeding in patients deficient in fibrinogen',\n",
       " 'hormone-refractory prostate cancer',\n",
       " 'neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck',\n",
       " 'gastric cancer, including gastroesophageal junction cancer',\n",
       " 'for the oral treatment of acromegaly',\n",
       " 'the clinical manifestations of mycobacterial infection caused by mycobacterium tuberculosis and non-tuberculous mycobacteria',\n",
       " \"for sequential administration with sargramostim to accelerate neutrophil and platelet recovery in patients undergoing autologous bone marrow transplantation for the treatment of hodgkin's disease or non-hodgkin's lymphoma\",\n",
       " 'increased bone resorption due to malignancy',\n",
       " 'congenital and acquired methemoglobinemia',\n",
       " 'symtomatic myoclonus',\n",
       " 'adults with growth hormone deficiency',\n",
       " 'rabies virus infections',\n",
       " 'for treatment of pancreatic cancer',\n",
       " 'the management of bronchiectasis',\n",
       " 'pediatric polycystic ovary syndrome',\n",
       " 'severe intrapartum hypertension (diastolic blood pressure greater than or equal to 110 or systolic blood pressure greater than or equal to 160) associated with severe preeclampsia/eclampsia of pregnancy',\n",
       " 'hairy cell leukemia (hcl)',\n",
       " 'arteriovenous fistula and arteriovenous graft failure in patients with chronic kidney disease (ckd) who are receiving hemodialysis or preparing for hemodialysis',\n",
       " 'cytomegalovirus retinitis in patients with aids',\n",
       " 'graft-versus-host-disease',\n",
       " 'reduction of the number (treatment) of new digital ulcers in patients with systemic sclerosis',\n",
       " 'autosomal dominant polycystic kidney disease',\n",
       " 'pediatric patients with sickle cell anemia',\n",
       " 'hiv associated anemia related to hiv infection or hiv treatment',\n",
       " 'cutaneous manifestations of scleroderma',\n",
       " 'for use in the treatment of cystic fibrosis resulting fron a nonsense (premature stopcodon) mutation in the cystic bibrosis transmembrane conductance regulatory gene',\n",
       " 'pulmonary infections caused by burkholderia cepacia',\n",
       " 'reduction of the risk of breast cancer in postmenopausal women',\n",
       " 'nonparenchymatous sarcomas',\n",
       " 'type 1 diabetes mellitus with residual beta cell function',\n",
       " 'patients undergoing solid organ transplantation',\n",
       " 'persons with myeloproliferative neoplasm-associated myelofibrosis and anemia who are red blood cell tranfusion dependent',\n",
       " '1. treatment of human cytomegalovirus infection in bone marrow and organ transplant patients 2. prevention of human cytomegalovirus infection in bone marrow and organ transplant patients',\n",
       " 'mitochondrial neurogastrointestinal encephalomyopathydue to thymidine phosphorylase deficiency',\n",
       " 'adjunctive treatment of chronic non-infectious uveitis requiring systemic immunosuppression',\n",
       " 'neuromyelitis optica and neuromyelitis optica spectrum disorders',\n",
       " 'chronic inflammatory demyelinating polyneuropathy (cidp)',\n",
       " 'for the treatment of cystic fibrosis',\n",
       " 'acute and chronic respiratory symptoms of bronchiectasis',\n",
       " 'cardiomyopathy associated with dystrophinopathies; duchenne muscular dystrophy (dmd), becker muscular dystrophy bmd), and x-linked dilated cardiomyopathy (xl-dcmp)',\n",
       " 'for use as a chemoprotective agent for cisplatin in the treatment of metastatic melanoma',\n",
       " \"intermetatarsal neuroma (morton's neuroma) that does not respond to conservative treatment and requires either neurectomy or neurolysis\",\n",
       " 'patients with severe chronic neutropenia (absolute neutrophil count less than 500/mm3)',\n",
       " 'for use in the evaluation of exocrine pancreas function',\n",
       " 'pediatric congestive heart failure',\n",
       " '1. detection of hepatocellular carcinoma and hepatoblastoma 2. detection of alpha-fetoprotein producing germ cell tumors',\n",
       " \"patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (wegener's granulomatosis, microscopic polyangiitis, and churg-strauss syndrome)\",\n",
       " 'active cytomegalovirus infections',\n",
       " 'hyperekplexia (startle disease)',\n",
       " \"seizures associated with pyridox(am)ine 5'-phosphate oxidase (pnpo) deficiency\",\n",
       " 'as an adjunct in leukapheresis to improve the harvesting and increase the yield of leukocytes by centrifugal means',\n",
       " 'for the induction of donor-specific immunologic unresponsiveness resulting in prophylaxis of organ rejection without the need for chronic immunosuppressive therapy, in patients receiving allogeneic renal transplants',\n",
       " 'pediatric ulcerative colitis (0 through 16 years of age)',\n",
       " 'renal and bladder calculi of the apatite or struvite variety',\n",
       " 'reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs',\n",
       " 'fontaine stage iv chronic critical limb ischemia',\n",
       " 'invasive melanoma',\n",
       " 'somatostatin receptor positive neuroendocrine tumors',\n",
       " 'visualization of malignant tissue during surgery for malignant glioma (who garde iii and iv)',\n",
       " 'hyperphosphatemia in patients with end stage renal disease',\n",
       " 'graft-versus-host disease (gvhd)',\n",
       " 'pediatric hyperparathyroidism',\n",
       " 'treatment-resistant schizophrenia',\n",
       " 'stage ii (t4), stage iii, and stage iv melanoma',\n",
       " 'in combination with a platinum and 5-fu or capecitabine for the treatment of stomach cancer',\n",
       " 'for replacement therapy in congenital protein c deficiency for the prevention and treatment of thrombosis, pulmonary emboli, and purpura fulminans',\n",
       " 'symptomatic sickle cell disease in pediatric patients, less than 17 years of age',\n",
       " 'advanced melanoma (stages iib, iic, iii, and iv)',\n",
       " 'for use in combination with paclitaxel in the treatment of esophageal cancer',\n",
       " 'non-small cell lung cancers that express desmocollin-3',\n",
       " 'severe congential factor xi deficiency',\n",
       " 'ocular surface diseases that are characterized by total limbal stem cell deficiency',\n",
       " 'cataplexy and narcolepsy',\n",
       " 'brain and cns tumors',\n",
       " 'severe diarrhea and flushing associated with malignant carcinoid tumors',\n",
       " 'capillary leakage syndrome',\n",
       " 'multiforme glioblastoma',\n",
       " 'staphylococcus epidermidis sepsis in low birth weight (1500 grams or less) infants',\n",
       " 'oral ulcerations and dysphagia in patients with epidermolysis bullosa',\n",
       " 'for the topical treatment of traumatic hyphema of the eye',\n",
       " 'scarring post ab externo glaucoma surgery',\n",
       " 'to slow the progression of immunoglobulin a nephropathy & delay kidney failure in patients affected by the disease',\n",
       " 'aids resulting from infection with hiv-1',\n",
       " 'cystic fibrosis patients to improve airway clearance and to improve or stabilize pulmonary function',\n",
       " 'amyotrophic lateral sclerosis (als)',\n",
       " 'pediatric patients infected with human immunodeficiency virus and acquired immunodeficiency syndrome',\n",
       " 'invasive aspergillus infections',\n",
       " 'for the systemic treatment of cutaneous t-cell lymphoma',\n",
       " 'congenital lymphatic malformations',\n",
       " 'short stature in pediatric patients with short stature homeobox-containing gene (shox) deficiency',\n",
       " 'inherited mitochondrial respiratory chain diseases',\n",
       " 'hereditary motor and sensory neuropathy type i (charcot-marie-tooth disease)',\n",
       " 'patients with severe dermal burns',\n",
       " 'constitutional delay of growth and puberty',\n",
       " 'for the treatment of sickle cell disease',\n",
       " 'retinopathy of prematurity in preterm infants at risk for developing retinopathy of prematurity',\n",
       " 'for use in detecting, by imaging, metastases of malignant melanoma',\n",
       " 'acute renal graft rejection episodes',\n",
       " 'for use in the prevention and treatment of purpura fulminans in meningococcemia',\n",
       " 'esophageal variceal hemorrhage patients with portal hypertension',\n",
       " 'human papillomavirus in patients with severe resistant/recurrent respiratory (laryngeal) papillomatosis',\n",
       " 'acute colonic pseudo-obstruction',\n",
       " 'pediatric hiv infection',\n",
       " 'telomerase reverse transcriptase (tert) positive non-small cell lung cancer in hla-a*0201 positive patients',\n",
       " 'for use with human growth hormone in the treatment of short bowel syndrome (nutrient malabsorption from the gastrointestinal tract resulting from an inadequate absorptive surface)',\n",
       " 'rejection in kidney, liver or heart transplant in pediatric patients',\n",
       " 'chronic malignant pleural effusion',\n",
       " 'for use in conjunction with diagnostic procedures (excluding ercp) for pancreatic disorders to increase pancreatic fluid secretion',\n",
       " 'ischemia reperfusion injury in all solid organ transplants',\n",
       " 'for slowing the progression of emphysema in alpha1-antitrypsin deficient patients',\n",
       " 'necrotizing enterocolitis in preterm infants with birth weight less than or equal to 1,500 grams',\n",
       " 'her2-expressing adenocarcinoma of the esophagus',\n",
       " 'upper tract urothelial carcinoma',\n",
       " 'her2-expressing advanced adenocarcinoma of the stomach and gastroesophageal junction',\n",
       " 'aids-associated catabolism/weight loss',\n",
       " 'ex-vivo preservation of cadaveric kidneys for transplantation',\n",
       " 'pigmented villonodular synovitis, including giant cell tumor of the tendon sheath',\n",
       " 'hepatitis delta virus (hdv)infection',\n",
       " 'hospital acquired pneumonia caused by serotype 011 positive pseudomonas aeruginosa',\n",
       " 'intrathecal treatment of intractable pain',\n",
       " \"duchennes and becker's muscular dystrophy\",\n",
       " 'duchenne and becker muscular dystrophies',\n",
       " 'treament of ovarian cancer',\n",
       " 'for the treatment of congenital factor xi deficiency',\n",
       " 'active chronic pouchitis',\n",
       " 'recent-onset type i diabetes',\n",
       " 'patients with hiv-associated adipose redistribution syndrome',\n",
       " 'homozygous familial hypercholesterolemia (hofh)',\n",
       " 'for the ex-vivo purging of leukemic cells from the bone marrow of non-t cell acute lymphocytic leukemia patients who are in complete remission',\n",
       " 'enhancement of stem cell engraftment through ex vivo treatment of human allogeneic hematopoietic stem cells (treatment of neuropenia, thrombocytopenia, lymphopenia, and anemia)',\n",
       " 'megaloblastic anemia caused by folate deficiency',\n",
       " 'stage iib to stage iv melanoma',\n",
       " 'drug resistant generalized tonic-clonic epilepsy in children and adults',\n",
       " 'liver and intrahepatic bile duct cancer',\n",
       " 'for use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds',\n",
       " 'hyperuricemia in patients intolerant to allopurinol',\n",
       " 'neutropenia associated with autologous bone marrow transplantation',\n",
       " 'relief of symptoms of multiple sclerosis',\n",
       " 'organ rejection in patients receiving heart transplants',\n",
       " 'symptoms associated with carcinoid syndrome',\n",
       " 'skin blistering and erosions associated with inherited epidermolysis bullosa',\n",
       " 'acute non-a, non-b hepatitis',\n",
       " 'for the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer',\n",
       " 'malignancy-associated or chemotherapy-induced hyperuricemia',\n",
       " 'for use in conjunction with the uvar photopheresis system to treat graft versus host disease',\n",
       " 'primary peritoneal cancer',\n",
       " 'myeloproliferative disorders (polycythemia vera, essential throbocythemia, and myelofibrosis)',\n",
       " 'recessive dystrophic epidermolysis bullosa (rdeb)',\n",
       " 'long-term enzyme replacement therapy for the treatment of fabry disease',\n",
       " 'familial benign chronic pemphigus (hailey-hailey disease)',\n",
       " 'velocardiofacial syndrome associated psychosis',\n",
       " 'treatament of myelodysplastic syndromes',\n",
       " 'subjects at risk of developing myelosuppression after a radiological or nuclear incident',\n",
       " 'clinical management of patients with neuroblastoma',\n",
       " 'increase survival and improve functioning of pancreatic islets following transplantation',\n",
       " 'v600 mutation positive stage iib through iv melanoma',\n",
       " 'primary hypertension with complications and secondary hypertension in pediatric patients (ages 0 through 16 years of age)',\n",
       " 'post-surgical apnea',\n",
       " 'for the enzymatic debridement of severe burns',\n",
       " 'invasive cutaneous melanoma',\n",
       " 'pulmonary infections associated with cystic fibrosis',\n",
       " 'to protect the liver from ischemia-reperfusion injury inherent to the procedure of transplantation',\n",
       " 'detecting early necrosis as an indication of rejection of orthotopic cardiac transplants',\n",
       " 'corneal ulcers',\n",
       " 'acute myeloid leulemia',\n",
       " \"mild hemophilia a and von willebrand's disease\",\n",
       " 'acute intermittent porphyria attacks',\n",
       " 'acute respiratory distress syndrome in adults',\n",
       " 'patients with angioimmunoblastic t-cell lymphoma',\n",
       " 'ovarian cancer refractory or resistant to standard chemotherapy',\n",
       " 'soil transmitted helminth infection strongyloidiasis',\n",
       " 'recurrent clostridium difficile infection (cdi)',\n",
       " \"follicular lymphoma, small lymphocytic lymphoma, lymphoplasmacytic lymphoma, splenic marginal zone lymphoma, extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoma tissue (malt), and nodal marginal zone lymphoma (collectively indolent b-cell non-hodgkin's lymphoma)\",\n",
       " 'scarring following glaucoma filtration surgery',\n",
       " 'for use as a chemoprotective agent for cisplatin in the treatment of advanced ovarian carcinoma',\n",
       " 'patients with secondary progressive multiple sclerosis',\n",
       " 'for the control of bleeding and prophylactic treatment of patients deficient in fibrinogen',\n",
       " 'reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia',\n",
       " 'patients with cutaneous melanoma',\n",
       " 'new-onset type i diabetes mellitus',\n",
       " 'patients with chondrosarcoma',\n",
       " 'mucopolysaccharidosis type iiib (sanfilippo syndrome type b)',\n",
       " 'anatomically accessible oral cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity)',\n",
       " 'for the reduction of the incidence and severity of toxicities associated with cisplatin administration',\n",
       " \"b-cell non-hodgkin's lymphoma\",\n",
       " 'non-infectious ocular inflammation of the posterior segment in patients with intermediate, posterior, and panuveitis',\n",
       " 'a diagnostic for management of patients with lesch-nyhan syndrome',\n",
       " \"patients with von willebrand's disease\",\n",
       " 'chronic pulmonary infection due to p. aeruginosa in cystic fibrosis patients',\n",
       " 'duchenne muscular dystrophy in patients with a deletion, duplication or frame shift mutation correctable by skipping of exon 50 of the dystrophin gene to allow restoration of the reading frame (including mutations within exons 51, 51-53, or 51-55)',\n",
       " 'inherited retinal dystrophy due to biallelic rpe65 gene mutations',\n",
       " 'for use in conjunction with high-dose methotrexate in the treatment of osteosarcoma',\n",
       " 'retinitis pigmentosa associated with usher syndrome 1b gene defect',\n",
       " 'adjunct to the non-operative management of secreting cutaneous fistulas of the stomach, duodenum, small intestine (jejunum and ileum), or pancreas',\n",
       " 'rejection of pancreatic islet cell transplants',\n",
       " 'iron overload in patients with hematologic disorders requiring chronic transfusion therapy',\n",
       " 'primary graft dysfunction following lung transplantation',\n",
       " 'to delay progression of chronic obstructive pulmonary disease resulting from aat deficiency-mediated emphysema and bronchiectasis',\n",
       " 'routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia a and b patients with inhibitors',\n",
       " 'oral manifestations of graft-versus-host disease',\n",
       " 'limb girdle muscular dystrophy type 2b',\n",
       " 'inhibition of the urotoxic effects induced by oxazaphosphorine compounds such as cyclophosphamide',\n",
       " 'for adjuvant therapy in melanoma patients with surgically resectable lymph node metastasis (stage iii and limited stage iv disease)',\n",
       " 'restore function to hemodialysis catheters',\n",
       " 'for use in accelerating platelet recovery in patients undergoing hematopoietic stem cell transplantation',\n",
       " 'cerebral vasospasm following subarachnoid hemorrhage',\n",
       " 'as a diagnostic for clinical management of soft tissue sarcoma, including rhabdomyosarcoma',\n",
       " 'delayed graft function in renal transplant patients',\n",
       " 'thymic epithelial tumors',\n",
       " 'heroin addicts suitable for maintenance on opiate agonists',\n",
       " 'chronic radiation proctitis',\n",
       " 'pulmonary arterial hypertention',\n",
       " 'beta-hemoglobinopathies and beta-thalassemia',\n",
       " 'mitochondrial cytopathies',\n",
       " 'viral hemorrhagic fever post-exposure to ebola virus (treatment of ebola)',\n",
       " 'adult tay-sachs disease',\n",
       " 'gastrointestinal stromal tumors (gist)',\n",
       " 'retinal detachment due to proliferative vitreoretinopathy',\n",
       " 'secondary pulmonary hypertension due to intrinsic precapillary pulmonary vascular disease',\n",
       " 'patients at risk of methotrexate toxicity',\n",
       " 'for use in association with recombinant human follicle stimulating hormone for the treatment of women with chronic anovulation due to hypogonadotropic hypogonadism',\n",
       " 'full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis',\n",
       " 'adjuvant treatment of ovarian cancer',\n",
       " 'corneal cystine crystal accumulation in cystinosis patients',\n",
       " 'trka-positive, trkb-positive, trkc-positive ros1-positive or alk-positive non-small cell lung cancer',\n",
       " 'high-risk stage ii, stage iii, and stage iv melanoma',\n",
       " 'cystathionine beta-synthase deficient homocystinuria',\n",
       " 'acute iron poisoning',\n",
       " 'cd30 positive t-cell lymphomas',\n",
       " 'acute antibody mediated rejection following kidney transplantation',\n",
       " 'anemia associated with hiv infection or hiv treatment',\n",
       " 'for use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion',\n",
       " 'hepatocellular carcinoma (hcc)',\n",
       " 'for mobilization of hematopoietic stem cells',\n",
       " 'complex regional pain syndrome (crps-1, crps-ii, crps-nos)',\n",
       " 'as a host-protective agent in the treatment of acute myelogenous leukemia',\n",
       " 'for use as a therapeutic agent for patients al amyloidosis',\n",
       " 'for use in combination with clindamycin hydrochloride in the treatment of pneumocystis carinii pneumonia associated with aids',\n",
       " 'for treatment of poisoning by or exposure to cesium',\n",
       " \"mild to moderate keratoconjunctivitis sicca in patients with sjogren's syndrome\",\n",
       " 'st-elevation myocardial infarcted patients who are undergoing primary percutaneous coronary intervention',\n",
       " 'stage iib, iic, iii, and iv melanoma with brafv600 mutation',\n",
       " 'to reverse the anticoagulant effect of dabigatran due to uncontrolled life-threatening bleeding requiring urgent intervention or a need to undergo an emergency surgery/urgent invasive procedure',\n",
       " 'patients with recent onset (<15 years)with type 1a diabetes mellitus with residual beta-cell function',\n",
       " 'acute painful sickling crises in patients with sickle cell disease',\n",
       " 'spinal cerebellar ataxia type 3 (also known as sca3 or machado joseph disease)',\n",
       " 'globoid cell leukodystrophy (krabbe disease)',\n",
       " 'ileal pouch anal anastomosis related fecal incontinence',\n",
       " 'for the photodynamic therapy of patients with transitional cell carcinoma in situ of the urinary bladder',\n",
       " 'treatment of choline deficiency in patients on long-term parenteral nutrition',\n",
       " 'primary cutaneous cd30-positive t-cell lymphoproliferative disorders',\n",
       " 'hyperuricemia in cancer patients prone to develop tumor lysis syndrome during chemotherapy',\n",
       " 'tnf-receptor associated periodic syndrome (traps)',\n",
       " 'invasive and metastatic melanoma (stages ii, iii, and iv)',\n",
       " 'intracranial malignancies',\n",
       " 'mucopolysaccharidosis type vi (maroteaux-lamy syndrome)',\n",
       " 'cias1-associated periodic syndromes',\n",
       " 'patients with gram-negative sepsis which has progressed to shock',\n",
       " 'neutropenia due to hairy cell leukemia',\n",
       " 'of the capacity of the pituitary gland to release growth hormone',\n",
       " 'as a diagnostic agent for the detection of growth hormone deficiency',\n",
       " 'ulcerative colitis in pediatric patients (revised indication 10/21/2010)',\n",
       " 'in combination with interferon alfa-2a for the treatment of metastatic malignant melanoma',\n",
       " 'neurofibromatosis type 2 (nf2)',\n",
       " 'active tuberculosis',\n",
       " 'spasticity associated with cerebral palsy',\n",
       " 'pulmonary infection due to pseudomonas aeruginosa in cystic fibrosis patients',\n",
       " 'idiopathic membranous glomerular nephropathy',\n",
       " 'disseminated mycobacterium avium-intracellulare infection',\n",
       " 'anaplastic thyroid cancer, medullary thyroid cancer, and stage iv papillary or follicular thyroid cancer',\n",
       " 'bleeding episodes in patients with congenital factor vii deficiency',\n",
       " 'lipase deficiencies, including wolman disease and cholesteryl ester storage disease',\n",
       " 'for treatment of shiga-toxin producing bacterial infection',\n",
       " 'for aerosolized administration in the prevention and treatment of lung allograft rejection and pulmonary rejection events associated with bone marrow transplantation',\n",
       " 'grade iii and iv hepatic encephalopathy',\n",
       " 'gastric (stomach cancer',\n",
       " 'empyema (pleural)',\n",
       " 'medullary thyroid cancer, anaplastic thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer',\n",
       " 'pompe disease (glycogen storage disease type ii)',\n",
       " 'hereditary and acquired methemoglobinemia',\n",
       " 'clostridium difficile infection in pediatric patients (0 through 16 years of age)',\n",
       " 'extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue',\n",
       " 'use with gancyclovir in the treatment of malignant glioma',\n",
       " 'vasospasm associated with subarachnoid hemorrhage',\n",
       " 'neuroleptic-induced tardive dyskinesia in schizophrenia patients',\n",
       " 'treatment of intrinsic acute renal failure due to ischemia',\n",
       " 'uveitis of the posterior segment of non-infectious etiology, and uveitis of the anterior segment of non-infectious etiology and refractory to conventional therapy',\n",
       " 'immediate treatment of malaria',\n",
       " 'glycogen storage disease type ia (von gierke disease)',\n",
       " \"late stage parkinson's disease\",\n",
       " 'hepatitis c recurrence in patients receiving liver transplantation',\n",
       " 'control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease)',\n",
       " 'maternal-fetal transmission of congenital cmv in pregnant women who acquire cmv infection during pregnancy',\n",
       " 'neutropenia associated with bone marrow transplants',\n",
       " 'non-hodgkin t-cell lymphomas',\n",
       " 'neuronal ceroid lipofuscinoses (batten disease)',\n",
       " 'acute cyanide poisoning',\n",
       " 'transient aplastic crisis in patients with sickle cell anemia',\n",
       " 'philadelphia chromosome-positive acute lymphoblastic leukemia (ph+all)',\n",
       " 'for use in combination with antimicrobial drugs for the treatment of drug resistant tuberculosis',\n",
       " 'an antidote in the treatment of 5-fluorouracil or capecitabine poisoning',\n",
       " 'for the treatment of hepatic veno-occlusive disease',\n",
       " 'delaying time to disease progression in patients with severe, malignant osteopetrosis',\n",
       " 'invasive protothecosis',\n",
       " 'for therapeutic treatment of barth syndrome',\n",
       " 'moderate to severe reflex sympathetic dystrophy and causalgia',\n",
       " 'detection of alpha-fetoprotein producing germ cell tumors',\n",
       " 'stage iib through stage iv braf mutant melanoma',\n",
       " 'for the treatment of immunologic corneal allograft rejection',\n",
       " 'individuals acutely exposed to myelosuppressive doses of radiation (hematopoietic syndrome of acute radiation syndrome)',\n",
       " 'treatment of ebv-post transplant lymphoproliferative disease after hematopoietic stem cell transplant or solid organ transplant',\n",
       " 'pediatric patients with ulcerative colitis',\n",
       " 'upper tract urothelial cell cancers (transitional cell carcinoma of the renal pelvis and ureter)',\n",
       " 'to increase the activity of regulatory t-cells (tregs) used in the prevention of graft versus host disease in patients undergoing hematopoietic stem cell transplantation',\n",
       " 'chlorine gas poisoning',\n",
       " 'dynamic muscle contractures in pediatric cerebral palsy patients',\n",
       " 'for the treatment of sandhoff disease',\n",
       " 'gastroenteropancreatic neuroendocrine tumors',\n",
       " 'glycogen storage disorder ii (pompe disease)',\n",
       " 'neonates and infants undergoing cardiopulmonary bypass during surgical repair of congenital heart lesions',\n",
       " 'gastric cancer, including cancer of the gastroesophageal junction',\n",
       " 'aids in patients infected with hiv virus',\n",
       " 'support of glutathione deficiency in individuals with inborn errors of metabolism of glutathione (iemg)',\n",
       " 'mucopolysaccharidosis iii type b (mps iiib, sanfilippo syndrome type b)',\n",
       " 'for in vivo serotherapy of patients with ovarian cancer',\n",
       " 'clinical sequelae of acute lung injury induced by cardiopulmonary bypass in pediatric patients',\n",
       " 'reduction (prevention) of nosocomial bacteremia caused by staphylococci in very low birth weight infants',\n",
       " 'to restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection',\n",
       " 'symptomatic treatment of self injurious behaviors in patients with lesch-nyhan disease',\n",
       " 'children with eosinophilic esophagitis',\n",
       " 'for blockade of the pharmacological effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals',\n",
       " 'for use in microinfusion devices for intraspinal administration in the treatment of intractable chronic pain',\n",
       " 'for use in magnetic resonance imaging to assess, and monitor treatment of solid tumor malignancies previously diagnosed in pediatric patients (age 16 years and younger)',\n",
       " 'for relief of severe intractable pain in narcotic-tolerant patients',\n",
       " 'adrenal insufficiency in pediatric patients',\n",
       " 'acute hepatitis b',\n",
       " 'management of glioma',\n",
       " 'for reducing the period of thrombocytopenia in patients undergoing hematopoietic stem cell transplantation',\n",
       " 'hepatocellular cancer (hcc)',\n",
       " \"for use in the treatment of 1d10+ b cell non-hodgkin's lymphoma\",\n",
       " 'polyarticular juvenile idiopathic arthritis in patients 0 through 18 years of age',\n",
       " 'pediatric ulcerative colitis',\n",
       " 'malignant brain and central nervous system tumors',\n",
       " 'neuropathic pain in patients with sarcoidosis',\n",
       " 'for use in the diagnosis of invasive mycobacterium avium disease in immunocompetent individuals',\n",
       " 'follicular, medullary, and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer',\n",
       " 'epstein-barr virus positive head and neck cancers (which includes nasopharyngeal carcinoma)',\n",
       " 'epstein-barr virus-positive post-transplant lymphoproliferative disorders',\n",
       " 'for cystic fibrosis transmembrane conductance regulator protein replacement therapy in cystic fibrosis patients',\n",
       " 'the behavorial abnormalities associated with fragile x syndrome',\n",
       " 'intramuscular treatment of patients with moderate to severe hemophilia',\n",
       " 'for the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism. amended indication 6/27/00: for the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure',\n",
       " 'aids-associated diarrhea unresponsive to initial antidiarrheal therapy',\n",
       " 'hypoglycemia in the congenital hyperinsulinism population',\n",
       " \"patients with acute liver failure presenting with encephalopathy deteriorating beyond parson's grade 2\",\n",
       " 'anemia associated with end stage renal disease',\n",
       " 'stages iib, iic, iii, and stage iv melanoma',\n",
       " 'pulmonary arterial hypertension (pah)',\n",
       " 'bacterial corneal ulcers',\n",
       " 'for use in combination with leucovorin for therapy of metastatic adenocarcinoma of the colon and rectum',\n",
       " 'neonates for disseminated group b streptococcal infection',\n",
       " 'detection of hcg producing tumors such as germ cell and trophoblastic cell tumors',\n",
       " 'for use as an adjuct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma',\n",
       " 'spinal cord injury patients with asia impairment grades a, b, or c',\n",
       " 'post-transplantation lymphoproliferative disorders in pediatric recipients of solid-organ transplantation',\n",
       " 'spinal muscular atrophies',\n",
       " 'non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis',\n",
       " 'corneal graft rejection',\n",
       " 'acute attacks of angioedema',\n",
       " 'aids-related diarrhea',\n",
       " 'intrathecal therapy for neoplastic meningitis',\n",
       " 'autoimmune uveitis',\n",
       " 'maintenance of reactional lepromatous leprosy',\n",
       " \"leber's congential amaurosis\",\n",
       " 'for use in the diagnosis of gastrinoma associated with zollinger-ellison syndrome',\n",
       " 'chronic iron overload resulting from conventional transfusional treatment of beta-thalassemia major and sickle cell anemia',\n",
       " 'brain metastasis',\n",
       " '1. prevention of acute graft versus host disease in allogenic bone marrow transplantation 2. treatment of patients with b-chronic lymphocytic leukemia',\n",
       " 'of complement-mediated thrombotic microangiopathy',\n",
       " 'philadelphia-positive acute lymphoblastic leukemia',\n",
       " 'liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end stage liver disease',\n",
       " 'mulitple myeloma and associated bone resorption',\n",
       " 'neonatal diabetes (monogenic forms of diabetes that present in infancy)',\n",
       " 'moderate to very severe clinical forms of transfusion reactions arising from abo incompatible transfusions of blood, blood products, and blood derivatives',\n",
       " 'acute rejection in patients requiring allogenic lung transplants',\n",
       " 'for use in boron neutron capture therapy (bnct) in the treatment of glioblastoma multiforme',\n",
       " 'major burns that require hospitalization',\n",
       " \"coat's disease\",\n",
       " 'use in the management of patients undergoing continuous renal replacement therapy with hemofiltration',\n",
       " 'multiple sclerosis patients who are both hla-dr2 positive and autoreactive to myelin oligodendrocyte glycoprotein residues 35-55',\n",
       " 'replacement treatment and prophylaxis of the hemorrhagic complications of hemophilia b',\n",
       " 'gastrointestinal disturbances (to include constipation, diarrhea, and abdominal pain) associated with regression-onset autism in pediatric patients',\n",
       " 'for slowing the progression of amyotrophic lateral sclerosis',\n",
       " 'invasive carcinoma of the uterine cervix',\n",
       " 'glycogen storage disease types ia and ib',\n",
       " \"immunoglobulin a nephropathy (igan, berger's disease)\",\n",
       " \"the clinical manifestations of endogenous cushing's syndrone\",\n",
       " 'b-cell acute lymphoblastic leukemia',\n",
       " 'for the prevention and lessening of photosensitivity in erythropoietic protoporphyria',\n",
       " 'anaplastic thyroid carcinoma and advanced papillary thyroid cancer whose tumors harbor a braf v600 mutation',\n",
       " 'arteriovenous(av) fistula or av graft failure in patients with end stage renal disease, receiving hemodialysis or preparing for hemodialysis',\n",
       " 'burns requiring skin grafting',\n",
       " 'stage iib to iv melanoma in hla-a2 positive patients',\n",
       " \"thromboangiitis obliterans (buerger's disease)\",\n",
       " 'fibrosis-associated chronic allograft nephropathy in kidney transplant patients',\n",
       " 'stage iib-iv melanoma positive for the braf mutation',\n",
       " 'arteriovenous fistula or arteriovenous graft failure in patients with end satge renal disease receiving hemodialysis or preparing for hemodialysis',\n",
       " 'sickle cell disease (scd)',\n",
       " 'therapeutic management of patients with lung disease attributable to cystic fibrosis',\n",
       " 'for the diagnosis of neuroblastomas',\n",
       " \"the on-off fluctuations associated with late-stage parkinson's disease\",\n",
       " 'beta-thalassemia intermedia and major',\n",
       " 'fatty acid oxidation disorders',\n",
       " 'neonatal seizures',\n",
       " 'idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia',\n",
       " 'inhalation therapy for control of gram-negative bacteria in the respiratory tract of patients with cystic fibrosis',\n",
       " 'for use in patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygen impairment',\n",
       " 'squamous metaplasia of the ocular surface epithelia (conjunctiva and/or cornea) with mucous deficiency and keratinization',\n",
       " 'for use in conjunction with the uvar photopheresis to treat diffuse systemic sclerosis',\n",
       " 'gastric cancer and gastro-esophageal junction cancer',\n",
       " 'for use as hematopoietic support in patients with myelodysplastic syndromes',\n",
       " 'prophyllaxis of bleeding episodes in patients with congenital hemophilia and inhibitors to coagulation factor viii or ix',\n",
       " 'use as an antidote in the management of systemic monochloroacetic acid poisoning',\n",
       " 'mucopolysaccharidosis type iiib (sanfilippo b syndrome)',\n",
       " 'duchenne muscular dystrophy in patients who have a mutation correctable by skipping of exon 44of the dystrophin gene',\n",
       " 'opiate addiction in opiate users',\n",
       " 'anaplastic lymphoma kinase (alk)-positive or ros1-positive non-small cell lung cancer',\n",
       " 'patients with cd55 (sc-1) positive gastric tumors',\n",
       " 'for use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia',\n",
       " 'pneumocystis carinii pneumonia associated with aids patients',\n",
       " 'neimann-pick disease, type c',\n",
       " 'persons with aids and in patients with symptomatic hiv infection and a cd4 count less than 200/mm3',\n",
       " 'organ rejection in patients receiving allogeneic kidney transplant',\n",
       " 'adjunctive treatment of chronic active hepatitis b',\n",
       " 'weight loss in aids patients with hiv-associated wasting',\n",
       " 'carcinoma in situ (cis) of the urinary bladder',\n",
       " 'fibrinogen deficient patients',\n",
       " 'for the treatment of gastric cancer including cancer of the gastro-esophageal junction',\n",
       " 'suppression of thyroid stimulating hormone in patients with well-differentiated cancer of the thyroid gland',\n",
       " 'for use as an adjunct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma',\n",
       " 'spasmodic torticollis (cervical dystonia)',\n",
       " 'pigmented villonodular synovitis and tenosynovial giant cell tumor',\n",
       " 'adenocarcinoma of the esophagus and stomach',\n",
       " 'patients with diffuse large b-cell lymphoma',\n",
       " 'localization of primary, residual, recurrent and metastatic medullary thyroid carcinoma',\n",
       " 'acute rejection of solid organ transplantation',\n",
       " 'vitamin deficiency and thromboembolic complications in people receiving home parenteral nutrition and warfarin-type anticoagulant therapy',\n",
       " 'complications of vaccinia vaccination',\n",
       " 'chronic non-infectious uveitis',\n",
       " \"fuch's dystrophy, pseudophakic bullous keratopathy, and bullous keratopathy\",\n",
       " 'antithrombin iii dependent heparin resistance requiring anticoagulation',\n",
       " 'oral mucositis and stomatitis following radiation therapy for head and neck cancer',\n",
       " 'mercury toxicity',\n",
       " 'non-small cell lung cancer with egfr, her2, her4, or ddr2 mutations',\n",
       " 'ischemia/reperfusion injury associated with solid organ tranplantation',\n",
       " 'for use in correcting vesicoureteral reflux in the pediatric population',\n",
       " 'patients with advanced non-small cell carcinoma of the lung',\n",
       " 'malignant hyperthermia syndrome',\n",
       " 'neonatal hypoxic ischemic encephalopathy',\n",
       " 'conditioning treatment prior to hematopoietic stem cell transplantation (hsct) in malignant and non-malignant diseases in adults and pediatric patients',\n",
       " 'acute chest syndrome in at-risk patients with sickle cell disease',\n",
       " 'painful vaso-occlusive episodes associated with sickle cell disease',\n",
       " \"patients with duchenne's muscular dystrophy and becker's muscular dystrophy\",\n",
       " 'for induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous gnrh secretion',\n",
       " 'merosin (laminin-alpha2) deficient congential muscular dystrophy type 1a',\n",
       " 'stargardt macular degeneration',\n",
       " 'peripheral t-cell lymphoma (ptcl)',\n",
       " 'patients with known or suspected internal contamination with plutonium, americium, or curium',\n",
       " 'treatment, in combination with radiotherapy and temozolomide chemotherapy, of patients with glioblastoma multiforme',\n",
       " 'respiratory distress syndrome',\n",
       " 'uncomplicated malaria caused by \"plasmodium falciparum,\" plasmodium vivax,\" plasmodium malariae,\" or \"plasmodium ovale.\"',\n",
       " 'chronic sarcoidosis',\n",
       " 'hepatocelular carcinoma',\n",
       " 'the chronic progressive form of multiple sclerosis',\n",
       " 'adjunctive treatment of acute myelogenous leukemia',\n",
       " \"tourette's syndrome in school-age children, ages 5-16\",\n",
       " 'glycogen storage disease type ia',\n",
       " '(acute attacks of) angioedema caused by hereditary or acquired c1-esterase inhibitor deficiency',\n",
       " 'attenuation of primary cytomegalovirus disease in immunosuppressed recipients of organ transplants',\n",
       " 'cysticercosis (including neurocysticercosis)',\n",
       " 'advanced metastatic melanoma',\n",
       " 'late-onset sepsis in very low birth weight infants',\n",
       " 'somatostatin receptor-positive neuroendocrine gastroenteropancreatic tumors',\n",
       " 'active tuberculosis (tb)',\n",
       " 'wilson’s disease',\n",
       " 'for use as a replacement solution in adults and children during continous renal replacement therapy',\n",
       " 'advanced or metastatic transitional cell carcinoma of the urinary bladder',\n",
       " 'mitochondrial myopathy, encephalopathy, lactic acidosis with stroke-like episodes syndrome (melas)',\n",
       " 'for oral administration in the treatment of intestinal graft-versus-host disease',\n",
       " 'type i diabetes mellitus with residual beta cell function',\n",
       " 'pediatric (age 16 and under) juvenile rheumatoid arthritis',\n",
       " 'severe combined immune deficiency-x1',\n",
       " 'selectively staining epiretinal membranes during ophthalmic surgical vitrectomy procedures',\n",
       " 'platinum-induced toxicities in pediatric patients (0 through 16 years of age)',\n",
       " 'systemic sclerosis (including the associated interstitial lung disease)',\n",
       " 'leakage from the surgical site following penetrating keratoplasty',\n",
       " 'initial therapy of toxoplasmosis in patients with aids',\n",
       " 'primary and metastatic brain tumors',\n",
       " 'mutliple myeloma',\n",
       " 'myelodysplastic syndromes requiring therapy',\n",
       " 'familial amyotrophic lateral sclerosis associated with a mutation of the gene (on chromosome 21q) for copper, zinc superoxide dismutase',\n",
       " 'for the promotion of early engraftment in bone marrow transplantation',\n",
       " 'the neuroleptic malignant syndrome',\n",
       " 'palliative treatment of recurrent, refractory or second primary squamous cell carcinomas of the head and neck in patients considered to be incurable with surgery or radiotherapy',\n",
       " 'gastric cancer including gastroesophageal cancer',\n",
       " 'patients with sickle cell anemia as shown by the presence of hemoglobin s',\n",
       " 'sickle cell disease and beta thalassemia',\n",
       " \"topical treatment of active perianal crohn's disease\",\n",
       " 'treatment of necrotizing enterocolitis (nec) in preterm infants with birth weight less than 1,500 grams',\n",
       " 'pain associated with postherpetic neuralgia',\n",
       " 'for use in combination with fluorouracil for the treatment of esophageal carcinoma',\n",
       " 'patients with primary biliary cirrhosis',\n",
       " 'patients with angiosarcoma',\n",
       " 'intractable pain at end-stage disease',\n",
       " 'patients with high-risk stage ii, stage iii, and stage iv malignant melanoma',\n",
       " 'follicullar, medullary, anaplastic, and metastatic or locally advanced papillary thyroid cancer',\n",
       " 'stage iii/iv non-small cell lung cancer',\n",
       " 'small-cell lung cancer',\n",
       " 'respiratory syncytial virus lower respiratory tract infections in infants and young children at high risk of rsv disease',\n",
       " 'acute lymphoblastic leukemia in the pediatric population',\n",
       " 'malignant melanoma stages iib to iv',\n",
       " 'for use as an alternative to e. coli asparaginase in those situations where repeat courses of asparaginase therapy for acute lymphoblastic leukemia are required or where allergic reactions force the discontinuance of the e. coli preparation',\n",
       " 'intraoperative aid in the identification and localization of intracranial tumors',\n",
       " 'chronic iron overload in alpha-thalassemia',\n",
       " 'anemias associated with myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasms',\n",
       " 'complications due to neointimal hyperplasia disease in certain vascular anastomoses',\n",
       " 'patients with stage iib, iic, iii, and iv melanoma',\n",
       " 'common variable immunodeficiency (cvid)',\n",
       " \"hoehn and yahr stage 3 and 4 parkinson's disease\",\n",
       " 'acute lymphoblastic leukemia in pediatric patients',\n",
       " 'hiv-infected pediatric patients',\n",
       " 'acute graft-versus-host disease (agvhd)',\n",
       " 'preventing hepatic injury from acetaminophin overdose',\n",
       " 'refractory glaucoma as an adjunct to ab externo glaucoma surgery',\n",
       " 'for prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary coronary artery bypass graft surgery where the risk of bleeding is especially high (impaired hemostasis) or where transfusion is unavailable or unacceptable',\n",
       " 'onchocerciasis volvulus in children and adults',\n",
       " 'human papillomavirus (hpv)-associated head and neck squamous cell carcinoma (hnscc)',\n",
       " 'primary immune thrombocytopenia',\n",
       " 'pediatric multiple sclerosis',\n",
       " 'preterm birth in women with a singleton pregnancy',\n",
       " 'advanced malignant melanoma (stages ii,iii, iv)',\n",
       " 'delayed graft function after renal transplantation',\n",
       " 'cystic fibrosis patients with pseudomonas aeruginosa lung infections',\n",
       " 'acute graft-vs-host disease following bone marrow transplantation',\n",
       " 'amelioration of recurrent attacks of acute intermittent porphyria (aip) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with aip, porphyria variegata and hereditary coproporphyria',\n",
       " 'treaatment of high risk stage ii, stage iii and stage iv melanoma',\n",
       " 'solid organ rejection',\n",
       " 'hyperammonemia and resultant hepatic encephalopathy (he) in patients with acute liver failure or acute on chronic liver disase',\n",
       " 'acute sensorineural hearing loss',\n",
       " 'esophageal dysplasia',\n",
       " 'pruritus in patients with alagille syndrome',\n",
       " 'primary fallopian tube cancer',\n",
       " 'congenital adrenal hyperpasia',\n",
       " 'patients with hepatocellular carcinoma',\n",
       " 'primary myelofibrosis (mf), post-polycythemia vera mf, and post-essential thrombocythemia mf',\n",
       " 'non-small cell lung cancer and mutations in the epidermal growth factor receptor',\n",
       " 'persistent corneal epithelial defects',\n",
       " 'human african trypanosomiasis (sleeping sickness)',\n",
       " 'for use in post-exposure prophylaxis for occupational exposure to human immunodeficiency virus',\n",
       " 'hepatitis b virus reinfection in liver transplant patients',\n",
       " 'insufficient hematopoietic stem cell production in patients with hematologic malignancies who have failed treatment with conventional chemotherapy',\n",
       " 'well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid',\n",
       " 'spasticity associated with spinal cord injury or multiple sclerosis',\n",
       " 'patients having experienced a severe traumatic brain injury (glasgow coma scale 3 to 8) in order to decrease early mortality and improve long-term functional and neurological outcome',\n",
       " 'advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy',\n",
       " 'stargardt disease (stgd)',\n",
       " 'primary ventricular fibrillation',\n",
       " 'stage iib, iic, iii & iv melanoma',\n",
       " \"friedreich's and other inherited ataxias\",\n",
       " 'intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy',\n",
       " 'mage-a3 positive non-small cell lung cancer',\n",
       " 'pediatic polycystic ovary syndrome (0 through 16 years of age)',\n",
       " 'chronic/refractory anterior noninfectious uveitis, noninfectious intermediate uveitis, noninfectious panuveitis and non-infectious, uveitis affecting the posterior of the eye (nicups)',\n",
       " 'dengue fever (includes dengue hemorrhagic fever and dengue shock syndrome)',\n",
       " 'brain metastases when used in combination with dna-damaging agents',\n",
       " 'serious burns requiring hospitalization',\n",
       " 'partial deep dermal and full thickness burn wounds',\n",
       " 'enhancement of cell engraftment in patients receiving hematopoietic stem cell transplant',\n",
       " 'for cleansing of the colon in preparation for colonoscopic diagnosis of colonic disease in children and adolescents',\n",
       " 'necrotizing enterocolitis (nec) in premature infants with very low birth weight less than or equal to 1500 grams',\n",
       " 'the preservation of organ function in brain-dead organ donors',\n",
       " 'envenomation by crotaline snakes',\n",
       " 'recurrence of pterygium after its surgical excision',\n",
       " 'to accelerate the re-epithelialization of donor sites in those hospitalized burn patients who must undergo autologous skin grafting',\n",
       " 'pediatric hiv infection/aids',\n",
       " 'antibiotic-associated pseudomembranous enterocolitis caused by toxins a and b elaborated by clostridium difficile',\n",
       " 'life-threatening ventricular arrhythmias in pediatric patients',\n",
       " 'tourette syndrome in the pediatric population (defined as 0 through 16 years of age)',\n",
       " 'to improve pulmonary function in conjunction with standard therapy in the management of patients with cystic fibrosis',\n",
       " 'ep-cam-positive squamous cell carcinoma of the head and neck',\n",
       " 'alpha-1 antitrypsin deficiency',\n",
       " 'induction treatment to prevent rejection and to minimize maintenance immunosupression in pediatric liver transplant recipients',\n",
       " 'persistent methicillin-resistant s. aureus lung infection in patients with cystic fibrosis',\n",
       " 'chronic active hepatitis b',\n",
       " 'mucopolysaccharidosis iii-b (sanfilippo syndrome type b)',\n",
       " \"aids-related kaposi's sarcoma\",\n",
       " 'vitamin e deficiency resulting from malabsorption due to prolonged cholestatic hepatobiliary disease',\n",
       " 'for use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients',\n",
       " 'post-cardiopulmonary bypass syndrome in children undergoing cardiopulmonary bypass',\n",
       " 'epstein-barr virus positive non-hodgkin lymphomas',\n",
       " 'acute ischemic stroke patients presenting within 3 hours of symptom onset',\n",
       " 'involving the posterior segment of the eye',\n",
       " 'topical treatment of metastatic melanoma',\n",
       " 'follicular non-hodgkin lymphoma',\n",
       " 'diarrhea associated with vasoactive intestinal peptide tumors (vipoma)',\n",
       " 'persistent pulmonary hypertension in the newborn',\n",
       " 'for the treatment of severe preeclampsia',\n",
       " 'mucopolysaccharidosis type i (mps i)',\n",
       " 'neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment',\n",
       " 'hyperbilirubinemia in newborn infants unresponsive to phototherapy',\n",
       " 'delayed graft function after solid organ transplantation',\n",
       " 'gastrointestinal symptoms with chronic graft versed host disease in patients undergoing allogenic hematopoietic cell transplantation',\n",
       " 'for prevention of recurrence of pneumothorax in patients at high risk of recurrence',\n",
       " 'sleep-wake disorder in smith-magenis syndrome associated with diurnal melatonin secretion',\n",
       " 'constitutional delay of growth and puberty in boys',\n",
       " \"short stature associated with turner's syndrome\",\n",
       " 'spasticity associated with multiple sclerosis and spinal cord injury',\n",
       " 'for use as an anticoagulant in patients with or at risk of heparin-induced thrombocytopenia/heparin-induced thrombocytopenia thrombosis syndrome',\n",
       " 'patients with primary immune deficiency (pid) that are intolerant to immune globulin intravenous (igiv) due to severe adverse events or poor venous access',\n",
       " 'paroxysmal nocturnal hemoglobinuria (pnh)',\n",
       " 'non-24-hour sleep-wake disorder in blind individuals without light perception',\n",
       " 'for patients with radiolucent stones in well opacifying gallbladders, in whom elective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age',\n",
       " 'adenosine deaminase deficient severe combined immunodeficiency',\n",
       " 'acute lymphoblastic leukemia in pediatric patients aged 0 through 16 years',\n",
       " 'patients with mucopolysaccharidosis-i',\n",
       " 'pulmonary arterial hypertension, who group 1',\n",
       " 'graft versus host disease following allogeneic hematopoietic stem cell transplant',\n",
       " 'graft-versus-host disease in patients undergoing allogenic hematopoietic cell transplantation',\n",
       " 'abo medical hemolytic reactions arising from abo-incompatible bone marrow transplantation',\n",
       " 'patients requiring stem cell transplantation to accelerate the mobilization of hematopoietic stem cells (cd34+) from the bone marrow to the peripheral blood when combined with a granulocyte colony-stimulating factor',\n",
       " 'metabolic disorders secondary to lipodystrophy',\n",
       " 'patients with congenital factor ix deficiency (hemophilia b)',\n",
       " 'for the detection, localization, and staging of pheochromocytomas',\n",
       " 'digeorge anomaly with immune defects',\n",
       " 'to reduce mucous viscosity and enable the clearance of airway secretions in patients with cystic fibrosis',\n",
       " 'high dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation',\n",
       " 'hiv-1 infection in treatment experienced adult patients with documented multi-antiretroviral class resistance and evidence of hiv-1 replication despite ongoing antiretroviral therapy',\n",
       " 'hypoplasminogenemia, or type i plasminogen deficiency',\n",
       " 'severe chemotherapy-induced thrombocytopenia',\n",
       " 'adjunct treatment of pancreatic cancer',\n",
       " 'vaso-occlusive crisis associated with sickle cell disease',\n",
       " 'mucopolysaccharidosis type iiia (sanfilippo a syndrome)',\n",
       " 'mild to moderate acute malaria caused by susceptible strains of p. falciparum and p. vivax',\n",
       " 'dermal injury due to nuclear/radiation incident',\n",
       " 'cd22-positive chronic lymphocytic leukemia',\n",
       " 'reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer',\n",
       " \"still's disease including juvenile rheumatoid arthritis and adult-onset still's disease\",\n",
       " 'prevention of chloroquine-resistant falciparummalaria',\n",
       " 'non-small cell lung cancer with squamous histology',\n",
       " 'aids-associated cachexia',\n",
       " 'for use in combination with levo-thyroxine to suppress thyroid stimulating hormone in patients with well-differentiated thyroid cancer who are intolerant to adequate doses of levo-thyroxine alone',\n",
       " 'patients with acute myocarditis',\n",
       " 'severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated',\n",
       " 'patients undergoing vitrectomy',\n",
       " 'all uncomplicated cutaneous leishmaniasis (both new world and old world)',\n",
       " 'maintenance treatment of patients with deficiencies in enzymes of the urea cycle',\n",
       " 'pediatric patients (age 16 years and younger) with polyarticular-course juvenile idiopathic arthritis',\n",
       " 'epidermal growth factor receptor (egfr) mutation-positive non-small cell lung cancer (nsclc)',\n",
       " \"replacement therapy in patients with types i, ii, and iii gaucher's disease\",\n",
       " 'for the treatment of acute lymphoblastic leukemia',\n",
       " 'selected, refractory patients with epilepsy who are on stable regimens of antiepileptic drugs (aed) and who require intermittent use of diazepam to control bouts of increased seizure activity (acute repetitive seizures)',\n",
       " 'emphysema secondary to alpha 1 antitrypsin deficiency',\n",
       " 'the respiratory symptoms of cystic fibrosis',\n",
       " 'primary prophylaxis of hiv-infected persons at high risk for developing toxoplasma gondii encephalitis',\n",
       " 'as an adjuvant to smallpox vaccination',\n",
       " 'chronic or recurrent central serous chorioretinopathy',\n",
       " 'acute lymphoblastic leukemia (all)',\n",
       " 'hpv-positive associated anal cancer',\n",
       " 'multiforme in pediatric patients',\n",
       " 'to reduce the risk of chronic lung disease in premature neonates',\n",
       " 'tumor lysis syndrome in cancer patients undergoing chemotherapy',\n",
       " 'cutaneous variants of porphyria (which includes treatment and prevention of cutaneous manifestations of disease)',\n",
       " 'organic acidemias',\n",
       " 'motor neuron disease/amyotrophic lateral sclerosis',\n",
       " 'type 1 diabetes mellitus patients with residual beta-cell function',\n",
       " 'reduction of adult respiratory distress syndrome',\n",
       " 'prophylactic treatment of patients exposed to inhalation anthrax',\n",
       " 'for the emergency rescue treatment of status epilepticus, grand mal type',\n",
       " 'proliferating infantile hemangiomas requiring systemic therapy',\n",
       " 'incessant ventricular tachycardia',\n",
       " 'for the prevention of acute rejection in cornea transplant patients',\n",
       " 'short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines',\n",
       " 'dental caries due to radiation-induced xerostomia in patients with head and neck cancer',\n",
       " 'stage iiib through iv metastatic melanoma',\n",
       " 'egfrviii-expressing glioblastoma multiforme',\n",
       " 'rabies virus infection including post-exposure prophylaxis (pep) for rabies',\n",
       " 'chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult t-cell leukemia, and hairy cell leukemia',\n",
       " 'for use in the emergency topical treatment of hydrogen fluoride (hydrofluoric acid) burns',\n",
       " 'hemiplegic migraine',\n",
       " 'alpha1-antitrypsin deficiency',\n",
       " 'reducing the incidence and severity of radiation-induced xerostomia',\n",
       " \"xerostomia and keratoconjunctivitis sicca in sjogren's syndrome patients\",\n",
       " 'invasive coccidioidomycosis',\n",
       " 'for replacement therapy in patients with congenital or acquired protein c deficiency for the prevention and treatment of warfarin-induced skin necrosis during oral anticoagulation',\n",
       " 'improvement of respiratory symptoms in patients with bronchiectasis and gram-negative bacteria in the airways',\n",
       " 'emphysema due to alpha1-antitrypsin deficiency',\n",
       " 'malignant brain tumors',\n",
       " 'pediatric nephrotic syndrome',\n",
       " 'for use in patients exposed to radiation following a nuclear accident or detonation in order to treat or mitigate acute radiation syndrome',\n",
       " 'uremic osteodystrophy',\n",
       " 'adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures',\n",
       " 'for use as a graft for restoring a cornea-like epithelial phenotype to substitute for the normal corneal epithelium that is lost in patients due to total limbal stem cell deficiency',\n",
       " \"anti-neutrophil cytoplasmic autoantibodies associated vasculitides (granulomatosis with polyangiitis or wegener's granulomatosis), microscopic polyangiitis, and churg-strauss syndrome\",\n",
       " \"bleeding episodes in glanzmann's thrombasthenia\",\n",
       " '1. treatment of human cytomegalovirus infection in patients diagnosed with aids 2. prevention of human cytomegalovirus infection in patients diagnosed with aids',\n",
       " 'adult t-cell leukemia/lymphoma (atll)',\n",
       " 'pediatric hiv/aids (age through 16 years)',\n",
       " 'mps-1, including hurler syndrome',\n",
       " 'topical treatment of children and adults with pouchitis',\n",
       " 'b-thalassemia major and intermedia',\n",
       " 'ascites due to all etiologies except cancer',\n",
       " \"t-cell non-hodgkin's lymphoma\",\n",
       " 'andrenoleukodystrophy',\n",
       " 'thrombotic thrombocytopenic purpura including its congential, acquired idiopathic, and secondary forms',\n",
       " \"cushing's syndrome secondary to ectopic acth secretion\",\n",
       " 'patients with a confirmed traumatic complete spinal cord injury where no motor or sensory function is preserved below the injury(scale a)',\n",
       " 'prophylactic treatment of sickle cell disease',\n",
       " 'for the prevention of hepatic veno-occlusive disease',\n",
       " 'von willebrand disease except for surgical and/or invasive procedures in patients with von willebrand disease in whom desmopressin is either ineffective or contraindicated',\n",
       " 'for the systemic treatment of cutaneous malignant melanoma',\n",
       " 'manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis',\n",
       " 'for use in combination with interferon alpha-2a, recombinant, for the treatment of advanced colorectal carcinoma',\n",
       " 'oral drug overdosage to speed lower bowel evacuation',\n",
       " 'gastro-entero-pancreatic neuroendocrine tumors',\n",
       " 'for the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism',\n",
       " \"hoehn and yahr stage 4 and 5 parkinson's disease\",\n",
       " 'endogenous and traumatic anterior uveitis and panuveitis',\n",
       " 'acute myeloid (myelogenous) leukemia',\n",
       " 'invasive malignant melanoma',\n",
       " 'assessment of rejection status in heart, heart-lung, single lung, or bilateral lung transplants',\n",
       " 'prophylactic use in pediatric patients (age 0 through 16 years) with esophageal varices that are at risk of bleeding to obliterate varices and to prevent bleeding',\n",
       " 'for the treatment of gastric cancer including gastroesophageal junction cancer',\n",
       " 'invasive candidiasis/candidemia',\n",
       " 'stage iib through stage iv melanoma',\n",
       " 'of hepatocellular carcinoma',\n",
       " 'use as a targeted contrast agent for diagnostic mri for the detection and localization of focal liver lesions in patients where use of gadolinium based contrast agents may be medically inadvisable or where gadolinium based contrast agents cannot be administered',\n",
       " 'malignant glioma with braf v600 mutation',\n",
       " 'high risk stage ii, stage iii, and stage iv melanoma',\n",
       " 'the management of neuroendocrine tumors',\n",
       " 'pancreatic cancer in combination with ifosfamide',\n",
       " 'pulmonary infections due to pseudomonas aeruginosa and other bacteria in patients with cystic fibrosis patients',\n",
       " 'therapeutic treatment of patients with ovarian cancer',\n",
       " 'patients with chronic lymphocytic leukemia',\n",
       " 'astrocytic tumors',\n",
       " 'replacement t-cell therapy for the treatment of immunodeficiency and graft versus host disease after allogeneic hematopoietic stem cell transplant',\n",
       " 'for use in conjunction with melphalen for the treatment of malignant melanoma, ajcc stages iib, iic, iii and iv',\n",
       " 'beta-hemoglobinopathies and beta-thalassemia syndromes',\n",
       " 'acute rejection following kidney, heart, and liver transplantation',\n",
       " 'graft rejection during pancreatic islet transplantation',\n",
       " 'congential hyperinsulinenic hypoglycemia and other causes of hyperinsulinemic hypoglycemia in adults and children',\n",
       " 'pre-exposure prophylaxis of ebola virus disease',\n",
       " 'pediatric adrenal insufficiency (0 through 16 years of age)',\n",
       " 'x-linked juvenile retinoschisis (xlrs)',\n",
       " 'thrombocytopenia associated with myelodysplasia syndrome',\n",
       " 'prophylactic treatment of mycobacterium avium complex in patients with aids and a cd4+ count less than or equal to 75/mm3',\n",
       " 'neuropathic pain in patients with postherpetic neuralgia',\n",
       " 'for the acute treatment of patients with status epilepticus of the grand mal type',\n",
       " 'scorpion envenomations requiring medical attention',\n",
       " \"acute flares in pediatric patients with ileo-cecal crohn's disease\",\n",
       " 'for use in conjunction with diagnostic, therapeutic, or combined diagnostic/therapeutic procedures for pancreatic disorders to increase pancreatic fluid secretion',\n",
       " 'pulmonary infection due to burkholderia cepacia complex pathogens in cystic fibrosis patients',\n",
       " 'bronchopulmonary dysplasia in premature infants',\n",
       " 'cln2 disease (neuronal ceroid lipofuscinosis (ncl)) caused by tpp1 deficiency',\n",
       " 'inflammatory complications of transthoracic esophagectomy',\n",
       " 'for use as physiologic testosterone replacement in androgen deficient hiv+ patients with an associated weight loss',\n",
       " 'thrombocytosis in chronic myelogenous leukemia',\n",
       " 'idiopathic or organic growth hormone deficiency in children with growth failure',\n",
       " 'intravenous treatment of patients presenting with moderate to severe acetaminophen overdose',\n",
       " 'for the treatment of of stage iib, stage iic, stage iii and stage iv melanoma',\n",
       " 'hepatitis b recurrence following orthotopic liver transplant',\n",
       " \"tourette's syndrome in pediatric patients\",\n",
       " 'sickle cell disease crisis',\n",
       " 'excessive daytime sleepiness in narcolepsy',\n",
       " 'spinocereballar ataxia',\n",
       " 'ulcerative colitis in pediatric patients age 0 through 16 years',\n",
       " 'patients with neurotrophic keratopathy',\n",
       " 'non-small cell lung cancer in patients expressing hla-a2',\n",
       " 'for the treatment of pediatric homozygous familial hypercholesterolemia',\n",
       " 'neuropathic pain associated with spinal cord injury',\n",
       " 'acute subarachnoid hemorrhage',\n",
       " 'fungal otitis externa (otomycosis)',\n",
       " 'to slow the progression of iga nephropathy and delay kidney failure in patients affected by the disease',\n",
       " 'non-superficial urothelial cancer',\n",
       " 'erbb2 positive esophageal cancer',\n",
       " 'for rescue use after high dose methotrexate therapy in the treatment of osteosarcoma',\n",
       " 'acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle',\n",
       " 'histologically confirmed advanced or metastatic pancreatic cancer',\n",
       " 'hereditary dystrophic epidermolysis bullosa (deb)',\n",
       " \"symptomatic paget's disease (osteitis deformans)\",\n",
       " 'pediatric patients with chronic hepatitis c virus infection',\n",
       " 'severe recurrent aphthous stomatitis in severely, terminally immunocompromised patients',\n",
       " 'patients with gram-negative bacteremia which has progressed to endotoxin shock',\n",
       " 'prevention of recurrence) of ovarian cancer',\n",
       " 'for symptomatic relief and parasitic cure of chronic cryptosporidiosis in patients with immunodeficiency',\n",
       " 'for the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (aeds), who require intermittent use of diazepam to control bouts of increased seizure activity',\n",
       " 'detection of suspected and previously unidentified tumor foci of recurrent colorectal carcinoma',\n",
       " 'for the prevention of acute rejection of cardiac allografts',\n",
       " 'patients with frederickson type i or v hyperlipoproteinemia',\n",
       " 'patients with brain stem glioma',\n",
       " ...}"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "diseases_not_matched"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "df['doid'] = df.indication.apply(doid_matches.get)\n",
    "df['hpo'] = df.indication.apply(hpo_matches.get)\n",
    "df['ordo'] = df.indication.apply(ordo_matches.get)\n",
    "df['mesh'] = df.indication.apply(mesh_matches.get)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "doid_wd = wdi_helpers.id_mapper(\"P699\")\n",
    "ordo_wd = wdi_helpers.id_mapper(\"P1550\")\n",
    "mesh_wd = wdi_helpers.id_mapper(\"P486\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'squamous non-small cell lung cancer'"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"squamous non-small cell lung cancer\"\n",
    "# http://www.ebi.ac.uk/ols/ontologies/hp/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FHP_0030359"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "df.loc[:,'indication_qid_doid'] = df.doid.dropna().apply(lambda x:doid_wd.get(x.split(\"/\")[-1].replace(\"_\",\":\")))\n",
    "df.loc[:,'indication_qid_ordo'] = df.ordo.dropna().apply(lambda x:ordo_wd.get(x.split(\"_\")[-1]))\n",
    "df.loc[:,'indication_qid_mesh'] = df.mesh.dropna().apply(mesh_wd.get)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "      <th>drug_qid</th>\n",
       "      <th>inchi</th>\n",
       "      <th>indication</th>\n",
       "      <th>doid</th>\n",
       "      <th>hpo</th>\n",
       "      <th>ordo</th>\n",
       "      <th>mesh</th>\n",
       "      <th>indication_qid_doid</th>\n",
       "      <th>indication_qid_ordo</th>\n",
       "      <th>indication_qid_mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid</td>\n",
       "      <td>Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy</td>\n",
       "      <td>03/31/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27088744</td>\n",
       "      <td>ZVVCSBSDFGYRCB-UHFFFAOYSA-N</td>\n",
       "      <td>serious adverse events associated with vascular leak syndrome caused by interleukin-2 therapy</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of Stage IIB through Stage IV malignant melanoma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>stage iib through stage iv malignant melanoma</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>cholangiocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4947</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0030153</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_70567</td>\n",
       "      <td>D018281</td>\n",
       "      <td>Q124292</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556554</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>pancreatic cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1793</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002894</td>\n",
       "      <td>None</td>\n",
       "      <td>D010190</td>\n",
       "      <td>Q212961</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q212961</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q6589598</td>\n",
       "      <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                     Generic Name  \\\n",
       "0  (+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid   \n",
       "1  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "2  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "3  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "4  (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                      \n",
       "\n",
       "                                                                                            Orphan Designation  \\\n",
       "0  Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy   \n",
       "1  Treatment of Stage IIB through Stage IV malignant melanoma                                                    \n",
       "2  Treatment of cholangiocarcinoma                                                                               \n",
       "3  Treatment of pancreatic cancer                                                                                \n",
       "4  Treatment of Fragile X syndrome                                                                               \n",
       "\n",
       "  Designation Date    Designation Status   drug_qid  \\\n",
       "0  03/31/2003       Designated/Withdrawn  Q27088744   \n",
       "1  02/01/2008       Designated/Withdrawn  None        \n",
       "2  01/10/2008       Designated/Withdrawn  None        \n",
       "3  01/10/2008       Designated/Withdrawn  None        \n",
       "4  10/12/2011       Designated            Q6589598    \n",
       "\n",
       "                         inchi  \\\n",
       "0  ZVVCSBSDFGYRCB-UHFFFAOYSA-N   \n",
       "1  None                          \n",
       "2  None                          \n",
       "3  None                          \n",
       "4  ZFPZEYHRWGMJCV-ZHALLVOQSA-N   \n",
       "\n",
       "                                                                                      indication  \\\n",
       "0  serious adverse events associated with vascular leak syndrome caused by interleukin-2 therapy   \n",
       "1  stage iib through stage iv malignant melanoma                                                   \n",
       "2  cholangiocarcinoma                                                                              \n",
       "3  pancreatic cancer                                                                               \n",
       "4  fragile x syndrome                                                                              \n",
       "\n",
       "                                        doid  \\\n",
       "0  None                                        \n",
       "1  None                                        \n",
       "2  http://purl.obolibrary.org/obo/DOID_4947    \n",
       "3  http://purl.obolibrary.org/obo/DOID_1793    \n",
       "4  http://purl.obolibrary.org/obo/DOID_14261   \n",
       "\n",
       "                                         hpo  \\\n",
       "0  None                                        \n",
       "1  None                                        \n",
       "2  http://purl.obolibrary.org/obo/HP_0030153   \n",
       "3  http://purl.obolibrary.org/obo/HP_0002894   \n",
       "4  None                                        \n",
       "\n",
       "                                       ordo     mesh indication_qid_doid  \\\n",
       "0  None                                      None     NaN                  \n",
       "1  None                                      None     NaN                  \n",
       "2  http://www.orpha.net/ORDO/Orphanet_70567  D018281  Q124292              \n",
       "3  None                                      D010190  Q212961              \n",
       "4  http://www.orpha.net/ORDO/Orphanet_908    D005600  Q221472              \n",
       "\n",
       "  indication_qid_ordo indication_qid_mesh  \n",
       "0  NaN                 NaN                 \n",
       "1  NaN                 NaN                 \n",
       "2  None                Q18556554           \n",
       "3  NaN                 Q212961             \n",
       "4  Q221472             Q221472             "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "collapsed": true,
    "deletable": true,
    "editable": true
   },
   "outputs": [],
   "source": [
    "df.to_csv(\"fda_orphan_match.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "      <th>drug_qid</th>\n",
       "      <th>inchi</th>\n",
       "      <th>indication</th>\n",
       "      <th>doid</th>\n",
       "      <th>hpo</th>\n",
       "      <th>ordo</th>\n",
       "      <th>mesh</th>\n",
       "      <th>indication_qid_doid</th>\n",
       "      <th>indication_qid_ordo</th>\n",
       "      <th>indication_qid_mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q6589598</td>\n",
       "      <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>(2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride</td>\n",
       "      <td>Treatment of Rett Syndrome.</td>\n",
       "      <td>05/18/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27252594</td>\n",
       "      <td>FEQOLYDPQKHFTD-UHFFFAOYSA-N</td>\n",
       "      <td>rett syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1206</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_778</td>\n",
       "      <td>D015518</td>\n",
       "      <td>Q917357</td>\n",
       "      <td>None</td>\n",
       "      <td>Q917357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>(2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>11/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258687</td>\n",
       "      <td>VLIUIBXPEDFJRF-UHFFFAOYSA-N</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>(2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)</td>\n",
       "      <td>Treatment of systemic sclerosis.</td>\n",
       "      <td>10/14/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258840</td>\n",
       "      <td>RGYQPQARIQKJKH-UHFFFAOYSA-N</td>\n",
       "      <td>systemic sclerosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_418</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_90291</td>\n",
       "      <td>D012595</td>\n",
       "      <td>Q5340515</td>\n",
       "      <td>None</td>\n",
       "      <td>Q5340515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>(3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate</td>\n",
       "      <td>Treatment of Gaucher disease</td>\n",
       "      <td>09/11/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27274745</td>\n",
       "      <td>YFHRCLAKZBDRHN-MRXNPFEDSA-N</td>\n",
       "      <td>gaucher disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1926</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_355</td>\n",
       "      <td>D005776</td>\n",
       "      <td>Q861645</td>\n",
       "      <td>Q861645</td>\n",
       "      <td>Q861645</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride</td>\n",
       "      <td>Treatment of erythromelalgia</td>\n",
       "      <td>01/30/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27268497</td>\n",
       "      <td>HEPUBAGOKRIZEO-PPPUBMIESA-N</td>\n",
       "      <td>erythromelalgia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9240</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_1956</td>\n",
       "      <td>D004916</td>\n",
       "      <td>Q524353</td>\n",
       "      <td>None</td>\n",
       "      <td>Q524353</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole</td>\n",
       "      <td>Treatment of pulmonary tuberculosis.</td>\n",
       "      <td>07/12/2007</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q15408413</td>\n",
       "      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>\n",
       "      <td>pulmonary tuberculosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2957</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D014397</td>\n",
       "      <td>Q18555243</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q18555243</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>(R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>05/05/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27292463</td>\n",
       "      <td>WDVGRPCSLPVWKC-VROLVAQFSA-N</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>(S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>11/05/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27236818</td>\n",
       "      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one</td>\n",
       "      <td>Treatment of follicular lymphoma</td>\n",
       "      <td>08/01/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27077129</td>\n",
       "      <td>SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>\n",
       "      <td>follicular lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050873</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_545</td>\n",
       "      <td>D008224</td>\n",
       "      <td>Q123251</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>(S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)-imidazo[1,5-a]pyrazine-1-yl)-N-(pyridine-2-yl)-benzamide</td>\n",
       "      <td>Treatment of mantle cell lymphoma.</td>\n",
       "      <td>09/21/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23668732</td>\n",
       "      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>\n",
       "      <td>mantle cell lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050746</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_52416</td>\n",
       "      <td>D020522</td>\n",
       "      <td>Q268713</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one</td>\n",
       "      <td>Treatment of Hodgkin lymphoma</td>\n",
       "      <td>04/29/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27254856</td>\n",
       "      <td>RSIWALKZYXPAGW-NSHDSACASA-N</td>\n",
       "      <td>hodgkin lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_8567</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0012189</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_98293</td>\n",
       "      <td>D006689</td>\n",
       "      <td>Q209369</td>\n",
       "      <td>Q209369</td>\n",
       "      <td>Q18557991</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid</td>\n",
       "      <td>Treatment of systemic sclerosis</td>\n",
       "      <td>03/31/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27896056</td>\n",
       "      <td>OQDQIFQRNZIEEJ-UHFFFAOYSA-N</td>\n",
       "      <td>systemic sclerosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_418</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_90291</td>\n",
       "      <td>D012595</td>\n",
       "      <td>Q5340515</td>\n",
       "      <td>None</td>\n",
       "      <td>Q5340515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>11/12/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27453557</td>\n",
       "      <td>LOLPPWBBNUVNQZ-UHFFFAOYSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione</td>\n",
       "      <td>Treatment of idiopathic pulmonary fibrosis.</td>\n",
       "      <td>09/21/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258840</td>\n",
       "      <td>RGYQPQARIQKJKH-UHFFFAOYSA-N</td>\n",
       "      <td>idiopathic pulmonary fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050156</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2032</td>\n",
       "      <td>D054990</td>\n",
       "      <td>Q2290446</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2290446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>2-chloroethyl-3-sarcosinamide-1-nitrosourea</td>\n",
       "      <td>Treatment for malignant glioma</td>\n",
       "      <td>11/15/2001</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27274664</td>\n",
       "      <td>None</td>\n",
       "      <td>malignant glioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3070</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005910</td>\n",
       "      <td>Q1365309</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q18556612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>2-methoxyestradiol</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>07/10/2001</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q4596897</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>2-methoxyestradiol</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>04/04/2005</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q4596897</td>\n",
       "      <td>None</td>\n",
       "      <td>ovarian cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2394</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_213500</td>\n",
       "      <td>D010051</td>\n",
       "      <td>Q172341</td>\n",
       "      <td>None</td>\n",
       "      <td>Q172341</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole</td>\n",
       "      <td>Treatment of hepatocellular carcinoma.</td>\n",
       "      <td>08/27/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q254296</td>\n",
       "      <td>MJIHNNLFOKEZEW-UHFFFAOYSA-N</td>\n",
       "      <td>hepatocellular carcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_684</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0001402</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_88673</td>\n",
       "      <td>D006528</td>\n",
       "      <td>Q1148337</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1148337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>3'-azido-2',3'dideoxyuridine</td>\n",
       "      <td>Treatment of acquired immunodeficiency syndrome.</td>\n",
       "      <td>11/20/1989</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27286725</td>\n",
       "      <td>ZSNNBSPEFVIUDS-SHYZEUOFSA-N</td>\n",
       "      <td>acquired immunodeficiency syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>3,4-diaminopyridine</td>\n",
       "      <td>Treatment of Lambert-Eaton myasthenic syndrome.</td>\n",
       "      <td>12/18/1990</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q411707</td>\n",
       "      <td>OYTKINVCDFNREN-UHFFFAOYSA-N</td>\n",
       "      <td>lambert-eaton myasthenic syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050214</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_43393</td>\n",
       "      <td>D015624</td>\n",
       "      <td>Q1756898</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1756898</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>3,5-diiodothyropropionic acid</td>\n",
       "      <td>Treatment of Allan-Herndon-Dudley syndrome</td>\n",
       "      <td>05/14/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27252433</td>\n",
       "      <td>None</td>\n",
       "      <td>allan-herndon-dudley syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050631</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_59</td>\n",
       "      <td>None</td>\n",
       "      <td>Q4731121</td>\n",
       "      <td>Q4731121</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>3-aminopropyl-butyl phosphinic acid</td>\n",
       "      <td>Treatment of succinic semialdehyde dehydrogenase deficiency.</td>\n",
       "      <td>12/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27075900</td>\n",
       "      <td>ONNMDRQRSGKZCN-UHFFFAOYSA-N</td>\n",
       "      <td>succinic semialdehyde dehydrogenase deficiency</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0060175</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_22</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2823333</td>\n",
       "      <td>Q2823333</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>3-bromopyruvate</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>04/29/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27073726</td>\n",
       "      <td>PRRZDZJYSJLDBS-UHFFFAOYSA-M</td>\n",
       "      <td>pancreatic cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1793</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002894</td>\n",
       "      <td>None</td>\n",
       "      <td>D010190</td>\n",
       "      <td>Q212961</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q212961</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>3-chloro-4-fluorophenyl-[4-fluoro-4-[[(5-methylpyrimidin-2-ylmethyl)amino]methyl]piperidin-1yl]methanone</td>\n",
       "      <td>Treatment of Rett syndrome</td>\n",
       "      <td>10/25/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q5423588</td>\n",
       "      <td>WAAXKNFGOFTGLP-UHFFFAOYSA-N</td>\n",
       "      <td>rett syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1206</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_778</td>\n",
       "      <td>D015518</td>\n",
       "      <td>Q917357</td>\n",
       "      <td>None</td>\n",
       "      <td>Q917357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol</td>\n",
       "      <td>Treatment of Angelman syndrome.</td>\n",
       "      <td>09/06/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4130924</td>\n",
       "      <td>ZXRVKCBLGJOCEE-UHFFFAOYSA-N</td>\n",
       "      <td>angelman syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1932</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_120365</td>\n",
       "      <td>D017204</td>\n",
       "      <td>Q535364</td>\n",
       "      <td>None</td>\n",
       "      <td>Q535364</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl</td>\n",
       "      <td>Treatment of Huntington's disease.</td>\n",
       "      <td>12/12/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27287263</td>\n",
       "      <td>YGRHOYQMBLLGEV-UHFFFAOYSA-N</td>\n",
       "      <td>huntington's disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12858</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D006816</td>\n",
       "      <td>Q190564</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q190564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide</td>\n",
       "      <td>Treatment of diffuse large B-cell lymphoma.</td>\n",
       "      <td>03/27/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>LQBVNQSMGBZMKD-UHFFFAOYSA-N</td>\n",
       "      <td>diffuse large b-cell lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050745</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_544</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2626074</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>4-[131I]iodo-L-phenylalanine</td>\n",
       "      <td>Treatment of glioma.</td>\n",
       "      <td>01/04/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27263179</td>\n",
       "      <td>PZNQZSRPDOEBMS-WPUCPVGPSA-N</td>\n",
       "      <td>glioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3070</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0009733</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_182067</td>\n",
       "      <td>D005910</td>\n",
       "      <td>Q1365309</td>\n",
       "      <td>Q1365309</td>\n",
       "      <td>Q18556612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid</td>\n",
       "      <td>Treatment of Acute Myeloid Leukemia</td>\n",
       "      <td>05/19/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27287480</td>\n",
       "      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>5,6-dihydro-5-azacytidine</td>\n",
       "      <td>Treatment of malignant mesothelioma.</td>\n",
       "      <td>05/11/1992</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27236168</td>\n",
       "      <td>LJIRBXZDQGQUOO-KVTDHHQDSA-N</td>\n",
       "      <td>malignant mesothelioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1790</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0100001</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1077603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine hydrochloride</td>\n",
       "      <td>Treatment of progressive supranuclear palsy.</td>\n",
       "      <td>04/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265266</td>\n",
       "      <td>FVWAMONNJGNNHY-UHFFFAOYSA-N</td>\n",
       "      <td>progressive supranuclear palsy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_678</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_683</td>\n",
       "      <td>D013494</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>5-aza-2'-deoxycytidine</td>\n",
       "      <td>Treatment of acute leukemia.</td>\n",
       "      <td>08/03/1987</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q1181878</td>\n",
       "      <td>XAUDJQYHKZQPEU-KVQBGUIXSA-N</td>\n",
       "      <td>acute leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12603</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002488</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q976388</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>5-[(E)-2-(4-hydroxyphenyl)-ethenyl] benzene-1,3 diol</td>\n",
       "      <td>Treatment of MELAS syndrome</td>\n",
       "      <td>03/13/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q407329</td>\n",
       "      <td>LUKBXSAWLPMMSZ-OWOJBTEDSA-N</td>\n",
       "      <td>melas syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3687</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D017241</td>\n",
       "      <td>Q2666433</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q2666433</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>5-[1-(2,6-Dichlorobenzyl)-piperidin-4-yl]methoxyquinazoline-2,4-diamine</td>\n",
       "      <td>Treatment of spinal muscular atrophy</td>\n",
       "      <td>08/25/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27282418</td>\n",
       "      <td>MNLHFGXIUJNDAF-UHFFFAOYSA-N</td>\n",
       "      <td>spinal muscular atrophy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12377</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0007269</td>\n",
       "      <td>None</td>\n",
       "      <td>D009134</td>\n",
       "      <td>Q580290</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q7577466</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6yl]-2-pyrimidinamine</td>\n",
       "      <td>Treatment of malignant mesothelioma</td>\n",
       "      <td>02/10/2015</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27089164</td>\n",
       "      <td>QYBGBLQCOOISAR-UHFFFAOYSA-N</td>\n",
       "      <td>malignant mesothelioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1790</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0100001</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1077603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>6,8-bis-benzylsulfanyl-octanoic acid</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>08/22/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27276958</td>\n",
       "      <td>ZYRLHJIMTROTBO-UHFFFAOYSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>6,8-bis-benzylsulfanyl-octanoic acid</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>02/06/2006</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27276958</td>\n",
       "      <td>ZYRLHJIMTROTBO-UHFFFAOYSA-N</td>\n",
       "      <td>pancreatic cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1793</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002894</td>\n",
       "      <td>None</td>\n",
       "      <td>D010190</td>\n",
       "      <td>Q212961</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q212961</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>6,8-bis-benzylsulfanyl-octanoic acid</td>\n",
       "      <td>Treatment of myelodysplastic syndrome</td>\n",
       "      <td>09/26/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27276958</td>\n",
       "      <td>ZYRLHJIMTROTBO-UHFFFAOYSA-N</td>\n",
       "      <td>myelodysplastic syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050908</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002863</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_52688</td>\n",
       "      <td>D009190</td>\n",
       "      <td>Q954625</td>\n",
       "      <td>None</td>\n",
       "      <td>Q954625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>6-methoxy-3-(3',4',5'-trimethoxybenzoyl) indole</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>05/11/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27292488</td>\n",
       "      <td>UZJVBXKFBQNDTQ-UHFFFAOYSA-N</td>\n",
       "      <td>cholangiocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4947</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0030153</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_70567</td>\n",
       "      <td>D018281</td>\n",
       "      <td>Q124292</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556554</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>8 Cyclopentyl 1,3-dipropylxanthine</td>\n",
       "      <td>Treatment of cystic fibrosis.</td>\n",
       "      <td>03/24/1997</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q5280076</td>\n",
       "      <td>FFBDFADSZUINTG-UHFFFAOYSA-N</td>\n",
       "      <td>cystic fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1485</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_586</td>\n",
       "      <td>D003550</td>\n",
       "      <td>Q178194</td>\n",
       "      <td>None</td>\n",
       "      <td>Q178194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one</td>\n",
       "      <td>Treatment of glioblastoma multiforme</td>\n",
       "      <td>01/21/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27294013</td>\n",
       "      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>\n",
       "      <td>glioblastoma multiforme</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3068</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0012174</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_360</td>\n",
       "      <td>D005909</td>\n",
       "      <td>Q282142</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18555280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>Abetimus</td>\n",
       "      <td>Treatment of lupus nephritis.</td>\n",
       "      <td>07/28/2000</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4667244</td>\n",
       "      <td>None</td>\n",
       "      <td>lupus nephritis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0080162</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D008181</td>\n",
       "      <td>Q1621830</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1621830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>acadesine</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>03/03/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4671562</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>acadesine</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>05/04/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4671562</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>acamprosate</td>\n",
       "      <td>Treatment of fragile X syndrome</td>\n",
       "      <td>03/25/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q337668</td>\n",
       "      <td>None</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>aceneuramic acid</td>\n",
       "      <td>Treatment of hereditary inclusion body myopathy</td>\n",
       "      <td>09/23/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27120624</td>\n",
       "      <td>None</td>\n",
       "      <td>hereditary inclusion body myopathy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3429</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1848471</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>acetyl-l-carnitine</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>07/24/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q311992</td>\n",
       "      <td>GJTJQSPLLQWKMB-SECBINFHSA-N</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>Aconiazide</td>\n",
       "      <td>Treatment of tuberculosis.</td>\n",
       "      <td>06/20/1988</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q15633956</td>\n",
       "      <td>None</td>\n",
       "      <td>tuberculosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_399</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_3389</td>\n",
       "      <td>D014376</td>\n",
       "      <td>Q12204</td>\n",
       "      <td>None</td>\n",
       "      <td>Q12204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>adalimumab</td>\n",
       "      <td>Treatment of juvenile rheumatoid arthritis</td>\n",
       "      <td>03/21/2005</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q348260</td>\n",
       "      <td>None</td>\n",
       "      <td>juvenile rheumatoid arthritis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_676</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005681</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_92</td>\n",
       "      <td>D001171</td>\n",
       "      <td>Q861224</td>\n",
       "      <td>Q861224</td>\n",
       "      <td>Q861224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3779</th>\n",
       "      <td>tigecycline</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>10/23/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q420595</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3782</th>\n",
       "      <td>tinidazole</td>\n",
       "      <td>Treatment of giardiasis</td>\n",
       "      <td>04/18/2002</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q1321320</td>\n",
       "      <td>None</td>\n",
       "      <td>giardiasis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_10718</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005873</td>\n",
       "      <td>Q326071</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q326071</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3783</th>\n",
       "      <td>Tinidazole</td>\n",
       "      <td>Treatment of amebiasis</td>\n",
       "      <td>08/20/2003</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q1321320</td>\n",
       "      <td>None</td>\n",
       "      <td>amebiasis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9181</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000562</td>\n",
       "      <td>Q949694</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q949694</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3786</th>\n",
       "      <td>tipelukast</td>\n",
       "      <td>Treatment of idiopathic pulmonary fibrosis</td>\n",
       "      <td>10/20/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27236352</td>\n",
       "      <td>None</td>\n",
       "      <td>idiopathic pulmonary fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050156</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2032</td>\n",
       "      <td>D054990</td>\n",
       "      <td>Q2290446</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2290446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3787</th>\n",
       "      <td>Tipifarnib</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>07/06/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7808830</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3789</th>\n",
       "      <td>tirapazamine</td>\n",
       "      <td>Treatment of hepatocellular carcinoma</td>\n",
       "      <td>11/30/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q3529346</td>\n",
       "      <td>None</td>\n",
       "      <td>hepatocellular carcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_684</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0001402</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_88673</td>\n",
       "      <td>D006528</td>\n",
       "      <td>Q1148337</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1148337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3790</th>\n",
       "      <td>tirapazamine</td>\n",
       "      <td>Treatment of head and neck cancer</td>\n",
       "      <td>10/23/2002</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q3529346</td>\n",
       "      <td>None</td>\n",
       "      <td>head and neck cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_11934</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0012288</td>\n",
       "      <td>None</td>\n",
       "      <td>D006258</td>\n",
       "      <td>Q1783924</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1783924</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3804</th>\n",
       "      <td>tocilizumab</td>\n",
       "      <td>Treatment of systemic sclerosis</td>\n",
       "      <td>04/17/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q425154</td>\n",
       "      <td>None</td>\n",
       "      <td>systemic sclerosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_418</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_90291</td>\n",
       "      <td>D012595</td>\n",
       "      <td>Q5340515</td>\n",
       "      <td>None</td>\n",
       "      <td>Q5340515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3807</th>\n",
       "      <td>Tolcapone</td>\n",
       "      <td>Treatment of transthyretin amyloidosis</td>\n",
       "      <td>12/24/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q413840</td>\n",
       "      <td>None</td>\n",
       "      <td>transthyretin amyloidosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050638</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2844603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3809</th>\n",
       "      <td>tolfenamic acid</td>\n",
       "      <td>Treatment of progressive supranuclear palsy</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q59412</td>\n",
       "      <td>None</td>\n",
       "      <td>progressive supranuclear palsy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_678</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_683</td>\n",
       "      <td>D013494</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3810</th>\n",
       "      <td>tolfenamic acid</td>\n",
       "      <td>Treatment of Frontotemporal Dementia</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q59412</td>\n",
       "      <td>None</td>\n",
       "      <td>frontotemporal dementia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9255</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002145</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_282</td>\n",
       "      <td>D057180</td>\n",
       "      <td>Q18592</td>\n",
       "      <td>Q18592</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3812</th>\n",
       "      <td>Topiramate</td>\n",
       "      <td>Treatment of Lennox-Gastaut syndrome.</td>\n",
       "      <td>11/25/1992</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q221174</td>\n",
       "      <td>None</td>\n",
       "      <td>lennox-gastaut syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050561</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2382</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1544884</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3817</th>\n",
       "      <td>Tosedostat</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>12/10/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27166812</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3824</th>\n",
       "      <td>tralokinumab</td>\n",
       "      <td>Treatment of idiopathic pulmonary fibrosis</td>\n",
       "      <td>07/24/2012</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q7833105</td>\n",
       "      <td>None</td>\n",
       "      <td>idiopathic pulmonary fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050156</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2032</td>\n",
       "      <td>D054990</td>\n",
       "      <td>Q2290446</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2290446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3844</th>\n",
       "      <td>tremelimumab</td>\n",
       "      <td>Treatment of malignant mesothelioma</td>\n",
       "      <td>03/18/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7838098</td>\n",
       "      <td>None</td>\n",
       "      <td>malignant mesothelioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1790</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0100001</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1077603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3847</th>\n",
       "      <td>Treosulfan</td>\n",
       "      <td>Treatment of ovarian cancer.</td>\n",
       "      <td>05/16/1994</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7838652</td>\n",
       "      <td>None</td>\n",
       "      <td>ovarian cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2394</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_213500</td>\n",
       "      <td>D010051</td>\n",
       "      <td>Q172341</td>\n",
       "      <td>None</td>\n",
       "      <td>Q172341</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3854</th>\n",
       "      <td>Tretinoin</td>\n",
       "      <td>Treatment of acute promyelocytic leukemia.</td>\n",
       "      <td>10/24/1990</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q29417</td>\n",
       "      <td>None</td>\n",
       "      <td>acute promyelocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0060318</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004836</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_520</td>\n",
       "      <td>D015473</td>\n",
       "      <td>Q612108</td>\n",
       "      <td>Q612108</td>\n",
       "      <td>Q612108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3856</th>\n",
       "      <td>triciribine</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27887003</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3857</th>\n",
       "      <td>triclabendazole</td>\n",
       "      <td>Treatment of fascioliasis.</td>\n",
       "      <td>06/27/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q419739</td>\n",
       "      <td>None</td>\n",
       "      <td>fascioliasis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_885</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005211</td>\n",
       "      <td>Q719656</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q719656</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3867</th>\n",
       "      <td>Trimetrexate glucuronate</td>\n",
       "      <td>Treatment of pancreatic adenocarcinoma.</td>\n",
       "      <td>07/25/1985</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27282570</td>\n",
       "      <td>None</td>\n",
       "      <td>pancreatic adenocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4074</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006725</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556189</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3880</th>\n",
       "      <td>Troxacitabine</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>04/04/2005</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q7846702</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3886</th>\n",
       "      <td>Tyloxapol</td>\n",
       "      <td>Treatment of cystic fibrosis.</td>\n",
       "      <td>03/08/1995</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7860340</td>\n",
       "      <td>None</td>\n",
       "      <td>cystic fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1485</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_586</td>\n",
       "      <td>D003550</td>\n",
       "      <td>Q178194</td>\n",
       "      <td>None</td>\n",
       "      <td>Q178194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3889</th>\n",
       "      <td>ubiquinol</td>\n",
       "      <td>Treatment of Huntington's Disease</td>\n",
       "      <td>04/12/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q411963</td>\n",
       "      <td>None</td>\n",
       "      <td>huntington's disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12858</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D006816</td>\n",
       "      <td>Q190564</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q190564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3892</th>\n",
       "      <td>ublituximab</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>08/06/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7876570</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3899</th>\n",
       "      <td>ulocuplumab</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>01/12/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q21098907</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3900</th>\n",
       "      <td>unoprostone isopropyl</td>\n",
       "      <td>Treatment of retinitis pigmentosa</td>\n",
       "      <td>09/16/2010</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27089094</td>\n",
       "      <td>None</td>\n",
       "      <td>retinitis pigmentosa</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_10584</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0000510</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_791</td>\n",
       "      <td>D012174</td>\n",
       "      <td>Q847057</td>\n",
       "      <td>Q847057</td>\n",
       "      <td>Q847057</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3920</th>\n",
       "      <td>vadastuximab talirine</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>11/10/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q17044502</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3923</th>\n",
       "      <td>Valproate</td>\n",
       "      <td>Treatment of fragile X syndrome</td>\n",
       "      <td>05/05/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27104876</td>\n",
       "      <td>NIJJYAXOARWZEE-UHFFFAOYSA-M</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3927</th>\n",
       "      <td>vamorolone</td>\n",
       "      <td>Treatment of Duchenne muscular dystrophy</td>\n",
       "      <td>12/02/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27089127</td>\n",
       "      <td>None</td>\n",
       "      <td>duchenne muscular dystrophy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_11723</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_98896</td>\n",
       "      <td>D020388</td>\n",
       "      <td>Q1648484</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1648484</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3928</th>\n",
       "      <td>vancomycin</td>\n",
       "      <td>Treatment of endophthalmitis</td>\n",
       "      <td>12/27/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q424027</td>\n",
       "      <td>None</td>\n",
       "      <td>endophthalmitis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4692</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_199323</td>\n",
       "      <td>D009877</td>\n",
       "      <td>Q1294912</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1294912</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3936</th>\n",
       "      <td>vapreotide</td>\n",
       "      <td>Treatment of acromegaly</td>\n",
       "      <td>11/04/2003</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4008670</td>\n",
       "      <td>None</td>\n",
       "      <td>acromegaly</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2449</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0000845</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_963</td>\n",
       "      <td>D000172</td>\n",
       "      <td>Q189580</td>\n",
       "      <td>None</td>\n",
       "      <td>Q189580</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3940</th>\n",
       "      <td>Varlitinib</td>\n",
       "      <td>Treatment of cholangiocarcinoma.</td>\n",
       "      <td>08/05/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27089126</td>\n",
       "      <td>None</td>\n",
       "      <td>cholangiocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4947</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0030153</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_70567</td>\n",
       "      <td>D018281</td>\n",
       "      <td>Q124292</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556554</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3947</th>\n",
       "      <td>vatiquinone</td>\n",
       "      <td>Treatment of Friedreich's ataxia</td>\n",
       "      <td>01/31/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265220</td>\n",
       "      <td>None</td>\n",
       "      <td>friedreich's ataxia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12705</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005621</td>\n",
       "      <td>Q913856</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q913856</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3948</th>\n",
       "      <td>vatiquinone</td>\n",
       "      <td>Treatment of Leigh Syndrome</td>\n",
       "      <td>06/04/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265220</td>\n",
       "      <td>None</td>\n",
       "      <td>leigh syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3652</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_506</td>\n",
       "      <td>D007888</td>\n",
       "      <td>Q1815019</td>\n",
       "      <td>Q1815019</td>\n",
       "      <td>Q1815019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3949</th>\n",
       "      <td>vatiquinone</td>\n",
       "      <td>Treatment of Rett syndrome</td>\n",
       "      <td>11/17/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265220</td>\n",
       "      <td>None</td>\n",
       "      <td>rett syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1206</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_778</td>\n",
       "      <td>D015518</td>\n",
       "      <td>Q917357</td>\n",
       "      <td>None</td>\n",
       "      <td>Q917357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3957</th>\n",
       "      <td>veltuzumab</td>\n",
       "      <td>Treatment of pemphigus</td>\n",
       "      <td>11/17/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4009438</td>\n",
       "      <td>None</td>\n",
       "      <td>pemphigus</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9182</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D010392</td>\n",
       "      <td>Q1483214</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1483214</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3959</th>\n",
       "      <td>veltuzumab</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>08/28/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4009438</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3960</th>\n",
       "      <td>vemurafenib</td>\n",
       "      <td>Treatment of Erdheim-Chester Disease</td>\n",
       "      <td>08/02/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q423111</td>\n",
       "      <td>None</td>\n",
       "      <td>erdheim-chester disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4329</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_35687</td>\n",
       "      <td>D031249</td>\n",
       "      <td>Q1349259</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1349259</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3965</th>\n",
       "      <td>Venetoclax</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>08/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3966</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>09/20/2012</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3967</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>02/04/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3975</th>\n",
       "      <td>vintafolide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>12/16/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7932801</td>\n",
       "      <td>None</td>\n",
       "      <td>ovarian cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2394</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_213500</td>\n",
       "      <td>D010051</td>\n",
       "      <td>Q172341</td>\n",
       "      <td>None</td>\n",
       "      <td>Q172341</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3979</th>\n",
       "      <td>volasertib</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>04/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7939986</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3981</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>06/12/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3985</th>\n",
       "      <td>vosaroxin</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>10/28/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q18395775</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3995</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>06/28/1988</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "      <td>aids</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3996</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>12/09/1986</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "      <td>aids</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3997</th>\n",
       "      <td>zidovudine</td>\n",
       "      <td>Treatment of AIDS</td>\n",
       "      <td>07/17/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q198504</td>\n",
       "      <td>None</td>\n",
       "      <td>aids</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3998</th>\n",
       "      <td>Zinc acetate</td>\n",
       "      <td>Treatment of Wilson's disease.</td>\n",
       "      <td>11/06/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q204639</td>\n",
       "      <td>DJWUNCQRNNEAKC-UHFFFAOYSA-L</td>\n",
       "      <td>wilson's disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_893</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D006527</td>\n",
       "      <td>Q117121</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q117121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4002</th>\n",
       "      <td>Zosuquidar trihydrochloride</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>12/15/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27269191</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>677 rows × 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                            Generic Name  \\\n",
       "4     (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                                                                                                                          \n",
       "16    (2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride                                                                                                                                              \n",
       "17    (2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)                                                                                                                         \n",
       "18    (2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)                                                                                                              \n",
       "30    (3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate                                                                                                                       \n",
       "40    (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride                                                                                                                                          \n",
       "57    (R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole                                                                                               \n",
       "58    (R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride   \n",
       "65    (S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine                                                   \n",
       "70    (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one                                                                                                                                           \n",
       "74    (S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)-imidazo[1,5-a]pyrazine-1-yl)-N-(pyridine-2-yl)-benzamide                                                                                                             \n",
       "76    (S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one                                                                                                                    \n",
       "102   1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid                                                                                                                                                      \n",
       "103   1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea                                                                                                                              \n",
       "129   2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione                                                                                                                  \n",
       "150   2-chloroethyl-3-sarcosinamide-1-nitrosourea                                                                                                                                                                          \n",
       "157   2-methoxyestradiol                                                                                                                                                                                                   \n",
       "158   2-methoxyestradiol                                                                                                                                                                                                   \n",
       "160   2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole                                                                                                                               \n",
       "182   3'-azido-2',3'dideoxyuridine                                                                                                                                                                                         \n",
       "184   3,4-diaminopyridine                                                                                                                                                                                                  \n",
       "186   3,5-diiodothyropropionic acid                                                                                                                                                                                        \n",
       "194   3-aminopropyl-butyl phosphinic acid                                                                                                                                                                                  \n",
       "195   3-bromopyruvate                                                                                                                                                                                                      \n",
       "197   3-chloro-4-fluorophenyl-[4-fluoro-4-[[(5-methylpyrimidin-2-ylmethyl)amino]methyl]piperidin-1yl]methanone                                                                                                             \n",
       "208   4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol                                                                                                                                                                       \n",
       "212   4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl                                                                                                                                                                  \n",
       "214   4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide                  \n",
       "230   4-[131I]iodo-L-phenylalanine                                                                                                                                                                                         \n",
       "236   4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid                                                    \n",
       "244   5,6-dihydro-5-azacytidine                                                                                                                                                                                            \n",
       "248   5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine hydrochloride                                                                                                                                          \n",
       "253   5-aza-2'-deoxycytidine                                                                                                                                                                                               \n",
       "258   5-[(E)-2-(4-hydroxyphenyl)-ethenyl] benzene-1,3 diol                                                                                                                                                                 \n",
       "259   5-[1-(2,6-Dichlorobenzyl)-piperidin-4-yl]methoxyquinazoline-2,4-diamine                                                                                                                                              \n",
       "260   5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6yl]-2-pyrimidinamine                                                                                                                                       \n",
       "265   6,8-bis-benzylsulfanyl-octanoic acid                                                                                                                                                                                 \n",
       "266   6,8-bis-benzylsulfanyl-octanoic acid                                                                                                                                                                                 \n",
       "267   6,8-bis-benzylsulfanyl-octanoic acid                                                                                                                                                                                 \n",
       "278   6-methoxy-3-(3',4',5'-trimethoxybenzoyl) indole                                                                                                                                                                      \n",
       "289   8 Cyclopentyl 1,3-dipropylxanthine                                                                                                                                                                                   \n",
       "290   8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one                                                                                                                                          \n",
       "311   Abetimus                                                                                                                                                                                                             \n",
       "313   acadesine                                                                                                                                                                                                            \n",
       "314   acadesine                                                                                                                                                                                                            \n",
       "315   acamprosate                                                                                                                                                                                                          \n",
       "316   aceneuramic acid                                                                                                                                                                                                     \n",
       "319   acetyl-l-carnitine                                                                                                                                                                                                   \n",
       "324   Aconiazide                                                                                                                                                                                                           \n",
       "331   adalimumab                                                                                                                                                                                                           \n",
       "...          ...                                                                                                                                                                                                           \n",
       "3779  tigecycline                                                                                                                                                                                                          \n",
       "3782  tinidazole                                                                                                                                                                                                           \n",
       "3783  Tinidazole                                                                                                                                                                                                           \n",
       "3786  tipelukast                                                                                                                                                                                                           \n",
       "3787  Tipifarnib                                                                                                                                                                                                           \n",
       "3789  tirapazamine                                                                                                                                                                                                         \n",
       "3790  tirapazamine                                                                                                                                                                                                         \n",
       "3804  tocilizumab                                                                                                                                                                                                          \n",
       "3807  Tolcapone                                                                                                                                                                                                            \n",
       "3809  tolfenamic acid                                                                                                                                                                                                      \n",
       "3810  tolfenamic acid                                                                                                                                                                                                      \n",
       "3812  Topiramate                                                                                                                                                                                                           \n",
       "3817  Tosedostat                                                                                                                                                                                                           \n",
       "3824  tralokinumab                                                                                                                                                                                                         \n",
       "3844  tremelimumab                                                                                                                                                                                                         \n",
       "3847  Treosulfan                                                                                                                                                                                                           \n",
       "3854  Tretinoin                                                                                                                                                                                                            \n",
       "3856  triciribine                                                                                                                                                                                                          \n",
       "3857  triclabendazole                                                                                                                                                                                                      \n",
       "3867  Trimetrexate glucuronate                                                                                                                                                                                             \n",
       "3880  Troxacitabine                                                                                                                                                                                                        \n",
       "3886  Tyloxapol                                                                                                                                                                                                            \n",
       "3889  ubiquinol                                                                                                                                                                                                            \n",
       "3892  ublituximab                                                                                                                                                                                                          \n",
       "3899  ulocuplumab                                                                                                                                                                                                          \n",
       "3900  unoprostone isopropyl                                                                                                                                                                                                \n",
       "3920  vadastuximab talirine                                                                                                                                                                                                \n",
       "3923  Valproate                                                                                                                                                                                                            \n",
       "3927  vamorolone                                                                                                                                                                                                           \n",
       "3928  vancomycin                                                                                                                                                                                                           \n",
       "3936  vapreotide                                                                                                                                                                                                           \n",
       "3940  Varlitinib                                                                                                                                                                                                           \n",
       "3947  vatiquinone                                                                                                                                                                                                          \n",
       "3948  vatiquinone                                                                                                                                                                                                          \n",
       "3949  vatiquinone                                                                                                                                                                                                          \n",
       "3957  veltuzumab                                                                                                                                                                                                           \n",
       "3959  veltuzumab                                                                                                                                                                                                           \n",
       "3960  vemurafenib                                                                                                                                                                                                          \n",
       "3965  Venetoclax                                                                                                                                                                                                           \n",
       "3966  venetoclax                                                                                                                                                                                                           \n",
       "3967  venetoclax                                                                                                                                                                                                           \n",
       "3975  vintafolide                                                                                                                                                                                                          \n",
       "3979  volasertib                                                                                                                                                                                                           \n",
       "3981  vorinostat                                                                                                                                                                                                           \n",
       "3985  vosaroxin                                                                                                                                                                                                            \n",
       "3995  Zalcitabine                                                                                                                                                                                                          \n",
       "3996  Zalcitabine                                                                                                                                                                                                          \n",
       "3997  zidovudine                                                                                                                                                                                                           \n",
       "3998  Zinc acetate                                                                                                                                                                                                         \n",
       "4002  Zosuquidar trihydrochloride                                                                                                                                                                                          \n",
       "\n",
       "                                                Orphan Designation  \\\n",
       "4     Treatment of Fragile X syndrome                                \n",
       "16    Treatment of Rett Syndrome.                                    \n",
       "17    Treatment of multiple myeloma                                  \n",
       "18    Treatment of systemic sclerosis.                               \n",
       "30    Treatment of Gaucher disease                                   \n",
       "40    Treatment of erythromelalgia                                   \n",
       "57    Treatment of pulmonary tuberculosis.                           \n",
       "58    Treatment of multiple myeloma                                  \n",
       "65    Treatment of acute myeloid leukemia                            \n",
       "70    Treatment of follicular lymphoma                               \n",
       "74    Treatment of mantle cell lymphoma.                             \n",
       "76    Treatment of Hodgkin lymphoma                                  \n",
       "102   Treatment of systemic sclerosis                                \n",
       "103   Treatment of acute myeloid leukemia                            \n",
       "129   Treatment of idiopathic pulmonary fibrosis.                    \n",
       "150   Treatment for malignant glioma                                 \n",
       "157   Treatment of multiple myeloma                                  \n",
       "158   Treatment of ovarian cancer                                    \n",
       "160   Treatment of hepatocellular carcinoma.                         \n",
       "182   Treatment of acquired immunodeficiency syndrome.               \n",
       "184   Treatment of Lambert-Eaton myasthenic syndrome.                \n",
       "186   Treatment of Allan-Herndon-Dudley syndrome                     \n",
       "194   Treatment of succinic semialdehyde dehydrogenase deficiency.   \n",
       "195   Treatment of pancreatic cancer                                 \n",
       "197   Treatment of Rett syndrome                                     \n",
       "208   Treatment of Angelman syndrome.                                \n",
       "212   Treatment of Huntington's disease.                             \n",
       "214   Treatment of diffuse large B-cell lymphoma.                    \n",
       "230   Treatment of glioma.                                           \n",
       "236   Treatment of Acute Myeloid Leukemia                            \n",
       "244   Treatment of malignant mesothelioma.                           \n",
       "248   Treatment of progressive supranuclear palsy.                   \n",
       "253   Treatment of acute leukemia.                                   \n",
       "258   Treatment of MELAS syndrome                                    \n",
       "259   Treatment of spinal muscular atrophy                           \n",
       "260   Treatment of malignant mesothelioma                            \n",
       "265   Treatment of acute myeloid leukemia.                           \n",
       "266   Treatment of pancreatic cancer                                 \n",
       "267   Treatment of myelodysplastic syndrome                          \n",
       "278   Treatment of cholangiocarcinoma                                \n",
       "289   Treatment of cystic fibrosis.                                  \n",
       "290   Treatment of glioblastoma multiforme                           \n",
       "311   Treatment of lupus nephritis.                                  \n",
       "313   Treatment of chronic lymphocytic leukemia                      \n",
       "314   Treatment of multiple myeloma                                  \n",
       "315   Treatment of fragile X syndrome                                \n",
       "316   Treatment of hereditary inclusion body myopathy                \n",
       "319   Treatment of Fragile X syndrome                                \n",
       "324   Treatment of tuberculosis.                                     \n",
       "331   Treatment of juvenile rheumatoid arthritis                     \n",
       "...                                          ...                     \n",
       "3779  Treatment of acute myeloid leukemia.                           \n",
       "3782  Treatment of giardiasis                                        \n",
       "3783  Treatment of amebiasis                                         \n",
       "3786  Treatment of idiopathic pulmonary fibrosis                     \n",
       "3787  Treatment of acute myeloid leukemia                            \n",
       "3789  Treatment of hepatocellular carcinoma                          \n",
       "3790  Treatment of head and neck cancer                              \n",
       "3804  Treatment of systemic sclerosis                                \n",
       "3807  Treatment of transthyretin amyloidosis                         \n",
       "3809  Treatment of progressive supranuclear palsy                    \n",
       "3810  Treatment of Frontotemporal Dementia                           \n",
       "3812  Treatment of Lennox-Gastaut syndrome.                          \n",
       "3817  Treatment of acute myeloid leukemia                            \n",
       "3824  Treatment of idiopathic pulmonary fibrosis                     \n",
       "3844  Treatment of malignant mesothelioma                            \n",
       "3847  Treatment of ovarian cancer.                                   \n",
       "3854  Treatment of acute promyelocytic leukemia.                     \n",
       "3856  Treatment of multiple myeloma                                  \n",
       "3857  Treatment of fascioliasis.                                     \n",
       "3867  Treatment of pancreatic adenocarcinoma.                        \n",
       "3880  Treatment of acute myeloid leukemia                            \n",
       "3886  Treatment of cystic fibrosis.                                  \n",
       "3889  Treatment of Huntington's Disease                              \n",
       "3892  Treatment of chronic lymphocytic leukemia                      \n",
       "3899  Treatment of acute myeloid leukemia                            \n",
       "3900  Treatment of retinitis pigmentosa                              \n",
       "3920  Treatment of acute myeloid leukemia.                           \n",
       "3923  Treatment of fragile X syndrome                                \n",
       "3927  Treatment of Duchenne muscular dystrophy                       \n",
       "3928  Treatment of endophthalmitis                                   \n",
       "3936  Treatment of acromegaly                                        \n",
       "3940  Treatment of cholangiocarcinoma.                               \n",
       "3947  Treatment of Friedreich's ataxia                               \n",
       "3948  Treatment of Leigh Syndrome                                    \n",
       "3949  Treatment of Rett syndrome                                     \n",
       "3957  Treatment of pemphigus                                         \n",
       "3959  Treatment of chronic lymphocytic leukemia                      \n",
       "3960  Treatment of Erdheim-Chester Disease                           \n",
       "3965  Treatment of multiple myeloma                                  \n",
       "3966  Treatment of chronic lymphocytic leukemia                      \n",
       "3967  Treatment of acute myeloid leukemia.                           \n",
       "3975  Treatment of ovarian cancer                                    \n",
       "3979  Treatment of acute myeloid leukemia                            \n",
       "3981  Treatment of multiple myeloma                                  \n",
       "3985  Treatment of acute myeloid leukemia                            \n",
       "3995  Treatment of AIDS.                                             \n",
       "3996  Treatment of AIDS.                                             \n",
       "3997  Treatment of AIDS                                              \n",
       "3998  Treatment of Wilson's disease.                                 \n",
       "4002  Treatment of acute myeloid leukemia                            \n",
       "\n",
       "     Designation Date    Designation Status   drug_qid  \\\n",
       "4     10/12/2011       Designated            Q6589598    \n",
       "16    05/18/2016       Designated            Q27252594   \n",
       "17    11/29/2016       Designated            Q27258687   \n",
       "18    10/14/2015       Designated            Q27258840   \n",
       "30    09/11/2014       Designated            Q27274745   \n",
       "40    01/30/2017       Designated            Q27268497   \n",
       "57    07/12/2007       Designated            Q15408413   \n",
       "58    05/05/2008       Designated/Withdrawn  Q27292463   \n",
       "65    11/05/2014       Designated            Q27236818   \n",
       "70    08/01/2013       Designated            Q27077129   \n",
       "74    09/21/2015       Designated            Q23668732   \n",
       "76    04/29/2015       Designated            Q27254856   \n",
       "102   03/31/2015       Designated            Q27896056   \n",
       "103   11/12/2009       Designated            Q27453557   \n",
       "129   09/21/2010       Designated            Q27258840   \n",
       "150   11/15/2001       Designated            Q27274664   \n",
       "157   07/10/2001       Designated/Withdrawn  Q4596897    \n",
       "158   04/04/2005       Designated/Withdrawn  Q4596897    \n",
       "160   08/27/2008       Designated            Q254296     \n",
       "182   11/20/1989       Designated/Withdrawn  Q27286725   \n",
       "184   12/18/1990       Designated            Q411707     \n",
       "186   05/14/2013       Designated            Q27252433   \n",
       "194   12/13/2016       Designated            Q27075900   \n",
       "195   04/29/2014       Designated            Q27073726   \n",
       "197   10/25/2013       Designated            Q5423588    \n",
       "208   09/06/2016       Designated            Q4130924    \n",
       "212   12/12/2005       Designated            Q27287263   \n",
       "214   03/27/2014       Designated            Q23671272   \n",
       "230   01/04/2011       Designated            Q27263179   \n",
       "236   05/19/2014       Designated            Q27287480   \n",
       "244   05/11/1992       Designated            Q27236168   \n",
       "248   04/18/2011       Designated            Q27265266   \n",
       "253   08/03/1987       Designated            Q1181878    \n",
       "258   03/13/2008       Designated            Q407329     \n",
       "259   08/25/2009       Designated            Q27282418   \n",
       "260   02/10/2015       Designated/Withdrawn  Q27089164   \n",
       "265   08/22/2011       Designated            Q27276958   \n",
       "266   02/06/2006       Designated            Q27276958   \n",
       "267   09/26/2013       Designated            Q27276958   \n",
       "278   05/11/2016       Designated            Q27292488   \n",
       "289   03/24/1997       Designated/Withdrawn  Q5280076    \n",
       "290   01/21/2015       Designated            Q27294013   \n",
       "311   07/28/2000       Designated            Q4667244    \n",
       "313   03/03/2011       Designated            Q4671562    \n",
       "314   05/04/2011       Designated            Q4671562    \n",
       "315   03/25/2013       Designated            Q337668     \n",
       "316   09/23/2011       Designated            Q27120624   \n",
       "319   07/24/2012       Designated            Q311992     \n",
       "324   06/20/1988       Designated/Withdrawn  Q15633956   \n",
       "331   03/21/2005       Designated/Approved   Q348260     \n",
       "...          ...                       ...       ...     \n",
       "3779  10/23/2013       Designated            Q420595     \n",
       "3782  04/18/2002       Designated/Approved   Q1321320    \n",
       "3783  08/20/2003       Designated/Approved   Q1321320    \n",
       "3786  10/20/2014       Designated            Q27236352   \n",
       "3787  07/06/2004       Designated            Q7808830    \n",
       "3789  11/30/2015       Designated            Q3529346    \n",
       "3790  10/23/2002       Designated            Q3529346    \n",
       "3804  04/17/2013       Designated            Q425154     \n",
       "3807  12/24/2013       Designated            Q413840     \n",
       "3809  07/13/2016       Designated            Q59412      \n",
       "3810  07/13/2016       Designated            Q59412      \n",
       "3812  11/25/1992       Designated/Approved   Q221174     \n",
       "3817  12/10/2008       Designated            Q27166812   \n",
       "3824  07/24/2012       Designated/Withdrawn  Q7833105    \n",
       "3844  03/18/2015       Designated            Q7838098    \n",
       "3847  05/16/1994       Designated            Q7838652    \n",
       "3854  10/24/1990       Designated/Approved   Q29417      \n",
       "3856  02/01/2008       Designated            Q27887003   \n",
       "3857  06/27/2016       Designated            Q419739     \n",
       "3867  07/25/1985       Designated/Withdrawn  Q27282570   \n",
       "3880  04/04/2005       Designated/Withdrawn  Q7846702    \n",
       "3886  03/08/1995       Designated            Q7860340    \n",
       "3889  04/12/2004       Designated            Q411963     \n",
       "3892  08/06/2010       Designated            Q7876570    \n",
       "3899  01/12/2015       Designated            Q21098907   \n",
       "3900  09/16/2010       Designated/Withdrawn  Q27089094   \n",
       "3920  11/10/2015       Designated            Q17044502   \n",
       "3923  05/05/2008       Designated            Q27104876   \n",
       "3927  12/02/2011       Designated            Q27089127   \n",
       "3928  12/27/2012       Designated            Q424027     \n",
       "3936  11/04/2003       Designated            Q4008670    \n",
       "3940  08/05/2015       Designated            Q27089126   \n",
       "3947  01/31/2014       Designated            Q27265220   \n",
       "3948  06/04/2014       Designated            Q27265220   \n",
       "3949  11/17/2014       Designated            Q27265220   \n",
       "3957  11/17/2014       Designated            Q4009438    \n",
       "3959  08/28/2008       Designated            Q4009438    \n",
       "3960  08/02/2016       Designated            Q423111     \n",
       "3965  08/29/2016       Designated            Q23671272   \n",
       "3966  09/20/2012       Designated/Approved   Q23671272   \n",
       "3967  02/04/2016       Designated            Q23671272   \n",
       "3975  12/16/2013       Designated            Q7932801    \n",
       "3979  04/14/2014       Designated            Q7939986    \n",
       "3981  06/12/2003       Designated/Withdrawn  Q905901     \n",
       "3985  10/28/2009       Designated            Q18395775   \n",
       "3995  06/28/1988       Designated/Approved   Q2344582    \n",
       "3996  12/09/1986       Designated            Q2344582    \n",
       "3997  07/17/1985       Designated/Approved   Q198504     \n",
       "3998  11/06/1985       Designated/Approved   Q204639     \n",
       "4002  12/15/2005       Designated            Q27269191   \n",
       "\n",
       "                            inchi  \\\n",
       "4     ZFPZEYHRWGMJCV-ZHALLVOQSA-N   \n",
       "16    FEQOLYDPQKHFTD-UHFFFAOYSA-N   \n",
       "17    VLIUIBXPEDFJRF-UHFFFAOYSA-N   \n",
       "18    RGYQPQARIQKJKH-UHFFFAOYSA-N   \n",
       "30    YFHRCLAKZBDRHN-MRXNPFEDSA-N   \n",
       "40    HEPUBAGOKRIZEO-PPPUBMIESA-N   \n",
       "57    XDAOLTSRNUSPPH-XMMPIXPASA-N   \n",
       "58    WDVGRPCSLPVWKC-VROLVAQFSA-N   \n",
       "65    KXMZDGSRSGHMMK-VWLOTQADSA-N   \n",
       "70    SJVQHLPISAIATJ-ZDUSSCGKSA-N   \n",
       "74    WDENQIQQYWYTPO-IBGZPJMESA-N   \n",
       "76    RSIWALKZYXPAGW-NSHDSACASA-N   \n",
       "102   OQDQIFQRNZIEEJ-UHFFFAOYSA-N   \n",
       "103   LOLPPWBBNUVNQZ-UHFFFAOYSA-N   \n",
       "129   RGYQPQARIQKJKH-UHFFFAOYSA-N   \n",
       "150   None                          \n",
       "157   None                          \n",
       "158   None                          \n",
       "160   MJIHNNLFOKEZEW-UHFFFAOYSA-N   \n",
       "182   ZSNNBSPEFVIUDS-SHYZEUOFSA-N   \n",
       "184   OYTKINVCDFNREN-UHFFFAOYSA-N   \n",
       "186   None                          \n",
       "194   ONNMDRQRSGKZCN-UHFFFAOYSA-N   \n",
       "195   PRRZDZJYSJLDBS-UHFFFAOYSA-M   \n",
       "197   WAAXKNFGOFTGLP-UHFFFAOYSA-N   \n",
       "208   ZXRVKCBLGJOCEE-UHFFFAOYSA-N   \n",
       "212   YGRHOYQMBLLGEV-UHFFFAOYSA-N   \n",
       "214   LQBVNQSMGBZMKD-UHFFFAOYSA-N   \n",
       "230   PZNQZSRPDOEBMS-WPUCPVGPSA-N   \n",
       "236   TVTXCJFHQKSQQM-LJQIRTBHSA-N   \n",
       "244   LJIRBXZDQGQUOO-KVTDHHQDSA-N   \n",
       "248   FVWAMONNJGNNHY-UHFFFAOYSA-N   \n",
       "253   XAUDJQYHKZQPEU-KVQBGUIXSA-N   \n",
       "258   LUKBXSAWLPMMSZ-OWOJBTEDSA-N   \n",
       "259   MNLHFGXIUJNDAF-UHFFFAOYSA-N   \n",
       "260   QYBGBLQCOOISAR-UHFFFAOYSA-N   \n",
       "265   ZYRLHJIMTROTBO-UHFFFAOYSA-N   \n",
       "266   ZYRLHJIMTROTBO-UHFFFAOYSA-N   \n",
       "267   ZYRLHJIMTROTBO-UHFFFAOYSA-N   \n",
       "278   UZJVBXKFBQNDTQ-UHFFFAOYSA-N   \n",
       "289   FFBDFADSZUINTG-UHFFFAOYSA-N   \n",
       "290   YEAHTLOYHVWAKW-UHFFFAOYSA-N   \n",
       "311   None                          \n",
       "313   None                          \n",
       "314   None                          \n",
       "315   None                          \n",
       "316   None                          \n",
       "319   GJTJQSPLLQWKMB-SECBINFHSA-N   \n",
       "324   None                          \n",
       "331   None                          \n",
       "...    ...                          \n",
       "3779  None                          \n",
       "3782  None                          \n",
       "3783  None                          \n",
       "3786  None                          \n",
       "3787  None                          \n",
       "3789  None                          \n",
       "3790  None                          \n",
       "3804  None                          \n",
       "3807  None                          \n",
       "3809  None                          \n",
       "3810  None                          \n",
       "3812  None                          \n",
       "3817  None                          \n",
       "3824  None                          \n",
       "3844  None                          \n",
       "3847  None                          \n",
       "3854  None                          \n",
       "3856  None                          \n",
       "3857  None                          \n",
       "3867  None                          \n",
       "3880  None                          \n",
       "3886  None                          \n",
       "3889  None                          \n",
       "3892  None                          \n",
       "3899  None                          \n",
       "3900  None                          \n",
       "3920  None                          \n",
       "3923  NIJJYAXOARWZEE-UHFFFAOYSA-M   \n",
       "3927  None                          \n",
       "3928  None                          \n",
       "3936  None                          \n",
       "3940  None                          \n",
       "3947  None                          \n",
       "3948  None                          \n",
       "3949  None                          \n",
       "3957  None                          \n",
       "3959  None                          \n",
       "3960  None                          \n",
       "3965  None                          \n",
       "3966  None                          \n",
       "3967  None                          \n",
       "3975  None                          \n",
       "3979  None                          \n",
       "3981  None                          \n",
       "3985  None                          \n",
       "3995  None                          \n",
       "3996  None                          \n",
       "3997  None                          \n",
       "3998  DJWUNCQRNNEAKC-UHFFFAOYSA-L   \n",
       "4002  None                          \n",
       "\n",
       "                                          indication  \\\n",
       "4     fragile x syndrome                               \n",
       "16    rett syndrome                                    \n",
       "17    multiple myeloma                                 \n",
       "18    systemic sclerosis                               \n",
       "30    gaucher disease                                  \n",
       "40    erythromelalgia                                  \n",
       "57    pulmonary tuberculosis                           \n",
       "58    multiple myeloma                                 \n",
       "65    acute myeloid leukemia                           \n",
       "70    follicular lymphoma                              \n",
       "74    mantle cell lymphoma                             \n",
       "76    hodgkin lymphoma                                 \n",
       "102   systemic sclerosis                               \n",
       "103   acute myeloid leukemia                           \n",
       "129   idiopathic pulmonary fibrosis                    \n",
       "150   malignant glioma                                 \n",
       "157   multiple myeloma                                 \n",
       "158   ovarian cancer                                   \n",
       "160   hepatocellular carcinoma                         \n",
       "182   acquired immunodeficiency syndrome               \n",
       "184   lambert-eaton myasthenic syndrome                \n",
       "186   allan-herndon-dudley syndrome                    \n",
       "194   succinic semialdehyde dehydrogenase deficiency   \n",
       "195   pancreatic cancer                                \n",
       "197   rett syndrome                                    \n",
       "208   angelman syndrome                                \n",
       "212   huntington's disease                             \n",
       "214   diffuse large b-cell lymphoma                    \n",
       "230   glioma                                           \n",
       "236   acute myeloid leukemia                           \n",
       "244   malignant mesothelioma                           \n",
       "248   progressive supranuclear palsy                   \n",
       "253   acute leukemia                                   \n",
       "258   melas syndrome                                   \n",
       "259   spinal muscular atrophy                          \n",
       "260   malignant mesothelioma                           \n",
       "265   acute myeloid leukemia                           \n",
       "266   pancreatic cancer                                \n",
       "267   myelodysplastic syndrome                         \n",
       "278   cholangiocarcinoma                               \n",
       "289   cystic fibrosis                                  \n",
       "290   glioblastoma multiforme                          \n",
       "311   lupus nephritis                                  \n",
       "313   chronic lymphocytic leukemia                     \n",
       "314   multiple myeloma                                 \n",
       "315   fragile x syndrome                               \n",
       "316   hereditary inclusion body myopathy               \n",
       "319   fragile x syndrome                               \n",
       "324   tuberculosis                                     \n",
       "331   juvenile rheumatoid arthritis                    \n",
       "...                             ...                    \n",
       "3779  acute myeloid leukemia                           \n",
       "3782  giardiasis                                       \n",
       "3783  amebiasis                                        \n",
       "3786  idiopathic pulmonary fibrosis                    \n",
       "3787  acute myeloid leukemia                           \n",
       "3789  hepatocellular carcinoma                         \n",
       "3790  head and neck cancer                             \n",
       "3804  systemic sclerosis                               \n",
       "3807  transthyretin amyloidosis                        \n",
       "3809  progressive supranuclear palsy                   \n",
       "3810  frontotemporal dementia                          \n",
       "3812  lennox-gastaut syndrome                          \n",
       "3817  acute myeloid leukemia                           \n",
       "3824  idiopathic pulmonary fibrosis                    \n",
       "3844  malignant mesothelioma                           \n",
       "3847  ovarian cancer                                   \n",
       "3854  acute promyelocytic leukemia                     \n",
       "3856  multiple myeloma                                 \n",
       "3857  fascioliasis                                     \n",
       "3867  pancreatic adenocarcinoma                        \n",
       "3880  acute myeloid leukemia                           \n",
       "3886  cystic fibrosis                                  \n",
       "3889  huntington's disease                             \n",
       "3892  chronic lymphocytic leukemia                     \n",
       "3899  acute myeloid leukemia                           \n",
       "3900  retinitis pigmentosa                             \n",
       "3920  acute myeloid leukemia                           \n",
       "3923  fragile x syndrome                               \n",
       "3927  duchenne muscular dystrophy                      \n",
       "3928  endophthalmitis                                  \n",
       "3936  acromegaly                                       \n",
       "3940  cholangiocarcinoma                               \n",
       "3947  friedreich's ataxia                              \n",
       "3948  leigh syndrome                                   \n",
       "3949  rett syndrome                                    \n",
       "3957  pemphigus                                        \n",
       "3959  chronic lymphocytic leukemia                     \n",
       "3960  erdheim-chester disease                          \n",
       "3965  multiple myeloma                                 \n",
       "3966  chronic lymphocytic leukemia                     \n",
       "3967  acute myeloid leukemia                           \n",
       "3975  ovarian cancer                                   \n",
       "3979  acute myeloid leukemia                           \n",
       "3981  multiple myeloma                                 \n",
       "3985  acute myeloid leukemia                           \n",
       "3995  aids                                             \n",
       "3996  aids                                             \n",
       "3997  aids                                             \n",
       "3998  wilson's disease                                 \n",
       "4002  acute myeloid leukemia                           \n",
       "\n",
       "                                             doid  \\\n",
       "4     http://purl.obolibrary.org/obo/DOID_14261     \n",
       "16    http://purl.obolibrary.org/obo/DOID_1206      \n",
       "17    http://purl.obolibrary.org/obo/DOID_9538      \n",
       "18    http://purl.obolibrary.org/obo/DOID_418       \n",
       "30    http://purl.obolibrary.org/obo/DOID_1926      \n",
       "40    http://purl.obolibrary.org/obo/DOID_9240      \n",
       "57    http://purl.obolibrary.org/obo/DOID_2957      \n",
       "58    http://purl.obolibrary.org/obo/DOID_9538      \n",
       "65    http://purl.obolibrary.org/obo/DOID_9119      \n",
       "70    http://purl.obolibrary.org/obo/DOID_0050873   \n",
       "74    http://purl.obolibrary.org/obo/DOID_0050746   \n",
       "76    http://purl.obolibrary.org/obo/DOID_8567      \n",
       "102   http://purl.obolibrary.org/obo/DOID_418       \n",
       "103   http://purl.obolibrary.org/obo/DOID_9119      \n",
       "129   http://purl.obolibrary.org/obo/DOID_0050156   \n",
       "150   http://purl.obolibrary.org/obo/DOID_3070      \n",
       "157   http://purl.obolibrary.org/obo/DOID_9538      \n",
       "158   http://purl.obolibrary.org/obo/DOID_2394      \n",
       "160   http://purl.obolibrary.org/obo/DOID_684       \n",
       "182   http://purl.obolibrary.org/obo/DOID_635       \n",
       "184   http://purl.obolibrary.org/obo/DOID_0050214   \n",
       "186   http://purl.obolibrary.org/obo/DOID_0050631   \n",
       "194   http://purl.obolibrary.org/obo/DOID_0060175   \n",
       "195   http://purl.obolibrary.org/obo/DOID_1793      \n",
       "197   http://purl.obolibrary.org/obo/DOID_1206      \n",
       "208   http://purl.obolibrary.org/obo/DOID_1932      \n",
       "212   http://purl.obolibrary.org/obo/DOID_12858     \n",
       "214   http://purl.obolibrary.org/obo/DOID_0050745   \n",
       "230   http://purl.obolibrary.org/obo/DOID_3070      \n",
       "236   http://purl.obolibrary.org/obo/DOID_9119      \n",
       "244   http://purl.obolibrary.org/obo/DOID_1790      \n",
       "248   http://purl.obolibrary.org/obo/DOID_678       \n",
       "253   http://purl.obolibrary.org/obo/DOID_12603     \n",
       "258   http://purl.obolibrary.org/obo/DOID_3687      \n",
       "259   http://purl.obolibrary.org/obo/DOID_12377     \n",
       "260   http://purl.obolibrary.org/obo/DOID_1790      \n",
       "265   http://purl.obolibrary.org/obo/DOID_9119      \n",
       "266   http://purl.obolibrary.org/obo/DOID_1793      \n",
       "267   http://purl.obolibrary.org/obo/DOID_0050908   \n",
       "278   http://purl.obolibrary.org/obo/DOID_4947      \n",
       "289   http://purl.obolibrary.org/obo/DOID_1485      \n",
       "290   http://purl.obolibrary.org/obo/DOID_3068      \n",
       "311   http://purl.obolibrary.org/obo/DOID_0080162   \n",
       "313   http://purl.obolibrary.org/obo/DOID_1040      \n",
       "314   http://purl.obolibrary.org/obo/DOID_9538      \n",
       "315   http://purl.obolibrary.org/obo/DOID_14261     \n",
       "316   http://purl.obolibrary.org/obo/DOID_3429      \n",
       "319   http://purl.obolibrary.org/obo/DOID_14261     \n",
       "324   http://purl.obolibrary.org/obo/DOID_399       \n",
       "331   http://purl.obolibrary.org/obo/DOID_676       \n",
       "...                                       ...       \n",
       "3779  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3782  http://purl.obolibrary.org/obo/DOID_10718     \n",
       "3783  http://purl.obolibrary.org/obo/DOID_9181      \n",
       "3786  http://purl.obolibrary.org/obo/DOID_0050156   \n",
       "3787  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3789  http://purl.obolibrary.org/obo/DOID_684       \n",
       "3790  http://purl.obolibrary.org/obo/DOID_11934     \n",
       "3804  http://purl.obolibrary.org/obo/DOID_418       \n",
       "3807  http://purl.obolibrary.org/obo/DOID_0050638   \n",
       "3809  http://purl.obolibrary.org/obo/DOID_678       \n",
       "3810  http://purl.obolibrary.org/obo/DOID_9255      \n",
       "3812  http://purl.obolibrary.org/obo/DOID_0050561   \n",
       "3817  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3824  http://purl.obolibrary.org/obo/DOID_0050156   \n",
       "3844  http://purl.obolibrary.org/obo/DOID_1790      \n",
       "3847  http://purl.obolibrary.org/obo/DOID_2394      \n",
       "3854  http://purl.obolibrary.org/obo/DOID_0060318   \n",
       "3856  http://purl.obolibrary.org/obo/DOID_9538      \n",
       "3857  http://purl.obolibrary.org/obo/DOID_885       \n",
       "3867  http://purl.obolibrary.org/obo/DOID_4074      \n",
       "3880  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3886  http://purl.obolibrary.org/obo/DOID_1485      \n",
       "3889  http://purl.obolibrary.org/obo/DOID_12858     \n",
       "3892  http://purl.obolibrary.org/obo/DOID_1040      \n",
       "3899  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3900  http://purl.obolibrary.org/obo/DOID_10584     \n",
       "3920  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3923  http://purl.obolibrary.org/obo/DOID_14261     \n",
       "3927  http://purl.obolibrary.org/obo/DOID_11723     \n",
       "3928  http://purl.obolibrary.org/obo/DOID_4692      \n",
       "3936  http://purl.obolibrary.org/obo/DOID_2449      \n",
       "3940  http://purl.obolibrary.org/obo/DOID_4947      \n",
       "3947  http://purl.obolibrary.org/obo/DOID_12705     \n",
       "3948  http://purl.obolibrary.org/obo/DOID_3652      \n",
       "3949  http://purl.obolibrary.org/obo/DOID_1206      \n",
       "3957  http://purl.obolibrary.org/obo/DOID_9182      \n",
       "3959  http://purl.obolibrary.org/obo/DOID_1040      \n",
       "3960  http://purl.obolibrary.org/obo/DOID_4329      \n",
       "3965  http://purl.obolibrary.org/obo/DOID_9538      \n",
       "3966  http://purl.obolibrary.org/obo/DOID_1040      \n",
       "3967  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3975  http://purl.obolibrary.org/obo/DOID_2394      \n",
       "3979  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3981  http://purl.obolibrary.org/obo/DOID_9538      \n",
       "3985  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3995  http://purl.obolibrary.org/obo/DOID_635       \n",
       "3996  http://purl.obolibrary.org/obo/DOID_635       \n",
       "3997  http://purl.obolibrary.org/obo/DOID_635       \n",
       "3998  http://purl.obolibrary.org/obo/DOID_893       \n",
       "4002  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "\n",
       "                                            hpo  \\\n",
       "4     None                                        \n",
       "16    None                                        \n",
       "17    http://purl.obolibrary.org/obo/HP_0006775   \n",
       "18    None                                        \n",
       "30    None                                        \n",
       "40    None                                        \n",
       "57    None                                        \n",
       "58    http://purl.obolibrary.org/obo/HP_0006775   \n",
       "65    http://purl.obolibrary.org/obo/HP_0004808   \n",
       "70    None                                        \n",
       "74    None                                        \n",
       "76    http://purl.obolibrary.org/obo/HP_0012189   \n",
       "102   None                                        \n",
       "103   http://purl.obolibrary.org/obo/HP_0004808   \n",
       "129   None                                        \n",
       "150   None                                        \n",
       "157   http://purl.obolibrary.org/obo/HP_0006775   \n",
       "158   None                                        \n",
       "160   http://purl.obolibrary.org/obo/HP_0001402   \n",
       "182   None                                        \n",
       "184   None                                        \n",
       "186   None                                        \n",
       "194   None                                        \n",
       "195   http://purl.obolibrary.org/obo/HP_0002894   \n",
       "197   None                                        \n",
       "208   None                                        \n",
       "212   None                                        \n",
       "214   None                                        \n",
       "230   http://purl.obolibrary.org/obo/HP_0009733   \n",
       "236   http://purl.obolibrary.org/obo/HP_0004808   \n",
       "244   http://purl.obolibrary.org/obo/HP_0100001   \n",
       "248   None                                        \n",
       "253   http://purl.obolibrary.org/obo/HP_0002488   \n",
       "258   None                                        \n",
       "259   http://purl.obolibrary.org/obo/HP_0007269   \n",
       "260   http://purl.obolibrary.org/obo/HP_0100001   \n",
       "265   http://purl.obolibrary.org/obo/HP_0004808   \n",
       "266   http://purl.obolibrary.org/obo/HP_0002894   \n",
       "267   http://purl.obolibrary.org/obo/HP_0002863   \n",
       "278   http://purl.obolibrary.org/obo/HP_0030153   \n",
       "289   None                                        \n",
       "290   http://purl.obolibrary.org/obo/HP_0012174   \n",
       "311   None                                        \n",
       "313   http://purl.obolibrary.org/obo/HP_0005550   \n",
       "314   http://purl.obolibrary.org/obo/HP_0006775   \n",
       "315   None                                        \n",
       "316   None                                        \n",
       "319   None                                        \n",
       "324   None                                        \n",
       "331   http://purl.obolibrary.org/obo/HP_0005681   \n",
       "...                                         ...   \n",
       "3779  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3782  None                                        \n",
       "3783  None                                        \n",
       "3786  None                                        \n",
       "3787  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3789  http://purl.obolibrary.org/obo/HP_0001402   \n",
       "3790  http://purl.obolibrary.org/obo/HP_0012288   \n",
       "3804  None                                        \n",
       "3807  None                                        \n",
       "3809  None                                        \n",
       "3810  http://purl.obolibrary.org/obo/HP_0002145   \n",
       "3812  None                                        \n",
       "3817  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3824  None                                        \n",
       "3844  http://purl.obolibrary.org/obo/HP_0100001   \n",
       "3847  None                                        \n",
       "3854  http://purl.obolibrary.org/obo/HP_0004836   \n",
       "3856  http://purl.obolibrary.org/obo/HP_0006775   \n",
       "3857  None                                        \n",
       "3867  http://purl.obolibrary.org/obo/HP_0006725   \n",
       "3880  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3886  None                                        \n",
       "3889  None                                        \n",
       "3892  http://purl.obolibrary.org/obo/HP_0005550   \n",
       "3899  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3900  http://purl.obolibrary.org/obo/HP_0000510   \n",
       "3920  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3923  None                                        \n",
       "3927  None                                        \n",
       "3928  None                                        \n",
       "3936  http://purl.obolibrary.org/obo/HP_0000845   \n",
       "3940  http://purl.obolibrary.org/obo/HP_0030153   \n",
       "3947  None                                        \n",
       "3948  None                                        \n",
       "3949  None                                        \n",
       "3957  None                                        \n",
       "3959  http://purl.obolibrary.org/obo/HP_0005550   \n",
       "3960  None                                        \n",
       "3965  http://purl.obolibrary.org/obo/HP_0006775   \n",
       "3966  http://purl.obolibrary.org/obo/HP_0005550   \n",
       "3967  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3975  None                                        \n",
       "3979  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3981  http://purl.obolibrary.org/obo/HP_0006775   \n",
       "3985  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3995  None                                        \n",
       "3996  None                                        \n",
       "3997  None                                        \n",
       "3998  None                                        \n",
       "4002  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "\n",
       "                                           ordo     mesh indication_qid_doid  \\\n",
       "4     http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "16    http://www.orpha.net/ORDO/Orphanet_778     D015518  Q917357              \n",
       "17    http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "18    http://www.orpha.net/ORDO/Orphanet_90291   D012595  Q5340515             \n",
       "30    http://www.orpha.net/ORDO/Orphanet_355     D005776  Q861645              \n",
       "40    http://www.orpha.net/ORDO/Orphanet_1956    D004916  Q524353              \n",
       "57    None                                       D014397  Q18555243            \n",
       "58    http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "65    http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "70    http://www.orpha.net/ORDO/Orphanet_545     D008224  Q123251              \n",
       "74    http://www.orpha.net/ORDO/Orphanet_52416   D020522  Q268713              \n",
       "76    http://www.orpha.net/ORDO/Orphanet_98293   D006689  Q209369              \n",
       "102   http://www.orpha.net/ORDO/Orphanet_90291   D012595  Q5340515             \n",
       "103   http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "129   http://www.orpha.net/ORDO/Orphanet_2032    D054990  Q2290446             \n",
       "150   None                                       D005910  Q1365309             \n",
       "157   http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "158   http://www.orpha.net/ORDO/Orphanet_213500  D010051  Q172341              \n",
       "160   http://www.orpha.net/ORDO/Orphanet_88673   D006528  Q1148337             \n",
       "182   None                                       D000163  Q12199               \n",
       "184   http://www.orpha.net/ORDO/Orphanet_43393   D015624  Q1756898             \n",
       "186   http://www.orpha.net/ORDO/Orphanet_59      None     Q4731121             \n",
       "194   http://www.orpha.net/ORDO/Orphanet_22      None     Q2823333             \n",
       "195   None                                       D010190  Q212961              \n",
       "197   http://www.orpha.net/ORDO/Orphanet_778     D015518  Q917357              \n",
       "208   http://www.orpha.net/ORDO/Orphanet_120365  D017204  Q535364              \n",
       "212   None                                       D006816  Q190564              \n",
       "214   http://www.orpha.net/ORDO/Orphanet_544     None     Q2626074             \n",
       "230   http://www.orpha.net/ORDO/Orphanet_182067  D005910  Q1365309             \n",
       "236   http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "244   None                                       None     Q1077603             \n",
       "248   http://www.orpha.net/ORDO/Orphanet_683     D013494  Q945930              \n",
       "253   None                                       None     Q976388              \n",
       "258   None                                       D017241  Q2666433             \n",
       "259   None                                       D009134  Q580290              \n",
       "260   None                                       None     Q1077603             \n",
       "265   http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "266   None                                       D010190  Q212961              \n",
       "267   http://www.orpha.net/ORDO/Orphanet_52688   D009190  Q954625              \n",
       "278   http://www.orpha.net/ORDO/Orphanet_70567   D018281  Q124292              \n",
       "289   http://www.orpha.net/ORDO/Orphanet_586     D003550  Q178194              \n",
       "290   http://www.orpha.net/ORDO/Orphanet_360     D005909  Q282142              \n",
       "311   None                                       D008181  Q1621830             \n",
       "313   None                                       D015451  Q1088156             \n",
       "314   http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "315   http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "316   None                                       None     Q1848471             \n",
       "319   http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "324   http://www.orpha.net/ORDO/Orphanet_3389    D014376  Q12204               \n",
       "331   http://www.orpha.net/ORDO/Orphanet_92      D001171  Q861224              \n",
       "...                                     ...          ...      ...              \n",
       "3779  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3782  None                                       D005873  Q326071              \n",
       "3783  None                                       D000562  Q949694              \n",
       "3786  http://www.orpha.net/ORDO/Orphanet_2032    D054990  Q2290446             \n",
       "3787  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3789  http://www.orpha.net/ORDO/Orphanet_88673   D006528  Q1148337             \n",
       "3790  None                                       D006258  Q1783924             \n",
       "3804  http://www.orpha.net/ORDO/Orphanet_90291   D012595  Q5340515             \n",
       "3807  None                                       None     Q2844603             \n",
       "3809  http://www.orpha.net/ORDO/Orphanet_683     D013494  Q945930              \n",
       "3810  http://www.orpha.net/ORDO/Orphanet_282     D057180  Q18592               \n",
       "3812  http://www.orpha.net/ORDO/Orphanet_2382    None     Q1544884             \n",
       "3817  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3824  http://www.orpha.net/ORDO/Orphanet_2032    D054990  Q2290446             \n",
       "3844  None                                       None     Q1077603             \n",
       "3847  http://www.orpha.net/ORDO/Orphanet_213500  D010051  Q172341              \n",
       "3854  http://www.orpha.net/ORDO/Orphanet_520     D015473  Q612108              \n",
       "3856  http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "3857  None                                       D005211  Q719656              \n",
       "3867  None                                       None     Q18556189            \n",
       "3880  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3886  http://www.orpha.net/ORDO/Orphanet_586     D003550  Q178194              \n",
       "3889  None                                       D006816  Q190564              \n",
       "3892  None                                       D015451  Q1088156             \n",
       "3899  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3900  http://www.orpha.net/ORDO/Orphanet_791     D012174  Q847057              \n",
       "3920  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3923  http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "3927  http://www.orpha.net/ORDO/Orphanet_98896   D020388  Q1648484             \n",
       "3928  http://www.orpha.net/ORDO/Orphanet_199323  D009877  Q1294912             \n",
       "3936  http://www.orpha.net/ORDO/Orphanet_963     D000172  Q189580              \n",
       "3940  http://www.orpha.net/ORDO/Orphanet_70567   D018281  Q124292              \n",
       "3947  None                                       D005621  Q913856              \n",
       "3948  http://www.orpha.net/ORDO/Orphanet_506     D007888  Q1815019             \n",
       "3949  http://www.orpha.net/ORDO/Orphanet_778     D015518  Q917357              \n",
       "3957  None                                       D010392  Q1483214             \n",
       "3959  None                                       D015451  Q1088156             \n",
       "3960  http://www.orpha.net/ORDO/Orphanet_35687   D031249  Q1349259             \n",
       "3965  http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "3966  None                                       D015451  Q1088156             \n",
       "3967  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3975  http://www.orpha.net/ORDO/Orphanet_213500  D010051  Q172341              \n",
       "3979  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3981  http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "3985  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3995  None                                       D000163  Q12199               \n",
       "3996  None                                       D000163  Q12199               \n",
       "3997  None                                       D000163  Q12199               \n",
       "3998  None                                       D006527  Q117121              \n",
       "4002  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "\n",
       "     indication_qid_ordo indication_qid_mesh  \n",
       "4     Q221472             Q221472             \n",
       "16    None                Q917357             \n",
       "17    None                Q467635             \n",
       "18    None                Q5340515            \n",
       "30    Q861645             Q861645             \n",
       "40    None                Q524353             \n",
       "57    NaN                 Q18555243           \n",
       "58    None                Q467635             \n",
       "65    None                Q264118             \n",
       "70    None                None                \n",
       "74    None                None                \n",
       "76    Q209369             Q18557991           \n",
       "102   None                Q5340515            \n",
       "103   None                Q264118             \n",
       "129   None                Q2290446            \n",
       "150   NaN                 Q18556612           \n",
       "157   None                Q467635             \n",
       "158   None                Q172341             \n",
       "160   None                Q1148337            \n",
       "182   NaN                 Q12199              \n",
       "184   None                Q1756898            \n",
       "186   Q4731121            NaN                 \n",
       "194   Q2823333            NaN                 \n",
       "195   NaN                 Q212961             \n",
       "197   None                Q917357             \n",
       "208   None                Q535364             \n",
       "212   NaN                 Q190564             \n",
       "214   None                NaN                 \n",
       "230   Q1365309            Q18556612           \n",
       "236   None                Q264118             \n",
       "244   NaN                 NaN                 \n",
       "248   Q945930             Q945930             \n",
       "253   NaN                 NaN                 \n",
       "258   NaN                 Q2666433            \n",
       "259   NaN                 Q7577466            \n",
       "260   NaN                 NaN                 \n",
       "265   None                Q264118             \n",
       "266   NaN                 Q212961             \n",
       "267   None                Q954625             \n",
       "278   None                Q18556554           \n",
       "289   None                Q178194             \n",
       "290   None                Q18555280           \n",
       "311   NaN                 Q1621830            \n",
       "313   NaN                 Q1088156            \n",
       "314   None                Q467635             \n",
       "315   Q221472             Q221472             \n",
       "316   NaN                 NaN                 \n",
       "319   Q221472             Q221472             \n",
       "324   None                Q12204              \n",
       "331   Q861224             Q861224             \n",
       "...       ...                 ...             \n",
       "3779  None                Q264118             \n",
       "3782  NaN                 Q326071             \n",
       "3783  NaN                 Q949694             \n",
       "3786  None                Q2290446            \n",
       "3787  None                Q264118             \n",
       "3789  None                Q1148337            \n",
       "3790  NaN                 Q1783924            \n",
       "3804  None                Q5340515            \n",
       "3807  NaN                 NaN                 \n",
       "3809  Q945930             Q945930             \n",
       "3810  Q18592              None                \n",
       "3812  None                NaN                 \n",
       "3817  None                Q264118             \n",
       "3824  None                Q2290446            \n",
       "3844  NaN                 NaN                 \n",
       "3847  None                Q172341             \n",
       "3854  Q612108             Q612108             \n",
       "3856  None                Q467635             \n",
       "3857  NaN                 Q719656             \n",
       "3867  NaN                 NaN                 \n",
       "3880  None                Q264118             \n",
       "3886  None                Q178194             \n",
       "3889  NaN                 Q190564             \n",
       "3892  NaN                 Q1088156            \n",
       "3899  None                Q264118             \n",
       "3900  Q847057             Q847057             \n",
       "3920  None                Q264118             \n",
       "3923  Q221472             Q221472             \n",
       "3927  None                Q1648484            \n",
       "3928  None                Q1294912            \n",
       "3936  None                Q189580             \n",
       "3940  None                Q18556554           \n",
       "3947  NaN                 Q913856             \n",
       "3948  Q1815019            Q1815019            \n",
       "3949  None                Q917357             \n",
       "3957  NaN                 Q1483214            \n",
       "3959  NaN                 Q1088156            \n",
       "3960  None                Q1349259            \n",
       "3965  None                Q467635             \n",
       "3966  NaN                 Q1088156            \n",
       "3967  None                Q264118             \n",
       "3975  None                Q172341             \n",
       "3979  None                Q264118             \n",
       "3981  None                Q467635             \n",
       "3985  None                Q264118             \n",
       "3995  NaN                 Q12199              \n",
       "3996  NaN                 Q12199              \n",
       "3997  NaN                 Q12199              \n",
       "3998  NaN                 Q117121             \n",
       "4002  None                Q264118             \n",
       "\n",
       "[677 rows x 14 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "good_df=df[df.indication_qid_doid.notnull() & df.drug_qid.notnull()]\n",
    "good_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "677"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(good_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "collapsed": false,
    "deletable": true,
    "editable": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Generic Name           4015\n",
       "Orphan Designation     4015\n",
       "Designation Date       4015\n",
       "Designation Status     4015\n",
       "drug_qid               1753\n",
       "inchi                  323 \n",
       "indication             4015\n",
       "doid                   1490\n",
       "hpo                    902 \n",
       "ordo                   1294\n",
       "mesh                   1735\n",
       "indication_qid_doid    1490\n",
       "indication_qid_ordo    286 \n",
       "indication_qid_mesh    1633\n",
       "dtype: int64"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.count()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
